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Abstract 
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) may serve as tools in 
pharmacology for drug screening and safety evaluations and in future cardiac regenerative 
therapies. However, the use of hPSC-CMs is hampered by their immature foetal-like 
structural and functional characteristics. This project aimed to evaluate two pro-maturation 
stimuli to enhance the maturation of hPSC-CMs: administration of triiodothyronine (T3), a 
hypertrophic stimulus known to be crucial for cardiac development, and overexpression of 
Bin1(-EGFP), which may be implicated in the formation of t-tubules (TTs). T3-signalling may 
be suboptimal during in vitro culture and TTs, a hallmark of mature ventricular 
cardiomyocytes, are absent in hPSC-CMs.   
To investigate the effect of the pro-maturation stimuli initially cardiomyocytes were derived 
from the human embryonic stem cell line Shef3 via spontaneous or directed differentiation 
methods but due to low differentiation efficiency all maturation studies were conducted on 
iCell-CMs, a commercially produced line of human induced pluripotent stem cell-derived 
cardiomyocytes. To assess their initial state of maturity and subsequently to evaluate the 
impact of the pro-maturation stimuli on iCell-CMs the molecular, structural and 
electrophysiological properties of the cells were extensively characterised using qRT-PCR, 
immunostaining, bright field and transmission electron microscopy, micro electrode array and 
the whole-cell patch-clamping technique.  
Characterisation of iCell-CMs revealed an overall immature phenotype: iCell-CMs were 
smaller than adult cardiomyocytes; exhibited relatively low expression of key ion channels 
(Kir2.1 and Kv4.3), major Ca
2+
 handling components (e.g. RyR2, SERCA2a and CSQ2) and 
TT-associated proteins (e.g. Bin1 and caveolin 3); showed poor ultrastructural organisation 
and lacked TTs. However, the sarcoplasmic reticulum (SR) Ca
2+
 contributed to cell 
contraction similarly to adult cardiomyocytes. Administration of T3 increased the expression 
of the hypertrophic marker ANP and enhanced the maturation of iCell-CMs as measured by a 
shift in the expression levels of SERCA2a, Kv4.3 and Cav3.1 closer to the levels of adult 
heart controls. Overexpression of Bin1(-EGFP) increased the expression of CSQ2, Kir2.1 
and Kv4.3 and induced formation of TT-like sarcolemmal invaginations. However, the tubular 
structures were not aligned to myofibrils and may have been connected to the SR at only few 
foci. Localisation of L-type Ca
2+
 channels on the induced tubules could not be definitely 
confirmed but the increased Ca
2+
 current density in transfected cells suggested that the 
channels may have been recruited to the tubules. Also, overall the expression levels of most 
analysed genes in T3-treated or Bin1-EGFP-transfected cells remained markedly below adult 
heart controls including RyR2, CSQ2, Kir.2.1, Kv4.3 and caveolin 3.  
In conclusion, both T3-treatment and overexpression of Bin1(-EGFP) promoted the 
maturation of iCell-CMs to some measure but did not induce a fully adult-like phenotype. 
Thus the ultimate maturation strategy for hPSC-CMs still remains to be found.  
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1.1. Introduction to human pluripotent stem cells:                  
human embryonic and human induced pluripotent stem 
cells                            
Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), 
two pluripotent stem cell types (PSCs), are of great interest in the biomedical field. Both cell 
types can be propagated in culture almost indefinitely and give rise to any cell type in the 
body (except placenta tissue) including cardiomyocytes (Thomson, 1998; Takahashi et al., 
2007). 
Cardiomyocytes derived from hESCs and hiPSCs (hESC-CMs and hiPSC-CMs) are 
advocated as valuable tools for a variety of applications. They could represent in vitro cardiac 
model systems for disease studies, drug discovery and drug safety evaluation and can also 
be used as cell transplants in cardiac regenerative medicine (Harding et al., 2007; Robinton 
and Daley, 2012). However, the use of hESCs and their derivates is ethically controversial 
because the derivation of hESCs from early human ex-utero embryos requires the 
destruction of the embryos. Although new derivation methods allow preservation of the 
embryo integrity (Klimanskaya et al., 2006) many of the well-characterised hESC lines [e.g. 
H1, H7 and H9 (Thomson, 1998)], which are used in stem cell research today, were isolated 
from embryos, which were subsequently destroyed.  
hiPSCs do not pose the ethical issues as hESCs. They are generated by conversion of 
somatic cells into pluripotent cells via the expression of four “stemness” factors Oct4, Sox2, 
cMyc and Klf (Takahashi et al., 2007). Furthermore, the iPSC technology allows the 
generation of disease- and patient-specific hiPSC-CMs, which opens opportunities for 
‘‘personalised’’ regenerative medicine and modelling of cardiac genetic diseases (Robinton 
and Daley, 2012).  
A variety of methods for the in vitro differentiation of hPSCs into functional cardiomyocytes 
has been already established for various stem cell lines. However, compared to adult 
cardiomyocytes both hESC-CMs and hiPSC-CMs show primarily an immature phenotype 
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with regard to their structural and functional features (Snir et al., 2003; Germanguz et al., 
2011). There are concerns that the immaturity of hPSC-CMs may affect their therapeutic 
potential and applications in research and pharmacology. Thus there is a focus in the cardiac 
stem cell research field on thorough characterisation of the structural and electrophysiological 
properties of hPSC-CMs and the development of strategies to promote their maturation.  
1.1.1. Definition of pluripotent stem cells 
Pluripotent stem cells are defined by two features: 1) they are able to proliferate sustainably 
in culture and 2) they are capable of differentiating into cells of all three embryonic germ 
layers (ectoderm, mesoderm and endoderm) except the extra-embryonic trophectoderm 
(gives rise to the placenta) (Thomson, 1998; Evans and Kaufman, 1981; Chambers and 
Smith, 2004). 
PSCs typically express the transcriptional factors OCT4, SOX2 and Nanog, which are 
thought to be the master regulators of pluripotency. They cooperatively activate the 
expression of genes which are necessary to maintain the pluripotent state, and repress 
genes which initiate differentiation. These factors also autoregulate their own promoters 
promoting their own expression and sustaining the pluripotent state (Chambers and Smith, 
2004; Niwa, 2007).  
A functional gold standard to assess the pluripotency of stem cells is to evaluate their 
capacity for teratoma formation in vivo. When injected into immunodefficient mice truly 
pluripotent stem cells usually spontaneously form tumor-like masses containing tissues from 
each of the three germ layers (Przyborski, 2005; Gutierrez-Aranda et al., 2010).  
hESCs and hiPSCs are characterised as pluripotent. In contrast, many of the adult stem cell 
types such as the bone-marrow-derived haemopoietic stem cells and the endogenous cardiac 
stem/progenitor cells are referred to as multipotent. That means they can differentiate into 
multiple but linage restricted cell types.   
Chapter 1: General introduction 
22 
 
 
1.1.2. Characterisation of hESCs 
Embryonic stem cells are isolated from the inner cells mass of early stage embryos 
(blastocysts). The first isolation of mouse ESCs was reported in 1981 (Evans and Kaufman, 
1981; Martin, 1981) and the first isolation of human ESCs from embryos produced by in vitro 
fertilisation almost twenty years later in 1998 (Thomson, 1998).  
Characteristic features of all hESCs include a high nucleus to cytoplasm morphology, high 
level of telomerase activity, which prevents telomere shortening in these highly proliferative 
cells, a high expression of cell surface markers such as the stage-specific embryonic antigen 
SSEA4, the glycoproteins TRa-1-60 and 81, and the transcription factors Oct4, Nanog and 
Sox2 (Thomson, 1998; Reubinoff et al., 2000). However, comparison of various hESC lines 
exhibited that there can be significant variations in the gene expression profiles (Skottman et 
al., 2005) and differentiation propensities between the lines (Osafune et al., 2008; Allegrucci 
and Young, 2007).  
1.1.3. Characterisation of hiPSCs 
In 2006 Takahashi and Yamanaka (Takahashi and Yamanaka, 2006) reported the successful 
generation of the so-called induced pluripotent stem cells (iPSCs) from adult mouse fibroblast 
cells through the ectopic expression of only four transcription factors (“stemness factors”), 
Oct3/4, Sox2, KLf4 and c-Myc. The generated iPSCs display the same key features as 
ESCs: self-renewal and the ability to form cells of all three embryonic germ layers (see 
above). Thus it was shown that it is possible to convert (“reprogramme”) fully differentiated 
somatic cells into pluripotent stem cells by overexpression of stemness genes. Shortly after 
the derivation of mouse iPSCs a similar method was used to generate the first human iPSCs 
(Takahashi et al., 2007).  
Later studies showed that not exclusively the expression of Oct3/4, Sox2, KLf4 and c-Myc but 
also the introduction of alternative combinations using only three or even two transcription 
factors (e.g. Oct4 and Sox2 with addition of the histone deacetylase inhibitor valproic acid) 
can reprogramme somatic cells into PSCs (Huangfu et al., 2008; Ichida et al., 2009).  
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In the first wave of reprogramming experiments iPSCs were generated using retroviruses to 
express the stemness factors. However, the use of retroviruses, which integrate permanently 
into the host genome, would highly limit the use of hiPSCs in clinical application because of 
the risk of insertional mutations and tumour formation due to residual transgene expression 
(Patel and Yang, 2010). Since the first derivation of iPSCs a variety of alternative 
reprogramming methods has been developed, which diminish or even abolish the risk of 
integration. These include the use of non-integrating adenoviral and plasmid vectors, 
excisable transposons and DNA-free approaches such as transfection of somatic cells with 
microRNAs, which are implicated in the control of pluripotency-related genes (Patel and 
Yang, 2010; Miyoshi et al., 2011). 
1.1.4. Comparison of hESCs with hiPSCs  
Comparison of hiPSCs with hESCs reveals similarity in morphology, cell surface marker 
expression and the ability of teratoma formation in vivo (Thomson, 1998). However, studies 
analysing the gene expression or DNA methylation pattern revealed that hiPSCs and hESCs 
lines are similar but not identical since numerous genetic (Chin et al., 2009) and epigenetic 
differences (Lister et al., 2011) could be identified. These differences may partially be 
attributed to aberrant methylation during the reprogramming process and partially to 
incomplete reprogramming. For example, it is reported that iPSCs retain some type of 
somatic (Lister et al., 2011) or epigenetic memory (Kim et al., 2010) displaying residual gene 
expression (Ghosh et al., 2010) or DNA methylation pattern (Kim et al., 2010; Polo et al., 
2010; Lister et al., 2011) characteristic to the cell of origin. This can affect gene expression 
and the differentiation propensity of hiPSCs towards a specific lineage.  
In light of the significant variability between hESCs and hiPSCs as well as between hESC 
and hiPSC lines themselves Bock and colleagues generated genome-wide reference 
“scorecards” to assist researchers to evaluate the quality and to predict the differentiation 
potential of individual hESC and hiPSC lines (Bock et al., 2011).  
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1.1.5. In vitro culture of hPSCs 
The initial and most widely used method to culture hPSCs is the maintenance on mitotically-
arrested feeder layers, typically mouse embryonic fibroblasts (MEFs), in medium containing 
serum or serum-replacement (Thomson, 1998; Reubinoff et al., 2000). MEFs serve as a 
basal layer and promote the survival and undifferentiated growth of hPSCs by secreting 
numerous soluble factors (Diecke et al., 2008; Villa-Diaz et al., 2008). These include 
adhesion molecules, extracellular matrix (ECM) components (e.g. type IV collagen, 
fibronectin and  laminin) and various growth factors such as basic fibroblast growth factor 
(bFGF), transforming growth factor beta 1 and 2 (TGFβ1 and TGFβ2), activins and bone 
morphogenic proteins (BMPs) (Diecke et al., 2008; Villa-Diaz et al., 2008).  
bFGF and members of the TGFβ family such as activin A and TGFβ1 (activate 
TGFβ/NodalActivin signalling) were shown to promote self-renewal and maintenance of the  
pluripotent state of hPSCs (Eiselleova et al., 2009; James et al., 2005; Vallier et al., 2005; 
Beattie et al., 2005). However, members of the TGFβ family have a paradoxical role and can 
maintain the pluripotent state and induce differentiation, respectively (Schuldiner et al., 2000; 
Laflamme et al., 2007). Their action likely depends on certain conditions such as the 
presence and concentration of different interaction partners.  
However, the culture on feeders and the use of animal-derived components such as serum 
and serum-replacement are associated with several disadvantages and would limit the use of 
hPSCs in clinical applications: a) the factors produced by MEFs are not fully defined; b) the 
performance of MEFs vary batch to batch, c) there are difficulties of scaling up and d) there is 
a risk of cross-species pathogen contaminations.   
Some of these limitations have been overcome by the development of new feeder-
independent culture conditions. Xu and colleagues introduced a culture system, in which 
hPSCs are maintained on Matrigel (a gelatinous protein matrix derived from mouse tumour 
cells) in MEF-conditioned medium (containing serum-replacement) (Xu et al., 2001). This 
feeder-free culture method facilitates large-scale production of hPSCs but still requires 
feeders and animal-derived serum-replacement for the production of MEF-conditioned 
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medium. Also, although Matrigel is readily available to use, it is not strictly chemically 
defined, exhibits lot to lot variations and may also introduce xenogeneic contaminations.  
Recently, a number of chemically defined, serum- and xeno-free (feeder-free) media were 
introduced which were shown to support self-renew of hPSCs in conjunction with Matrigel as 
substrate [e.g. mTeSR, NutriStem and StemPro (Ludwig et al., 2006a; Wu et al., 2012; Wang 
et al., 2007)]. These media comprise a bovine albumin source and specific cytokines and 
growth factors such as bFGF, activin A and TGFβ1, which were identified to support 
undifferentiated proliferation of hPSCs in vitro.  
A further step to completely xeno-free and fully defined culture conditions is the recent 
development of alternative synthetic substrates, which show little batch-to-batch variation, 
are defined, stable and were shown to be suitable for prolonged culture of undifferentiated 
hPSCs (Brafman et al., 2010; Mei et al., 2010; Melkoumian et al., 2010). 
1.2. Applications of hPSCs 
1.2.1. Application of pluripotent and adult stem cells in regenerative medicine 
Myocardial infarction (MI; heart attack) and chronic heart disease causing heart failure is 
associated with a severe loss in cardiomyocytes, which the normal regenerative capacity of 
the human heart cannot compensate. Although there is growing evidence that the heart has 
the potential to regenerate itself via endogenous, multipotent cardiac stem/progenitor cells 
(CSCs) (Torella et al., 2007) the regenerative potential of the heart is very limited. A study 
analysing the integration of carbon 14 (generated during nuclear weapon testing in the 
1960s) into the DNA of cardiomyocytes revealed that the normal human heart of a 25 year 
old regenerates at a rate of only 1 % per year (Bergmann et al., 2009). Heart transplantation 
is often the last resort for end stage heart disease patients but is hampered by the severe 
shortage of donor organs (Gepstein, 2002).  
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Recently, cell transplantation (cell-therapy) has been proposed as a potential approach for 
the regeneration of the damaged heart. Due to their self-renew ability and great potential to 
differentiate into cardiomyocytes hESCs and hiPSCs are considered as candidates for 
cardiac cell-therapy. Other candidate cell types are skeletal myoblasts, various bone marrow-
derived adult stem and progenitor cells (BMDCs; haematopoietic and mononuclear cells, 
endothelial progenitor cells and mesenchymal stem cells) and heart-resident CSCs (Segers 
and Lee, 2008). 
An overview about the suitability of the different candidate cell types for cardiac cell-therapy 
and recent experiences of the use of various cell types in animal models and clinical studies 
is given below.      
1.2.2. Bone marrow-derived cells 
Numerous clinical trials have already evaluated the capacity of different BMDC populations 
for cardiac cell-therapy for patients either with acute myocardial infarction or chronic ischemic 
heart disease and gave mixed results. Some studies showed no effect whereas others 
demonstrated that transplantation of BMDCs had a modest beneficial effect on the damaged 
heart as manifested by improvement in tissue perfusion, tissue viability and/or cardiac left 
ventricular function (Abdel-Latif et al., 2007; Janssens, 2010). 
It is widely believed that the beneficial effects of BMDCs on the diseased myocardium are 
predominantly due to paracrine effects rather than direct differentiation of the transplanted 
cells into cardiac myocytes. BMDCs can secrete a variety of growth factors and cytokines, 
which may promote myocyte survival and angiogenesis, decrease the postinfarction 
inflammation and fibrosis and possibly also induce endogenous regeneration by activation of 
CSCs (Gnecchi et al., 2008).  
The cardiomyogenic potential of BMDCs is generally very limited in vivo (Badorff et al., 2003; 
Murry et al., 2004; Segers and Lee, 2008). However, a subset of BMDCs such as the 
multipotent MSCs was shown to differentiate into cardiomyocytes under specific conditions in 
vitro and in vivo (Caplan and Dennis, 2006).  
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1.2.3. Heart-resident cardiac stem/progenitor cells 
Heart-resident CSCs can differentiate into cardiomyocytes and other cell types found in the 
myocardium including endothelial and vascular smooth muscle cells but do not form 
teratomas in immunodefficient mice (Chong et al., 2011; Bollini et al., 2011). Various pools of 
CSCs have been identified in the adult heart and classified based on their properties and 
stem cell surface marker expression: e.g. c-kit+, Sca-1+, Islet 1+ and SSEA-1+ and 
cardiospheres (Bollini et al., 2011). Cardiospheres are clusters, which arise spontaneously 
from in vitro cultures of biopsied heart tissue and contain proliferative cardiac stem cells 
expressing stem and endothelial progenitor markers (e.g. c-kit, Sca-1 CD31, and CD34) 
(Messina et al., 2004; Bollini et al., 2011). 
Therapeutic approaches using CSCs for cell-therapy focus either on transplantation of 
autologous CSCs, which were isolated from patient-specific biopsies and expanded ex vivo 
beforehand or in situ stimulation of heart resident CSCs via growth factor administration or 
paracrine factors secreted by CSC-transplants.  
Initial two-year results of a pioneering clinical trial with autologous CSCs (c-kit+ CSCs) are 
encouraging [Cardiac Stem cell Infusion in Patients with Ischemic Cardiomyopathy (SCIPIO); 
(Bolli et al., 2011)]. The administration of autologous CSCs to patients with LV dysfunction 
caused by MI resulted in substantial and sustained improvement of LV function which was 
accompanied by a reduction in infarct size and an increase in LV viable mass (Bolli et al., 
2011; Chugh et al., 2012). However, because only a relatively low number of CSCs were 
administrated, the beneficial effects on the myocardium are probably associated with indirect 
paracrine effects of the CSCs, which may promote survival and recovery of resident cardiac 
cells, rather than direct participation of the injected CSCs to the production of myocytes 
(Ellison et al., 2011; Ellison et al., 2012). 
Furthermore, pre-clinical studies focusing on stimulation of endogenous CSC proliferation in 
situ revealed that the intracoronary injection of allogeneic CSCs into pigs after myocardial 
infarction (a clinically relevant MI model) lead to a significant activation of endogenous CSCs 
via paracrine stimulation This resulted in enhanced myocardial cell survival, increased new 
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cardiomyocyte and capillary formation and improved cardiac function (Ellison et al., 2012). 
These results are promising and demonstrate feasibility and safety of CSCs cell-therapy for 
the diseased heart.  
In addition, it was shown in the pig model that endogeneous CSCs can also be stimulated by 
paracrine growth factors such as insulin-like growth factor (IGF-1) and hepatocyte growth 
factor (HGF) (Ellison et al., 2011). These growth factors are known to be secreted by 
transplanted cells and to be involved in their regenerative paracrine effect. However, the 
newly formed myocytes after growth factor administration show slow and heterogeneous 
maturation so that despite the regeneration of the cardiomyocyte numbers there is no 
prominent increase in cardiac function. 
1.2.4. hESCs 
hESCs can be expanded in vitro and a have great potential to differentiate into 
cardiomyocytes. A variety of differentiation methods to generate hESC-CMs in vitro is 
described in the following section (see section 1.3.2.). 
So far, the potential of hESC-CMs as therapeutic cell transplants has been evaluated in 
different studies using mainly rodent models of myocardial infarction. Most of these studies 
revealed that transplanted hESC-CMs can survive for at least three months in infarcted 
hearts and can significantly improve cardiac function and structure at least in the short-term 
(Laflamme et al., 2007; van Laake et al., 2007; Cai et al., 2007; Caspi et al., 2007a; Singla et 
al., 2007). However, whether the reconstitutive effects of transplanted hESC-CMs are 
associated with direct contribution of the engrafted hESC-CMs to heart contractility is not 
completely clear. On the one hand it was observed that hESC-CMs engrafted in the injured 
heart of mice couple predominately with each other rather than with the host tissue and are 
isolated from the host myocardium by fibrotic tissue, which could impair electrophysiological 
coupling (van Laake et al., 2007; van Laake et al., 2010). Furthermore, studies by van Laake 
and colleagues showed that no significant difference could be observed between hESC-CMs 
transplant and control groups in the long-term in models of acute myocardial infarction (van 
Laake et al., 2007; van Laake et al., 2008). Thus the investigators concluded that the short-
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term beneficial effects of hESC-CMs may be driven by a paracrine mechanism. On the other 
hand several studies provided evidence for electromechanical integration of the grafted 
hESC-CMs by demonstrating gap junction formation between the transplanted cells and the 
host myocardium (Caspi et al., 2007a; Kehat et al., 2004). Direct evidence for 
electromechanical coupling was provided recently by Shiba et al., who generated hESC-CMs 
which stably express a fluorescent calcium sensor (Shiba et al., 2012). By monitoring 
epicardial fluorescent transients in vivo the research group demonstrated that hESC-CMs 
engrafted into injured myocardium of immunosuppressed guinea pigs, which show a slower 
heart rate than mice and rats [200–250 beats per minute (bpm)], could not only beat 
synchronically with the host tissue but also protect it from induced arrhythmias. However, the 
authors noted that graft integration into the host tissue was incomplete and needs to be 
improved. The poor graft integration may be due to biological differences between the 
species. The heart rate of guinea pigs (200-250 bpm) is still approximately two to four times 
higher than the spontaneous beating rate of hESC-CMs (50-150 bpm).    
Human clinical trials with hESC-CMs for myocardial cell-therapy are hampered by various 
issues. Apart from the ethical debate these include the risk of teratomas formation by 
undifferentiated hESCs and the need for life-long immunosuppression to prevent graft 
rejection by the host immune system. However, advances have been made to develop 
strategies for hESC-CMs purification [e.g. Percoll gradient separation (Xu et al., 2002) and 
genetic selection of hESC-CMs (Huber et al., 2007)] to avoid teratomas formation and 
immune rejection may be avoided by the generation of HLA(human leukocyte antigen)-
matched hESC-lines.     
1.2.5. hiPSCs  
hiPSCs are generally similar to hESCs. They can be expanded and differentiated into 
cardiomyocytes in vitro. Also, comparison of hESC-CMs and hiPSC-CMs showed that these 
cells are overall similar in their structural and functional properties (see section 1.5.1.).  
The use of hiPSCs provides several advantages over hESCs (Alcon et al., 2012). hiPSCs are 
devoid of the ethical issues of hESCs since they can be derived for example from skin 
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biopsies, which are easily obtainable; patient-specific autologous hiPSCs can be produced,  
which could be immune-tolerated. However, the immunogenicity of autologous hiPSCs-CMs 
should be evaluated before implantation because it was reported that even autologous 
hiPSC-derivates can provoke an immune response (Zhao et al., 2011). Also, it has to be 
considered that autologous cells may show the same genetic abnormalities (e.g. genetic 
arrhythmia) as the donor patient thus autologous cells may not always be suitable for cell-
therapy. Furthermore, it was reported that some hiPSC lines can display genetic and 
epigenetic differences compared to hESCs (see section 1.1.4.) and it is not known so far how 
this may affect the function of cardiomyocytes derived from these cells. Also, for both hESCs 
and hiPSCs there are concerns about the immaturity of their cardiac derivates, which 
generally show foetal-like structural and functional properties.  
1.2.6. The use of hPSCs in drug development and disease modelling 
For drug screening and cardiotoxicity assays the pharmaceutical industry currently relies 
mainly on animal primary cardiac cells, whole animal models and immortalised human cell 
lines, which for example overexpress specific ion channels [e.g. CHO overexpressing HERG 
(Meyer et al., 2004)] (Rajamohan et al., 2012). The use of human primary cardiac tissue for 
drug development is problematic because the access to healthy or disease-specific cardiac 
material is limited and primary cardiomyocytes are not expandable, structurally and 
functionally not stable in long-term cultures (more than 48 h) and their genetic manipulation is 
inefficient (Harding et al., 2007). However, the use of immortal cell lines and animal models 
bears several disadvantages. These models cannot always accurately predict the efficacy 
and toxicity of a compound on the human heart because they cannot fully represent the 
complex human biology and there are substantial differences in gene expression and 
physiology between animals and humans [e.g. heart rate in mouse approximately 500 bpm 
versus 60 in human] (Rajamohan et al., 2012). 
In the past years various drugs including the anti-inflammatory drug Vioxx and the anti-
cancer drug doxorubicin had to be withdrawn from the market due to side effects on the 
human heart, which were not detected in animal models (Zeevi-Levin et al., 2012). Besides 
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being a health risk for patients the withdrawn drugs are also associated with a substantial 
financial loss for the pharmaceutical companies since the costs for the development of a drug 
(over an average period of 13 years) can reach 900 million US dollars (Kola and Landis, 
2004). The pharmaceutical industry and the cardiac field in general needs new cardiac 
(disease) model systems, which are relevant to the human phenotype, and can reliably 
predict compound effectiveness and cardiotoxic side effects.   
hPSCs can be expanded almost indefinitely and differentiated into cardiomyocytes with 
structural and functional characteristics of their adult counterparts. The potential of hPSC-
CMs to serve as in vitro (disease) model systems for drug screening and cardiotoxicity 
assays is currently investigated in detail. 
The response of hPSC-CMs to pharmacological agents has been already validated for 
several drugs, the effect of which is known in humans (Rajamohan et al., 2012). The results 
are promising revealing that for a variety of tested compounds (e.g. antiarrhythmic agent 
quinidine and arrhythmias-associated cisapride) the drug response of hPSC-CMs showed 
good association with clinically observed results (Braam et al., 2010; Zeevi-Levin et al., 2012; 
Liang et al., 2013). Many reports have also demonstrated that hPSC-CMs show iontropic 
responsiveness to β-adrenergic stimulation (e.g. with isoproteronol) (Kehat et al., 2001; Xu et 
al., 2002; Yokoo et al., 2009; Germanguz et al., 2011).  
Also, several studies have already demonstrated the use of hiPSC-CMs as cardiac disease 
models (Moretti et al., 2010; Itzhaki et al., 2011b; Carvajal-Vergara et al., 2010; Sun et al., 
2012; Lan et al., 2013). For example various research groups generated hiPSC-CMs derived 
from patients with long QT and LEOPARD syndrome (an acronym formed from its main 
characteristics: lentigines, electrocardiographic abnormalities, ocular hypertelorism, 
pulmonary valve stenosis, abnormal genitalia, retardation of growth and deafness) and 
showed that these in vitro models could recapitulate the major disease phenotype such as 
prolonged action potential duration and cardiomyocyte hypertrophy, respectively (Moretti et 
al., 2010; Itzhaki et al., 2011b; Carvajal-Vergara et al., 2010). In addition, these studies 
elucidated, which signalling pathways may be implicated in the disease phenotype, or 
identified compounds, which could aggravate or ameliorate the condition.  
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The findings of the studies using hPSC-CMs for disease modelling and drug screening are 
encouraging. However, the use of hPSC-based models for drug discovery and safety 
evaluation by the pharmaceutical industry still faces various challenges. These include the 
generally immature phenotype of hPSC-CMs [e.g. low density of IK1 potassium current 
(Jonsson et al., 2012)], which raises concerns whether they can respond to all 
pharmacological compounds in the same way as their adult counterparts; the cost-effective 
scale-up of hPSC-CM production; the integration of hPSC-CMs into automated high 
throughput analysis platforms (Zeevi-Levin et al., 2012). 
1.3. Differentiation of hPSCs to cardiomyocytes 
1.3.1. Molecular specification during hPSC cardiomyocyte differentiation  
hPSC differentiation is thought to recapitulate embryonic development therefore many of the 
developed cardiac differentiation protocols are based on our knowledge of molecular 
mechanisms, which govern the formation of the three germ layers during gastrulation and 
further cardiogenesis in the developing embryo (Murry and Keller, 2008). Similar to 
processes during embryonic cardiogenesis hPSCs are thought to differentiate into 
cardiomyocytes by sequential transition over several progenitor cell stages in four major 
steps (Fig. 1.1): 1) mesoderm formation; 2) mesoderm specification; 3) cardiac specification; 
and 4) cardiomyocyte formation (Burridge et al., 2012).   
In various studies with chick, amphibian and mouse embryos a number of signalling 
pathways and factors, which drive cardiogenesis in vivo, have been identified. The induction 
of mesoderm (step 1) seems to be cooperatively regulated by members of the TGF-β 
superfamily such as bone morphogenetic protein 4 (BMP4) and Nodal/actinin A, 
wingless/Int(Wnt)/β-catenin proteins and fibroblast growth factors (FGF) (Gadue et al., 2006; 
Lindsley et al., 2006; Naito et al., 2006). In vivo, all of these factors and their inhibitors are 
secreted by the endoderm layer and their expression is temporarily and spatially tightly 
regulated. Mesoderm formation is characterised by the downregulation of
      
Fig.  1.1. Diagram of cardiac differentiation of hPSCs via sequential progenitor stages. 
Immature cardiomyocytes are formed from hPSCs in four sequential steps: 1) mesoderm formation; 2) mesoderm specification; 3) cardiac 
specification; 4) cardiomyocyte formation. Some of the identified signalling pathways, which mediate the transition of hPSCs through the major 
progenitor stages (mesoderm, cardiac mesoderm and cardiac progenitor) towards immature cardiomyocytes, are displayed. Also shown are 
markers associated with each of the cell types of the differentiation process. Adapted from Vidarsson and co-workers (Vidarsson et al., 2010).
 pluripotent markers such as Oct4, nanog and Sox2 and induced expression of mesodermal 
markers such as Brachyury and MXL1.  
Once mesoderm is induced stage-specific inhibition of canonical Wnt/β-catenin signalling is 
necessary for specification of cardiac mesoderm (step 2) (Naito et al., 2006). For this step the 
transcription factor Sox17 was reported to be important. Sox17 appears to mediate the 
inactivation of the canonical Wnt/β-catenin pathway by inhibiting β-catenin transcriptional 
function (Liu et al., 2007b). The cells in the cardiac mesodermal stage typically express cell 
surface marker such as the receptor tyrosine kinase KDR, PDGFRA and the transcription 
factor Mesp1, which has been described as a master regulator for cardiac progenitor 
specification (step 3) (Bondue et al., 2008; Murry and Keller, 2008). Mesp1 can promote 
cardiac differentiation via Dkk-1-mediated inhibition of Wnt-signalling and may directly 
activate the expression of cardiovascular transcription factors such as Nkx2-5 and Gata4 by 
binding to their promoter regions (David et al., 2008; Bondue and Blanpain, 2010). 
The committed cardiac progenitors express multiple factors including Nkx2.5, Gata4, Tbx5 
and Mef2. These transcriptional factors play a key role in cardiomyocyte differentiation (step 
4) and can in cooperation with other proteins activate cardiac structural genes such as 
actinin, troponin (cTnT), myosin heavy chain (MHC) and myosin light chain (MLC2v) 
(Sepulveda et al., 2002; Molkentin, 2000).   
1.3.2. Cardiac differentiation methods 
A number of cardiac differentiation approaches have been developed and improved in the 
past decade. The initial and most commonly used strategy to generate cardiomyocytes in 
vitro is the differentiation of hPSCs via embryoid body (EB) formation (Itskovitz-Eldor et al., 
2000). In this method differentiation is induced by culturing hPSCs in suspension in three 
dimensional cell aggregates (termed EBs) with foetal calf serum (FCS). FCS and the 
aggregation process promote the spontaneous differentiation of the cells into all three germ 
layers including cardiomyocytes. Since the EB formation is not cardiac specific the proportion 
of cardiomyocytes within EBs is typically less than 5 % even though the proportion of 
contracting EBs can be high (Harding et al., 2007). 
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Another cardiac differentiation approach comprises the co-culture of hPSCs with endoderm-
like cells, typically a mouse visceral endoderm-like cell line (END-2), which promotes the 
formation of cardiomyocytes presumably by secreting endoderm-like signals (Mummery et 
al., 2003). This method has been reported to yield more than 10 % of cardiomyocyte in a 
differentiated cell population. Addition of ascorbic acid or the small molecular inhibitor of the 
p38 mitogen-activated protein kinase (p38 MAPK) was shown to enhance cardiogenesis 
(Passier et al., 2005; Graichen et al., 2008).  
In order to increase the reproducibility and yield of cardiomyocytes various research groups 
have for example modified the EB-based differentiation method. The recent protocols focus 
on the production of EBs of uniform and defined size (Ng et al., 2005; Ungrin et al., 2008) 
and replacement of FCS with defined medium supplemented with a growth factor cocktail 
containing activin A, BMP4, FGF, Dkk1 and other factors, which were described to guide 
cardiac differentiation in vivo (see above) (Yang et al., 2008).  
Similarly, a serum-free differentiation approach described by Laflamme and colleagues 
(Laflamme et al., 2007) relies on guided cardiac differentiation with growth factors but without 
EB formation. In this method hPSCs are first cultured at high-densities in feeder-free 
conditions on Matrigel and then differentiated into cardiomyocytes by sequential treatment 
with activin A and BMP4. High levels of activin A have been shown to have endoderm and 
mesoderm inducing activity and BMP4 is important for the specification of mesoderm to the 
cardiac-muscle lineage (Kubo et al., 2004). This guided differentiation technique using hPSC 
monolayers is described to be more efficient than the classical EB formation method yielding 
more than 30 % cardiomyocytes (derived from the H7 hESC line).  
The protocol for guided cardiac differentiation on cell monolayers has been recently improved 
by several research groups. For example, differentiation efficiency was shown to be 
enhanced by addition of Wnt (Wnt3a) in an early and the Wnt-inhibitor Dkk1 in a later stage 
of differentiation (Paige et al., 2010). In another approach hPSCs are treated sequentially 
with a combination of growth factors [Activin A, BMP4, and bFGF], which are administrated in 
an extracellular matrix overlay (Matrigel sandwich approach) to support soluble growth factor 
signalling (Zhang et al., 2012). This protocol produces cardiomyocytes at a purity of 40-90 %.  
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1.4. Characterisation of adult cardiomyocytes 
1.4.1. Structural features of adult cardiomyocytes 
The heart is a highly organised tissue and contains various cell types including 
cardiomyocytes (ventricular, atrial and nodal), fibroblasts, endothelial cells and vascular 
smooth muscle cells (Walker and Spinale, 1999). Although, cardiomyocytes represent only 
30-40 % of the total cardiac cells population, they account for 80-90 % of the heart volume. 
The cardiomyocytes are the cells which contract to enable the myocardium to pump blood. 
However, cardiomyocytes located in the heart nodal areas (coordinate heart contraction), the 
atria (pump blood to the ventricles) and ventricles (pump blood to the body) are 
morphologically, molecularly, and functionally distinct. They differ significantly in both their 
electrophysiological and contractile properties. A distinctive feature of nodal myocytes is the 
spontaneous generation of action potentials, which spread through the atria and ventricles 
and lead to contraction of atrial and ventricular cardiomyocytes. Comparison of atrial and 
ventricular muscle showed that ventricular myofibrils generate more active tension than atrial 
myofibrils, whereas atrial muscle contracts and relaxes more quickly (Sprung et al., 2000; 
Piroddi et al., 2007). The later is believed to be related to the difference in expression of 
myosin heavy chain (α- and βMHC) and myosin light chain (atrial and ventricular myosin 
essential light chains, ALC-1 and VLC-1) isoforms, which have an impact on the cross-bridge 
kinetics (Hoh et al., 1978; Piroddi et al., 2007; Morano et al., 1996). A common feature of 
adult nodal, atrial and ventricular cardiomyocytes is that they do not divide. They are 
terminally differentiated and permanently withdrawn from the cell cycle (Torella et al., 2007). 
Structural analysis of cardiac musle cells showed that cardiomyocytes display an elongated, 
rod-shaped morphology and that the bulk of each cell is composed of highly aligned bundles 
of myofibrils (contractile fibres; Fig. 1.2), which are made up of chains of sarcomeres, the 
basic contractile units of striated muscle cells. A sarcomere primarily contains thin and thick 
filaments, which can slide along each other during muscle contraction and relaxation. The 
thin filaments are formed by actins and their associated proteins such as troponins and 
tropomyosin and thick filaments are formed by myosin proteins. The borders of sarcomeres 
Chapter 1: General introduction 
37 
 
 
are confined by the Z-lines, to which the thin and thick filaments are connected (Walker and 
Spinale, 1999). In the light microscope the regions with thin and thick filaments of 
sarcomeres appear as alternating bright (I-band) and dark (A-band) bands, which give the 
cells their banding pattern characteristic for striated muscles.   
Apart from myofibrils the characteristic structural features of cardiomyocytes include a high 
amount of mitochondria, which supply the energy for contraction, the sarcoplasmic reticulum 
(SR) membrane network and a transverse tubule (T-tubule or TT) system.  
The sarcoplasmic reticulum is the main intracellular store for Ca
2+
 ions required for 
contraction. It forms a web-like system around each myofibril and is in close opposition to the 
TT system. TTs are deep invaginations of the cell plasma membrane (sarcolemma), which 
run transversely at the Z-line level of sarcomeres of all myofibrils, but can also have 
longitudinal elements (Brette and Orchard, 2003). TTs can be found mainly in ventricular 
cardiomyocytes being absent or only rudimentarily developed in atrial and nodal 
cardiomyocytes. Together with the SR TTs are central structures for mature excitation-
contraction coupling (ECC) in adult cardiomyocytes. TT invaginations allow uniform 
propagation of action potentials throughout the cell depth and synchronous contraction of all 
myofibrils.  
Another distinctive feature of cardiomyocytes are intercalated discs, the connections between 
adjacent cardiomyocytes. These specialised regions of the sarcolemma comprise fascia 
adherens (anchoring junctions), macula adherens (expanded desmosomes) and gap 
junctions, which together allow mechanical connection and rapid conduction of action 
potentials between myocytes (Walker and Spinale, 1999).  
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Fig.  1.2. Cross section of a cardiomyocyte. 
The image shows bundles of aligned myofibrils, which are composed of arrays of 
sarcomeres, the contractile units within the myocytes. Each myofibril is surrounded by the 
sarcoplasmic reticulum network, the cardiac Ca
2+
 store. Transverse tubules occur at the Z-
lines of each sarcomere. The imaged sarcomeres show the characteristic A-band and I-
bands corresponding to regions containing thick and thin filaments, respectively. The image 
also shows the cell plasma membrane (sarcolemma) and various mitochondria, which are in 
close proximity to myofibrils. Adapted from Katz (Katz, 2001). 
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1.4.2. Excitation-contraction coupling in adult cardiomyocytes 
During a cardiac action potential a small amount of Ca
2+
 enters the cell through voltage-
sensitive L-type Ca
2+
-channels, which occur highly concentrated in the TT membrane, and 
triggers a bulk Ca
2+
 release from the SR via the cardiac ryanodine receptors (RyR2), the SR 
Ca
2+
 release channels. This process, known as calcium-induced calcium release (CICR), 
occurs at functional units termed couplons, where the SR RyR are localised in close 
adjacency (less than 20 nm) to the TT-resident L-type Ca
2+
 channels. The SR Ca
2+
 flooding 
into the cytosol initiates the contraction of myofibrils. For relaxation Ca
2+
 is transported out of 
the cytosol by reuptake of Ca
2+
 into the SR by the cardiac SR Ca
2+
-ATPase pump SERCA2a 
and ejection of Ca
2+
 from the cell by the sodium-calcium exchanger (NCX) and the 
sarcolemmal Ca
2+
-ATPase (Bers, 2002). 
1.4.3. Proteins involved in T-tubule formation and maintenance 
TTs in cardiac cells are dynamic but labile structures. They are absent in neonatal 
cardiomyocytes of smaller mammals but develop rapidly after birth (Ziman et al., 2010; 
Sedarat et al., 2000). TTs decrease progressively, when primary cells are placed in culture, 
and a loss of TTs has also been reported in cardiomyocytes from failing hearts (Brette and 
Orchard, 2003; Ibrahim et al., 2011).  
The mechanisms responsible for TT formation are widely unknown. However, it is assumed 
that TTs form initially at the cell edge as invaginations of the sarcolemma and then penetrate 
inward. Various proteins have been implicated in TT formation or their structural organisation. 
Caveolin 3 is a muscle-specific member of the caveolin family, which are structural proteins 
of caveolae, the specialized lipid rafts in the plasma membrane (Parton et al., 1997). It may 
be involved in the organisation and maintenance of the TT system in cardiomyocytes since 
mice lacking caveolin 3 develop TTs with abnormal morphology (Parton et al., 1997; Carozzi 
et al., 2000; Galbiati et al., 2001).  
The titin-binding protein titin-cap (Tcap; also called telethonin) is described to be part of a 
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stretch-sensing complex at the Z-disc, which can trigger downstream pathways in response 
to mechanical stretch (Knoll et al., 2002). Its role in TT formation in cardiomyocytes has not 
been studied in detail so far. However, a recent study demonstrated that disruption of T-cap 
in zebrafish leads to a muscular dystrophy-like phenotype with impaired TT development 
(Zhang et al., 2009b).  
Junctophilins 2 (JP2), an isoform abundantly expressed in the heart, functions as a structural 
bridging protein between the SR and the plasma membrane, thus ensuring that the 
intracellular and the surface ion channels RyR2 and L-type Ca
2+
 channels are in close 
juxtaposition, which is required for the CICR mechanism in mature cardiomyocytes (Pozzan 
et al., 1994; Takeshima et al., 2000). Loss of JP2 in mice resulted in a significant disruption 
of normal TT structure and impaired CICR causing heart failure (van Oort et al., 2011).  
Finally, the muscle-specific bridging integrator 1 (Bin1; also called M-amphiphysin 2) has 
been shown to induce tubulogenesis in skeletal muscle and was suggested to play an 
important role in induction of TT formation (Lee et al., 2002). 
The muscle-specific Bin1 is a splice variant of the Bin1 protein. Bin1 has a dozen of 
ubiquitous and tissue-specific isoforms, which were implicated in various different cellular 
processes including endocytosis, intracellular trafficking and regulation of cell growth (Elliott 
et al., 1999; Leprince et al., 2003; Ren et al., 2006).  
Structurally, the muscle-specific Bin1 isoform (isoform 8) is similar to other Bin1 splice 
variants and contains several domains (Fig. 1.3): the amino-terminal N-BAR 
(Bin/amphiphysin/Rvs) domain comprising an amphipathic helix, which is thought to initiate 
membrane deformation, and the BAR domain, which forms a banana-like structure and can 
sense and stabilise membrane curvature (Itoh and De Camilli, 2006); a Myc binding domain 
(MBD) (Sakamuro et al., 1996); and a carboxy-terminal Src homology 3 (SH3) domain, which 
can bind numerous proteins including dynamin (David et al., 1996), which is involved in the 
fission of clathrin-coated endocytic vesicles (Kohji Takei et al., 1995). Furthermore, the 
central region of the muscle-specific Bin1 isoform contains a unique phosphoinositide-binding 
domain (PI), which was shown to be important for targeting of Bin1 to the sarcolemma  
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Fig.  1.3. Domain diagram of the muscle-specific Bin1. 
The muscle-specific Bin1 isoform 8 contains an N-terminal amphipathic helix (N) adjacent to 
the BIN1/amphiphysin/Rvs167 (BAR) domain, a phospoinositide-binding (PI) domain, a Myc-
binding domain (MBD) and a Src homology 3 (SH3) domain, which can bind various proteins 
including dynamin. Adapted from Nicot and colleagues (Nicot et al., 2007). 
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 (Lee et al., 2002). In contrast to other Bin1 isoforms it does not contain clathrin-binding sites.  
The muscle-specific Bin1 is highly expressed in striated muscle and is concentrated at TTs 
(Butler et al., 1997; Wechsler-Reya et al., 1997). A common feature of all BAR domain 
containing proteins is their ability to induce membrane curvature (Ren et al., 2006). The 
muscle-specific Bin1 may be involved in the formation or organisation of TT biogenesis. It 
was shown to induce membrane tubule formation in non-muscle and in skeletal muscle cells 
(Takei et al., 1999; Farsad et al., 2001; Razzaq et al., 2001). Also, disruption of the  Bin1 
gene in Drosophila results in a severely disorganised TT system (Razzaq et al., 2001).  
Whether Bin1 is involved in TT formation in cardiac cells is not clear yet. However, deletion of 
the Bin1 gene in mice caused severe ventricular cardiomyopathy and was perinatal lethal 
(Muller et al., 2003). Moreover, recently it was shown that Bin1 can interact with microtubule 
and recruit L-type Ca
2+
 channels to TTs (Hong et al., 2010). Collectively these reports 
suggest that Bin1 may play a role in TT biogenesis and localisation of L-type Ca
2+
 channels 
to TTs in cardiomyocytes.  
Henceforth, the muscle-specific isoform of Bin1 (isoform 8) will be referred to as Bin1. 
1.4.4. The role of triiodothyronine in cardiomyocyte maturation in vivo 
Triiodothyronine (T3) is known to have a variety of effects in the cardiovascular system and 
particularly on the development and function of cardiomyocytes (Klein and Ojamaa, 2001; 
Pantos et al., 2008). T3 is the active cellular form of the thyroid hormone. However, the 
thyroid gland initially secrets the pro-hormone tetraiodothyronine (T4) and T3 is generated via 
removal of an iodine residue from T4 by the deiodinase enzymes D1 and D2.  
Many of the actions of T3 in cardiomyocytes (Fig. 1.4) are mediated via the classic genomic 
pathway by binding of T3 to its nuclear-localised receptors, thyroid hormone receptor alpha 
and beta (THRα and THRβ), which then can bind to response elements in T3-targeted 
genes. T3-responsive genes encode various structural and regulatory cardiac proteins 
including α- and βMHC (Morkin, 1993), β-adrenergic receptor and Ca2+ handling proteins 
Chapter 1: General introduction 
43 
 
 
such as SERCA2a and phospholamban (Cernohorsky et al., 1998; Ojamaa et al., 2000).  In 
addition, it was demonstrated that T3 can modulate the expression and performance of a 
number of ion transporters and channels via transcriptional and post-transcriptional 
regulation. These include the plasma-membrane ion transporters Na
+
/K
+
-ATPase and 
Na
+
/Ca
2+
-exchanger (NCX) and the voltage-gated potassium channels such as Kv1.5, Kv4.2 
and Kv4.3 (Ojamaa et al., 1999; Kahaly and Dillmann, 2005). In the absence of T3 the 
unliganded thyroid hormone receptors can repress the expression of genes, which are 
positively regulated by T3 (Klein and Ojamaa, 2001). During early foetal life T3 levels are low 
mainly due to the high expression levels of the enzyme deiodinase 3 (D3; inactivates T3) in 
the placenta and foetal tissue. Thus thyroid hormone receptors in the foetal tissue are mainly 
present in the unliganded state blocking the expression of a number of genes (Pantos et al., 
2008).  
In addition to direct transcriptional regulation via its intracellular receptors T3 can also affect 
cellular function through different non-genomic signalling pathways including mitogen-
activated protein kinases (MAPK) and phosphoinositide 3-kinase (PI3K) signalling cascades 
(Lin et al., 1999; Storey et al., 2002). Also, cytosol-localised TRα seems to play an important 
role in non-genomic signalling pathways. Recently it was demonstrated that T3 can induce 
physiological hypertrophy in cardiomyocytes by activating the PI3K\Akt-mTOR signalling 
pathway through direct interaction of PI3K with cytosolic TRα (Kenessey and Ojamaa, 2006). 
Furthermore T3 was shown to mediate changes in cell geometry promoting a more elongated 
cell form, which involves ERK signalling (Pantos et al., 2007). In contrast to the effects of 
phenylephrine the T3-induced hypertrophic growth is not accompanied by cardiac fibrosis or 
activation of a foetal gene programme (Ziegelhoffer-Mihalovicova et al., 2003).   
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Fig.  1.4. Effect of triiodothyronine on cardiomyocytes. 
Triiodothyronine (T3) exerts both genomic and non-genomic effects on cardiomyocytes. 
Genomic mechanisms involve T3 binding to nuclear T3 receptors, which can bind to T3 
hormone response elements of several cardiac genes and regulate transcription of these 
genes, including Ca
2+
-ATPase (SERCA) and phospholamban in the sarcoplasmic reticulum, 
myosin, β-adrenergic receptors, adenylyl cyclase, guanine-nucleotide–binding proteins, 
Na
+
/Ca
2+
-exchanger, Na
+
/K
+
-ATPase and voltage-gated K
+
-channels. Non-genomic 
mechanisms include direct modulation of membrane ion channels (e.g. Na
+
, K
+
 and Ca
2+
 ion 
channels). Dashed arrows indicate pathways with multiple steps. 
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1.5. Characterisation of human pluripotent stem cell-
derived cardiomyocytes 
1.5.1. Comparison of hESC-CMs and hiPSC-CMs 
Both hESC-CMs and hiPSC-CMs display key cardiac molecular, structural and 
electrophysiological characteristics and show generally similar structural and functional 
features. Also, various studies have demonstrated that they are highly comparable in terms 
of global transcriptional signatures, sarcomeric organisation, electrophysiological 
characteristics and calcium handling properties (Gupta et al., 2010; Gherghiceanu et al., 
2011). Comparison with adult cardiomyocytes showed, however, that the structural and 
functional properties of hPSC-CMs are largely immature resembling a foetal-like stage of 
development but structural and functional maturation during long-term in vitro culture has 
been described (Snir et al., 2003; Sartiani et al., 2007; Lundy et al., 2013).  
When characterising hPSC-CMs, the cells are often categorised according to their time in 
culture in days post induction of differentiation (dpi): early stage (10-40 dpi), intermediate 
stage (41-60 dpi) and late stage (more than 60 dpi) (Földes et al., 2011). However, this 
division is not uniform and different research groups may refer to slightly different time 
periods. Also, comparison of the maturation state of hPSC-CMs is often difficult due to the 
variation in phenotype between the different hESC-CM and hiPSC-CM populations (Boheler 
et al., 2011; Robertson et al., 2013). The heterogeneity of distinct hPSC-CM populations may 
be partially due to intrinsic properties of the original hPSC lines, different differentiation 
methods or different culture conditions.   
1.5.2.  Gene expression profile and structural properties of hPSC-CMs 
Global gene expression analysis showed that from the early stage hPSC-CMs express key 
proteins characteristic for the cardiac phenotype. They express multiple myofilament proteins 
such as α-myosin heavy chain (αMHC), α-actinin and troponin, major calcium handling 
proteins including RyR, SERCA2a and PLN, ion channels including L-type Ca
2+
 channels and 
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other cardiac markers such as GATA4 and atrial natriuretic peptide (ANP). Overall the gene 
expression profile of hPSC-CMs resemble foetal cardiomyocytes (Beqqali et al., 2006; Cao et 
al., 2008). However, various studies demonstrated that the expression levels of many cardiac 
genes [e.g. α-/βMHC, SERCA2a and connexion 43 (Földes et al., 2011; Lundy et al., 2013)] 
approach the adult gene expression levels with further in vitro culture time.  
Similarly, (ultra)structural studies demonstrated a largely immature structural phenotype in 
early stage hPSC-CMs. These cells are typically small and round [5-10 µm in diameter (Snir 
et al., 2003; Gherghiceanu et al., 2011)] and have myofibrils, which  are unaligned, randomly 
distributed within the cell and show a variable degree of sarcomeric organisation (Mummery 
et al., 2003; Snir et al., 2003; Germanguz et al., 2011). However, after prolonged in vitro 
culture the morphology of hPSC-CMs changed from small round cells to larger more 
elongated cells resembling the rod-shaped adult cardiomyocytes. Myofibrillar alignment and 
sarcomeric organisation gradually increased with recognisable A, I and Z-bands in late stage 
hPSC-CMs (Snir et al., 2003; Lundy et al., 2013). Yet TTs could be detected neither in early 
nor in late stage hPSC-CMs (Snir et al., 2003; Lundy et al., 2013).  
1.5.3. Electrophysiological properties of hPSC-CMs 
hPSC-CMs display contractile activity (contract spontaneously and synchronously) and 
cardiac electrophysiological properties with atrial-, ventricular- and pacemaker-like action 
potential (AP) morphologies from early stages (He et al., 2003; Zhang et al., 2009a).  
However, compared to adult cardiomyocyte most AP characteristics in early stage hPSC-
CMs are immature but improve with extended culture period. Late stage hPSC-CMs display 
faster AP upstroke velocity (represents a measure of the depolarisation rate) and their 
relatively positive resting membrane potential becomes more negative (Lundy et al., 2013). 
However, even late stage hPSC-CMs show spontaneous contraction, which is typical for 
embryonic cardiomyocytes but is normally not found in adult atrial or ventricular 
cardiomyocytes (DeHaan and Gottlieb, 1968; Lundy et al., 2013).   
Furthermore, it was shown that hPSC-CMs express various ion channels such as cardiac-
specific L-type calcium channel Cav1.2 (α1C subunit), the sodium channel Nav1.5, the 
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inward rectifier Kir2.1 [though at very low levels (Otsuji et al., 2010; Jonsson et al., 2012)], 
the transient outward potassium channel Kv4.3, and the delayed rectifier potassium channel 
IKr (HERG) (Satin et al., 2004; Sartiani et al., 2007; Yokoo et al., 2009). 
Also, hPSC-CMs exhibit major ionic currents, though often at relatively small levels, including 
L-type Ca
2+
 current ICa,L (mediated by Cav1.2), which triggers excitation-contraction 
coupling, transient outward potassium currents Ito1 (mediated by Kv4.3), which contributes to 
the repolarisation of AP, inward rectifier potassium current IK1 (encoded by Kir2.1), which 
plays an important role in stabilising cardiac resting membrane potential, and a large sodium 
current INa (Mummery et al., 2003; Satin et al., 2004; Sartiani et al., 2007). 
The density of ICaL, IK1 and Ito1 was shown to increase during in vitro culture (Sartiani et al., 
2007). However, compared to adult cardiomyocytes the amplitude of the IK1 current and the 
expression of Kir2.1 remains very low even at late stage hPSC-CMs (Otsuji et al., 2010).  
1.5.4. Excitation-contraction coupling in hPSC-CMs 
Similar to adult cardiomyocytes hPSC-CMs show Ca
2+
 transients and express L-type Ca
2+
 
channels and key SR proteins such as RyR2 (though usually dramatically lower than in adult 
cardiomyocytes) and SERCA2a (Mummery et al., 2003; Germanguz et al., 2011; Itzhaki et 
al., 2011a). However, at least for hESC-CMs there are conflicting reports in the literature 
about the mechanism of excitation-contraction coupling (ECC) and the development of 
functional SR Ca
2+
 stores due to variable responses of different hESC-CM populations to 
caffeine (induces SR Ca
2+
-release by opening RyR2), ryanodine (inhibits RyR2) and 
thapsigargin (inhibits SERCA2a). Dolnikov and colleagues (Dolnikov et al., 2006) for example 
reported that neither caffeine, nor ryanodine or thapsigargin affected Ca
2+
 transients in 
hESC-CMs (7 or 55 days old) and noted further that the cells did not express calsequestrin, 
the major SR Ca
2+
 binding protein and regulator of RyRs. Thus they concluded that SR 
stores are not functional in hESC-CMs and that contraction did not depend on SR Ca
2+
 
release but largely on transsarcolemmal Ca
2+
 influx. In contrast various other studies 
demonstrated that functional SR stores, which are sensitive to caffeine, ryanodine and 
thapsigargin respectively, can be found in hESC-CMs even at early developmental stages 
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(Liu et al., 2007a; Satin et al., 2008) and that the SR Ca
2+
 release is a major contributor to 
overall intracellular Ca
2+
 transients (Satin et al., 2008; Zhu et al., 2009). A study by Zhu and 
colleagues (Zhu et al., 2009) also showed that Ca
2+
 influx via L-type Ca
2+
 channels was 
necessary for ECC and that SR Ca
2+
 release in hESC-CMs is activated by a tight local 
mechanism similar to mature ventricular cardiomyocytes. Similarly, it was shown for hiPSC-
CMs that functional RyR2- and SERCA2a-mediated SR stores are present in the cells and 
that the whole cell Ca
2+
 transients were dependent on both Ca
2+
 influx via L-type Ca
2+
 
channels and Ca
2+
 release from SR stores (Germanguz et al., 2011; Itzhaki et al., 2011a).  
Overall, the Ca
2+
 handling properties of hPSC-CMs improve during prolonged in vitro culture 
as evident by increased cytosolic Ca
2+
 transients, enhanced transient kinetics and increased 
SR Ca
2+
 content (Liu et al., 2007a; Satin et al., 2008; Lundy et al., 2013). However, the 
absence of a TT system and an underdeveloped SR contribute to non-uniform Ca
2+
 
dynamics (Lieu et al., 2009).  
1.6.  Maturation of hPSC-CMs 
Various reports demonstrated that hPSC-CMs are capable to mature structurally and 
functionally during prolonged in vitro culture (Satin et al., 2008; Sartiani et al., 2007; Lundy et 
al., 2013). However, prolonged cell culture is expensive and can be laborious. Depending on 
the purity of the hPSC-CM population the cells may need regular replating on a fresh matrix 
and excision of overgrowing non-cardiac cells may be necessary. Furthermore, for various 
features hPSC-CMs do not reach the adult phenotype completely even after long culture 
periods. For example, the cell size of elongated late stage hPSC-CMs (25 µm x 10µm) does 
not reach the typical size of human adult cardiomyocytes (20 µm x 120 µm) (Snir et al., 2003; 
del Monte et al., 1995), the cells lack TTs (Snir et al., 2003; Lundy et al., 2013), show 
relatively immature AP characteristics (Robertson et al., 2013) and at least for hESC-CMs the 
expression of Kir2.1 and the corresponding IK1 current was shown to be significantly smaller 
than in adult cardiomyocytes (Otsuji et al., 2010).  
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The inability of hPSC-CMs to reach the same degree of maturity as adult cardiomyocytes 
might have different explanations (Snir et al., 2003): intrinsic genetic properties of the original 
hPSC line; in vitro culturing conditions; lack of in vivo signals for hypertrophic growth; lack of 
hemodynamic workload, which was shown to be important for appropriate cell alignment and 
ultrastructural development (Bishop et al., 1990).  
1.6.1. Strategies to promote hPSC-CM maturation 
In recent years in addition to prolonged in vitro culture various approaches, which apply 
exogenous stimuli, have been evaluated to facilitate cardiac maturation of human or mouse 
PSC-CMs (mPSC-CMs): temporal three-dimensional (3-D) culturing conditions (Otsuji et al., 
2010); administration of T3 [so far reported only for mPSC-CMs; (Lee et al., 2010)];  
mechanical stress (Tulloch et al., 2011; Földes et al., 2011); culture on a structured substrate 
(Rao et al., 2012); forced expression of calsequestrin (Liu et al., 2009); forced expression of 
Kir2.1 (Liao et al., 2013; Lieu et al., 2013). These approaches mimic in vivo physiological 
cues, which are missing during in vitro culture, or apply genetic manipulation to introduce a 
specific factor, which is absent in hPSC-CMs. The impact of some of these pro-maturation 
approaches on hPSC-CMs is described below.  
Regular replating and temporal culturing of hPSC-CMs in suspension in three-dimensional 
aggregates was demonstrated to enhance the maturation of the cells by increasing the 
expression of various genes (e.g. ion αMHC, HERG1b, and HCN1) and enhancing ionic 
channel function (e.g. HERG channels). This approach by Otsuji and colleagues (Otsuji et al., 
2010) showed that cell culturing conditions can influence the maturation process of hPSC-
CMs and implied that suspension culture, which allows free contractility of the cells, can 
promote functional maturation of hPSC-CMs by increasing expression of several genes, 
inhibited during adhesive culturing.  
Administration of T3 during the differentiation of mESCs into cardiomyocytes was shown to 
enhance cardiogenesis and maturation of generated mESC-CMs with regard to 
electrophysiological and Ca
2+
 handling properties (Lee et al., 2010). T3-treatment was shown 
to increase various cardiac genes including Nkx2.5, MLC2v, α-and βMHC and the SR Ca2+ 
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handling proteins SERCA2a and RyR2. The increase in SERCA2a and RyR2 expression was 
accompanied with enhanced Ca
2+
 handling as manifested by higher SR Ca
2+
 content and 
improved Ca
2+
 dynamics (increased cytosolic Ca
2+
 transient and improved Ca
2+
 kinetics). T3-
treated mESC-CMs also showed improved AP characteristics. 
Mechanical stretch of hPSC-CMs was shown to improve sarcomere alignment, enhance the 
expression of contractile proteins and increase cell size (Tulloch et al., 2011; Földes et al., 
2011). Mechanical stretch is known to be a hypertrophic stimulus, which induces hypertrophic 
cell growth and reexpression of a set of foetal genes including ANP and βMHC. This effect is 
similar to the hypertrophic effects of phenylephrine (Frank et al., 2008) and seems to rely on 
active p38-MAPK-signalling (Földes et al., 2011). 
Also, we recently showed that the culture of hiPSC-CMs (iCell cardiomyocytes, iCell-CMs; 
Cellular Dynamics International) in a structured substrate (microgrooved 
polydimethylsiloxane scaffolds) promoted cellular alignment and sarcomeric organisation and 
improved Ca
2+
 cycling properties. This was evident by shorter time to peak Ca
2+
 transient 
amplitudes and a more organised release of Ca
2+
 from SR stores in response to treatment 
with caffeine. However, the changes were not accompanied with increased expression of SR 
calcium handling components or other cardiac genes (Rao et al., 2012). 
Transgenic overexpression of calsequestrin, the Ca
2+
 binding protein and regulator of RyR2 
in the SR, mainly enhanced SR function by increasing SR Ca
2+
 load and improving RyR2-
mediated SR Ca
2+
 release. This resulted in larger Ca
2+
 transients and enhanced Ca
2+
 
transient kinetics. However, it did not alter the expression of other Ca
2+
 handling proteins 
such as RyR2 and Cav1.2, triadin and junctin and did not promote the formation of TTs (Liu 
et al., 2009). 
Forced expression of the inward rectifier potassium channel Kir2.1 in mouse and human 
PSC-CMs enhanced the electrical properties of the cells as evident by a more negative 
resting membrane potential and the appearance of a robust IK1 current (Liao et al., 2013; 
Lieu et al., 2013). 
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In summary, each of the described pro-maturation strategies so far has enhanced the 
maturity of hPSC-CMs. However, usually only a limited set of properties was improved. Also, 
it was not reported that any of the stimuli induced the formation of TTs.     
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1.7. Aims of the study 
This project aimed to explore pro-maturation strategies to facilitate the structural and 
functional maturation of early-stage hESC-CMs and hiPSC-CMs towards an adult phenotype. 
The hypothesis was that the maturation of hPSC-CMs can be enhanced via a) stimulation 
with the thyroid hormone triiodothyronine (T3), which induces hypertrophy and maturation in 
vivo but is suboptimal during in vitro cell culture and b) overexpression of Bin1, which 
potentially induces TT structures, which are absent in hPSC-CMs.   
To test the hypothesis the specific aims were: 
 To derive cardiomyocytes from the Shef3 hESC line by establishing a feeder-free 
culture system and a robust cardiac differentiation protocol for the Shef3 hESCs. This 
to our knowledge has not been reported before.  
 To assess the impact of the pro-maturation strategies on Shef3-CMs and a 
commercially available hiPSC-CM line [iCell-CMs, Cellular Dynamics International, 
(Madison, USA)] by characterising the gene expression profile and the structural and 
electrophysiological properties of non-stimulated and stimulated hPSC-CMs and 
comparison with adult cardiomyocytes. 
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2.1. hESC culture  
Cell culture reagents were purchased from Invitrogen (Paisley, U.K.) unless otherwise 
specified. Cell culture was carried out at 37 °C in a humidified atmosphere containing 5 % 
CO2. 
2.1.1. Feeder-based hESC culture on mouse embryonic fibroblasts  
The hESC line Shef3 (Draper et al., 2004) with normal male karyotype was obtained from the 
UK Stem Cell Bank (UKSCB; South Mimms, U.K.).  
In order to maintain Shef3s in an undifferentiated state hESCs colonies were cultured on 
monolayers of mitotically inactivated mouse embryonic fibroblasts (iMEFs) typically in 6-well 
culture plates in hESC medium (2.5 ml/well), containing knock-out DMEM, 20 % knock-out 
serum-replacement (KO SR), 2 mM GlutaMAX, 10 mM non-essential amino acids and 0.1M 
β-mercaptoethanol, and supplemented with 4 ng/ml basic fibroblast growth factor (bFGF). 
hESCs were fed every other day by complete medium change. Undifferentiated hESC 
colonies were sub-cultured after six to seven days by manually-dissecting individual colonies 
under a dissecting microscope. Cell supernatant was discarded and replaced with fresh 
hESC medium, undifferentiated areas of a hESC colony were dissected into sections 
(approximately 400 µm by 400 µm) via a 10 µm pipette tip and lifted from the feeders 
carefully by scraping with the same tool. Finally, the floating sections were transferred onto a 
fresh iMEF layer (typically at a split ratio of 1:5 or 1:6). Typically, hESCs were not used 
beyond passage 100. Shef3 hESCs were tested for karyotypic abnormalities. For karyotype 
analysis living hESC cultures were sent to The Doctors Laboratory (London, U.K.).   
2.1.1.1. Mouse embryonic fibroblast culture  
Mouse embryonic fibroblasts (MEFs), isolated from mouse embryos of the MF-1 strain at 
13.5 days of gestation (P0), were provided by UKSCB. MEFs were typically cultured and 
expanded up to passage 3 before being mitotically inactivated with mitocycin C (see 2.1.1.2.) 
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to be used as supportive feeder layers in feeder-based hESC culture or for the preparation of 
mouse embryonic fibroblast conditioned medium for the feeder-free hESC culture on Matrigel 
(see 2.1.2.). MEFs were cultivated as a monolayer in T75 or T175 tissue culture flasks pre-
coated with gelatin (0.2 %) and maintained in MEF medium, containing DMEM, 10 % foetal 
calf serum (FCS) and 2 mM GlutaMAX. MEFs were passaged when cells were at 70-80 % 
confluency. The cell supernatant was discarded, the cells were washed once with phosphate 
buffered saline (PBS, without calcium and magnesium) and incubated with the cell 
dissociation enzyme TrypLE Express (3-5 min, at 37 °C; Invitrogen). The flask was tapped 
gently to ensure complete cell detachment and two volume of MEF medium containing FCS 
was added to the flask to inactivate the enzyme. The cell suspension was transferred into a 
sterile tube and pelleted by centrifugation (5 min at 300xg), cell supernatant was removed, 
the cells resuspended in the required volume of fresh MEF medium and aliquoted into new 
pre-gelatinised tissue culture flasks at a split ratio of 1:5.  
2.1.1.2. Mitomycin C inactivation of MEFs 
In order to maintain a defined number of MEFs in feeder-based hESC culture and during the 
preparation of MEF-conditioned medium, MEFs were mitotically arrested using mitomycin C 
at passage 3.  
The cell supernatant was discarded and the cells were incubated for 2 h at 37 °C with MEF 
medium containing mitomycin C (10 µg/ml). After inactivation the cell medium was removed, 
the cells were washed twice with PBS and either used immediately for preparation of MEF-
conditioned medium or cryopreserved and stored in liquid nitrogen for later applications.  
2.1.1.3. Cryopreservation of inactivated MEFs 
Mytomycin C inactivated MEFs were detached from culture vessels using TrypLE Express (3-
5 min, at 37 °C) and pelleted by centrifugation (5 min, 400xg). Cell supernatant was 
removed, the cells were resuspended in 90 % FCS (v/v), containing 10 % dimethyl sulfoxide 
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(v/v), and aliquoted into 1 ml cryovials at a density of 1x10
6
 cells/ml. Finally the vials were 
placed at -80 °C overnight and then transferred into liquid nitrogen for long term storage. 
2.1.1.4. Cell count using a haemocytometer 
In experiments, in which a definite cell number was required, cells were counted using a 
disposable haemocytometer (Labtech International, Ringmer, U.K.). The single cell 
suspension to be counted was well mixed before an aliquot (typically 10 μl-100 μl) was 
removed and mixed with a trypan blue solution (Sigma-Aldrich, Dorset, U.K.) with the dilution 
factor depending on the expected concentration of the cell sample (typically 1:10). 10 μl of 
the cell suspension/trypan blue mix was carefully pipetted into a chamber of the 
haemocytometer and viable cells were counted in 4x 1 mm
2
 squares under a light 
microscope. Viable cells appear phase bright whereas non-viable cells, the membrane of 
which is porous and permeable for the trypan blue stain, appear blue. The total number of 
viable cells per ml was determined by multiplying the average number of viable cells per 1 
mm
2
 by the dilution factor and 1x10
4
. 
2.1.1.5. Plating of MEFs for the feeder-based hESC culture  
In order to prepare feeder layers to support the maintenance of hESC in an undifferentiated 
state iMEFs were seeded in MEF medium into 6-well plates pre-coated with gelatin (0.2 %) at 
a density of 2x10
4
 cells/cm
2
 and incubated overnight at 37 °C for cell attachment. One day 
before passaging of hESCs on the feeders, MEF medium was replaced by hESC medium to 
optimise the attachment of hESC colonies to the feeders.  
2.1.2. Feeder-free hESC culture on Matrigel 
The Shef3 hESC line was cultured on MEFs for more than six passages before being 
transferred to a feeder-free culture on Matrigel. hESCs on Matrigel were cultured either in 
MEF-conditioned medium supplemented with further 8 ng/ml bFGF or mTeSR1 medium 
(Stemcell Technologies, Grenoble, France). mTeSR1 medium was prepared by combining 
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mTeSR1 Basal Medium (400 ml) with mTeSR1 5X Supplement (100 ml) as indicated by the 
manufacturer.  
2.1.2.1. Preparation of MEF-conditioned medium for the feeder-free hESC 
culture 
For the preparation of MEF-conditioned medium MEFs (P0) were expanded up to passage 3 
and mitotically inactivated with mitocycin C (see section 2.1.1.2.). Subsequently, iMEFs were 
attached overnight onto pre-gelatinised (0.2 %) T175 flasks in MEF medium at 80000 
cells/cm
2
. MEF medium was then replaced with hESC medium (114 ml/T175 flask) 
supplemented with 4 ng/ml bFGF and incubated with iMEFs for 24 h (conditioned). The MEF-
conditioned medium was harvested and replaced by fresh hESC medium daily. The iMEFs 
were used for the production of conditioned medium for up to 7 days. The harvested medium 
was vacuum filtered through a 0.2 µm membrane (Stericup filter units; Fisher Scientific, 
Loughborough, U.K.) and stored at -80 °C. 
2.1.2.2. Matrigel specification 
Matrigel (hESC-qualified Matrix; BD Biosciences, Oxford, U.K.) is a solubilised basement 
membrane isolated from the Engelbreth-Holm-Swarm tumour. It polymerizes at room 
temperature (RT) forming a membrane, which is similar to the mammalian cellular basement 
matrix. Its major components are laminin and other extracellular matrix proteins such as 
collagen IV, entactin and heparan sulfate proteoglycan (Kleinman et al., 1986). In addition, it 
was reported to contain growth factors, collagenases, plasminogen activators and other 
undefined components (Vukicevic et al., 1992, McGuire and Seeds, 1989). 
2.1.2.3. Preparation of Matrigel-coated plates 
Matrigel was thawed overnight on ice (1-2 h), aliquoted into lot-specific volumes indicated by 
the manufacturer and stored at -80 °C. An aliquot was thawed on ice (1-2 h) and diluted with 
cold DMEM/F-12 medium [25 ml (Stemcell Technologies)]. Diluted Matrigel was added 
Chapter 2: Materials and methods 
58 
 
 
immediately to 6-well culture plates (1 ml/well) and left to polymerise at RT for at least one 
hour prior to use. Coated plates could be stored at 4 °C up to seven days. If stored at 4°C, 
plates were moved to RT one hour prior to use. Matrigel was removed immediately before 
use and MEF-conditioned medium, mTeSR1 medium, respectively (2-3 ml) was added to the 
6-well plate. 
2.1.2.4. Transfer of hESCs on Matrigel  
Shef3s, cultured on iMEFs for six to seven days, were detached from the feeders by manual 
dissection as described in 2.1.1. and transferred on Matrigel-coated culture plates either into 
MEF-conditioned medium (with 8 ng/ml bFGF) or mTeSR1 medium. 
2.1.2.5. Culture of hESC on Matrigel 
Shef3 cells on Matrigel were fed daily (except of first day after passaging) by complete 
medium change. Undifferentiated colonies were sub-cultured after 6-7 days of growth. For 
cultures grown in MEF-conditioned medium (with 8 ng/ml bFGF) cell medium was removed 
and the cells were incubated for 3-5 min with collagenase IV (200 U/ml, 1 ml/well), which 
mediates the dissociation of the cells from the Matrigel matrix. Next, cells were washed once 
with PBS, coated with MEF-conditioned medium (with 8 ng/ml bFGF) and passaged by 
manual dissection (see 2.1.1.) onto fresh Matrigel plates. Shef3s cultured in mTeSR1 were 
passaged on to fresh Matrigel plates coated with mTeSR1 medium as described above 
except that no enzyme treatment was required.  
2.2. Cardiac differentiation of hESCs 
2.2.1. Differentiation via conventional EB formation 
hESC colonies at 5-6 days of culture on iMEFs in hESC medium or on Matrigel in mTeSR1 
medium were dispersed into small clumps by manually dissecting individual colonies into 
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sections (approximately 800 µm by 800 µm) and uplifting from the culture surface using a 10 
µm pipette tip. Culture medium with the floating cell clumps was then filtered through a 40 µm 
cell strainer (BD Biosciences, Oxford, U.K.) to remove single cells and cell debris, the hESC 
clumps remaining on the filter were transferred to 6-well low adherence plates (Corning, 
Corning, USA) and grown in suspension for four days in standard differentiation medium, 
containing 20 % FCS (γ-irradiated, Australian origin; Biosera, Ringmer, U.K.), 2 mM 
GlutaMAX, 10 mM non-essential amino acids and 0.1M β-mercaptoethanol. During the first 
day in suspension the cell clumps were treated with Y-27632 (Calbiochem, Nottingham, 
U.K.), a selective inhibitor of p-160-Rho-associated coiled-coil kinase (ROCK inhibitor), to 
decrease dissociation-induced apoptosis. After four days of suspension culture the formed 
EBs were plated onto 0.5 % gelatin-coated plates with typically 10-20 EBs/well of a 6-well 
plate. The medium was replaced every day during EB formation in suspension and changed 
every two to three days when EBs were plated on gelatin. Adherent EBs gave rise to beating 
clusters from day six onwards. The numbers of contracting EBs were counted visually using 
a conventional light microscope. 
2.2.2. Differentiation via the non-EB-based activin A/BMP4 method  
Manually dissected hESCs colonies were seeded onto Matrigel-coated surfaces (24-well 
plates) at densities of 200x10
3
 cells/cm
2
 and were cultured for a further six days under 
feeder-free conditions in MEF-conditioned medium (1 ml/well, with 8 ng/ml bFGF) or in 
mTeSR1 medium. In order to obtain accurate cell seeding densities hESC colonies in one or 
two wells to be used for differentiation were trypsinised into single cells and counted. The 
results of the cell count were used to estimate cell number in the other wells, which were 
passaged for differentiation by manual dissection. For induction of differentiation MEF-
conditioned medium was replaced with RPMI-B27 (0.5 ml/well) containing activin A (100 
ng/ml). After 24 h medium was replaced by RPMI-B27 (1 ml/well) containing BMP4 (10 
ng/ml). After four continuous days of culture with BMP4 the medium was replaced by RPMI-
B27 alone (1 ml/well), feeding cells every 2-3 days. Spontaneously contracting hESC-clusters 
were typically observed 12 days after induction of differentiation. 
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2.2.3. Cardiac differentiation of AggreWell-formed EBs 
2.2.3.1. EB formation in AggreWells 
AggreWell plates represent a standardised approach to produce EBs of uniform size and 
shape, which aims to make differentiation experiments involving EB formation more 
reproducible. In this project AggreWell 400 plates were used. These plates contain eight 
wells with silicon wafer based surfaces, which are micropatterned forming approximately 
1200 microwells per well. A microwell is approximately 400 µm in diameter. EB formation 
was performed as described in the AggreWell protocol by Stemcell Technologies. Briefly, 
Shef3 hESCs (previously cultured in mTeSR1) were dissociated with TrypLE Express into 
single cells and 1.2x10
6
 cells and 2.4 x 10
6
 cells were added per well to the AggreWell plate 
(Fig.  2.1) in 2 ml medium in order to generate EBs containing 1000 cells/EB and 2000 
cells/EB, respectively. The AggreWell plates were then centrifuged (100xg for 3 min) to 
distribute the cells in the microwells and cultured for a minimum of 24 h to allow aggregation 
of hESCs and formation of EBs within each microwell. All EBs were formed with ROCK 
inhibitor in serum-free and chemically defined STEMdiff APEL medium (APEL medium; 
albumin, polyvinyl alcohol, essential lipids; Stemcell Technologies) (Ng et al., 2008).  
2.2.3.2. Differentiation of AggreWell-formed EBs with serum 
EBs were formed in AggreWells as described above in APEL medium. For cardiac 
differentiation with serum 24 h or 48 h after formation EBs were harvested from the 
AggreWell plates. EBs were dislodged from AggreWells by firmly pipetting medium in a well 
up and down 2-3 times using a micropipettor with a 1 ml pipette tip. Subsequently the EB 
suspension was filtered through a 40 µm cell strainer (BD Biosciences) and the aggregates 
remaining on the filter were washed five times with PBS. Finally the EBs were placed into 6-
well low adherence plates (Corning) in standard differentiation medium and differentiated as 
described for conventional EB formation in section 2.2.1.   
 
Chapter 2: Materials and methods 
61 
 
 
 
Fig.  2.1. EB formation in microwells of an AggreWell 400 plate. 
A single cell suspension of Shef3 hESCs was seeded into an AggreWell plate in serum-free 
APEL medium supplemented with ROCK inhibitor and centrifuged for 3 min at 100xg to 
capture the cells in the microwells. Scale bar 800 µm. 
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2.2.3.3. Growth factor-directed cardiac differentiation of AggreWell-formed 
EBs in APEL medium 
In this differentiation experiment serum-free APEL medium supplemented with combinations 
of growth factors was used to direct the differentiation of AggreWell-formed EBs to 
cardiomyocytes. Shef3 hESCs used for EB formation were previously cultured on Matrigel in 
mTeSR1 medium. Differentiation was performed as described in the protocol published by 
Stemcell Technologies (Stemcell Technologies, 2012b) and based on the report by Yang and 
colleagues (Yang et al., 2008). The entire differentiation procedure of 16 days was 
accomplished in the AggreWell plates. The differentiation protocol included the following 
steps: 
1) On day 0 EBs of 1000 or 2000 hESCs each were prepared in AggreWell 400 plates 
in APEL medium in the presence of ROCK inhibitor and BMP4 (0.5 ng/ml). 
2) On day 1 the medium was replaced with APEL medium with addition of BMP4 (10 
ng/ml), activin A (10 ng/ml) and bFGF (5 ng/ml).  
3) On day 4 the medium was replaced with APEL medium supplemented with VEGF (10 
ng/ml) and Dkk1 (150 ng/ml) and cells were incubated for four days.  
4) On day 8 the medium was changed to APEL medium with addition of VEGF (10 
ng/ml), Dkk1 (150 ng/ml) and bFGF (10 ng/ml).  
5) On day 12 the medium was replaced with fresh APEL medium supplemented with the 
same growth factor combination as on day 8 and cultured without any further medium 
change for additional 4 days.  
The AggreWell plates were monitored daily for the emergence of beating clusters though the 
peak of beating was reported to be on day 16.  
2.2.4. Culture of Shef3-EBs 
Shef3-EBs, which contained spontaneously contracting clusters, were cultured on gelatin-
coated plates in differentiation medium. The medium was changes every other day. Beating 
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clusters were manually microdissected and re-plated on fresh pre-gelatinised plates every 
two weeks to avoid overgrowth by non-cardiac cells. 
2.3. Culture of hiPSC-CMs (iCell-CMs) 
iCell-CMs were purchased from Cellular Dynamics International (CDI; Madison, USA) 
(Cellular Dynamics International, 2012a). These cells are cardiomyocytes terminally 
differentiated from hiPSCs, which in turn were formed presumably from a commercially 
available human foetal lung fibroblast line (correspondence with CDI). iCell-CMs are shipped 
as cryopreserved single-cell suspensions in 1 ml cryogenic vials (approximately 1.5x10
6
 
platable cells). The shipped cells are approximately 30 days old (correspondence with CDI). 
When received, the frozen cryovials with iCell-CMs were transferred immediately into liquid 
nitrogen.  
The culture of iCell-CMs is described in the user’s guide by CDI (Cellular Dynamics 
International, 2012b). As recommended by the guide iCell-CMs were cultured at 37 °C in a 
humidified atmosphere containing 7 % CO2. Briefly, the cryopreserved cells were thawed and 
plated on pre-gelatinised (0.5 %) cell culture plates, typically 1 vial into one 6-well plate, in 
serum-containing iCell-CMs Plating Medium (CDI) and incubated for 48 h at 37 °C. The 
plating medium was then replaced with serum- and antibiotic-free iCell-CMs Maintenance 
Medium (CDI), which was used for further iCell-CM culture. The iCell-CMs Maintenance 
Medium was changed every other day.  
2.4. Isolation and culture of adult rat cardiomyocytes 
2.4.1. Isolation of adult rat cardiomyocytes 
Adult rat ventricular cardiomyocytes were isolated from male Sprague-Dawley rats (8-12 
weeks old) by Dr. Peter O’Gara. Briefly, rats were heparinised (1000 U/kg), killed by cervical 
dislocation and the heart was rapidly removed and immersed in ice-cold Krebs-Henseleit 
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(KH) solution (119 mM NaCl, 4.7 mM KCl, 0.94 mM MgSO4, 1.2 mM KH2PO4, 25 mM 
NaHCO3, 11.5 mM glucose, 1 mM CaCl2; equilibrated to pH 7.4 with 95 % O2/5 % CO2). The 
heart was then perfused with KH solution via the Langendorff perfusion method for 5 min 
after a steady flow was established. A further perfusion step was performed for 5 min with a 
low calcium solution [120 mM NaCl, 5.4 mM KCl, 5 mM MgSO4, 5 mM pyruvate, 20 mM 
glucose, 20 mM taurine, 10 mM HEPES and 5 mM nitrilotriacetic acid (NTA) with a pH of 
6.95 and calcium added to achieve a final concentration of 12-14 mmol/l; equilibrated with 
100 % O2]. The heart was then perfused for 10 min with enzyme solution [composition as low 
calcium solution but without NTA and with addition of 200 µM Ca
2+
, collagenase (1 mg/ml) 
and hyaluronidase (0.6 mg/ml)]. The ventricles were then cut into 5-6 strips and shaken at 35 
°C under 100 % O2 for 5 min with the same enzyme solution as above. Subsequently the 
tissue strips were filtered and incubated once more with the enzyme solution for further 10-30 
min until all tissue was digested. The cell suspension was then centrifuged at 400xg for 1 min 
at RT, the supernatant was discarded and the cell pellet resuspended in the low calcium 
solution but without NTA and with added Ca
2+
 (200 μmol/l) or in M199 culture medium [M199 
DMEM, 1 % P/S (100 U/ml penicillin, 100 μg/ml streptomycin), 0.2 % BSA, 100 mmol/l 
ascorbate, 5 mmol/l creatine, 5 mmol/l taurine and 2 mmol/l carnitine]. 
All chemicals and culture medium components were purchased from Sigma-Aldrich.  
2.4.2. Short-term culture of adult rat cardiomyocytes  
Freshly-isolated adult rat cardiomyocytes were cultured short-term (up to 2 h) on culture 
surfaces pre-coated with laminin (14 mg/ml; Cultrex 3D Culture Matrix Laminin; R&D 
Systems) in M199 culture medium at 37 C ° with 4 % CO2. Typically, approximately 1 million 
cells (a mixture of living and dead cells) were resuspended in 10 ml M199 culture medium in 
a 15 ml tube. The cells were mixed by carefully inverting the tube and 150-200 µl of cell 
suspension per cm
2
 were transferred on laminin-coated culture dishes. The cells were left to 
attach at 37 °C for 1 h, were then washed once with M199 culture medium to remove 
unattached dead cells, covered with fresh M199 culture medium and processed for 
transmission electron microscopy or immunofluorescence studies within 1 h.    
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2.4.3. Coating of cell culture surfaces with laminin 
Cell culture surfaces were coated with laminin (14 mg/m; Cultrex 3D Culture Matrix Laminin; 
R&D Systems) by applying 100 µl of undiluted laminin per cm
2
 on the culture surface, 
removing the laminin after 1 min and leaving the substrate to air dry for 20 min at RT.  
2.5. Real-time quantitative reverse transcription 
polymerase chain reaction 
2.5.1. Principles of standard polymerase chain reaction 
The polymerase chain reaction (PCR) allows amplification of a target sequence in a DNA 
strand in vitro using primers specific for the target region (Avison, 2007). Usually, a PCR 
consists of a series of 20-40 cycles with each cycle typically comprising three discrete 
temperature steps: 
1) Denaturation: The PCR reaction mix is heated to a temperature usually above 90 °C. 
This causes the hydrogen bonds between complementary bases in double-stranded 
DNA to break and results in separation of double-stranded DNA into two single 
strands.  
2) Primer annealing: The temperature is lowered to 40–65 °C to allow primers to bind 
(anneal) to their complementary target sequence. The annealing temperature is 
typically approximately 3-5 °C below the primer melting temperature.  
3) Elongation: The temperature is raised to approximately 72 °C to allow optimal activity 
of the Taq polymerase (a thermostable DNA polymerase enzyme), which binds to the 
primer-template hybrid and begins to replicate the DNA strand. The DNA polymerase 
synthesises a new DNA strand, which is complementary to the DNA template, by 
promoting the binding of complementary deoxyribonucleoside triphosphates (dNTPs) 
to the template in 5' to 3' direction. 
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2.5.1.1. Limitations of standard PCR  
The amplification product of a standard PCR reaction is usually detected in the final phase of 
the PCR process for example by gel electrophoresis. However, the end-point detection 
generally delivers only qualitative but no quantitative data because in the end stage of a PCR 
reaction the DNA amplification does not occur at an exponential rate (as in initial phases) due 
to substrate and reagent limitation and self-annealing of the accumulating product among 
others. 
2.5.2. Principles of real-time quantitative reverse transcription polymerase   
chain reaction 
Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) allows 
continuous detection of the concentration of the generated PCR product during each cycle of  
a PCR run (Avison, 2007). The term “reverse transcription” indicates that the real-time 
quantitative PCR is combined with a reverse transcription step. That is, in order to analyse 
gene expression of tissues the total RNA (messenger RNA and non-coding RNA) is reverse 
transcribed into complementary DNA (cDNA), which is considerably more stable than RNA.   
To quantify an amplified PCR product during qRT-PCR there are generally two approaches:  
 The use of fluorescent dyes such as SYBR Green I and EvaGreen, which can bind to 
double-stranded DNA. The intensity of the dye fluorescence increases proportional to 
the amount of DNA generated during the PCR process.      
 The application of fluorophore-containing DNA probes such as TaqMan probes, 
Molecular Beacons and Scorpion Primers, which are sequence specific. So that the 
fluorescence intensity is proportional to the amount of amplified product with a 
particular sequence.    
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2.5.2.1. Quantification of PCR product via SYBR Green I 
SYBR Green I is the most commonly used reporter dye for double-stranded DNA reported for 
real-time PCR. The dye can bind to the minor groove of the DNA double helix. When 
unbound SYBR Green I displays only little fluorescence. However, its fluorescence increases 
significantly (approximately 1000-fold) upon binding to double-stranded DNA. SYBR Green I 
fluorescence is usually measured in the end of the elongation step of each PCR cycle when 
new DNA strands are synthesised by the DNA polymerase so that double-stranded DNA 
molecules occur (Fig.  2.2). Since with each elongation step the amount of DNA template 
doubles the fluorescence of SYBR Green I also increases approximately twice.   
2.5.2.2. Quantification of PCR product via fluorescent probes  
The probes such as Taq Man employed to monitor the DNA amplification during real-time 
PCR are usually designed to bind to a region of a specific PCR product. The probes also 
usually contain a fluorophore and a quencher. When the target is absent the quencher 
prevents the fluorophore from emitting light. However, when the target sequence becomes 
available and the probe binds to it the fluorophore and the quencher separate, which results 
in increased fluorescence. The intensity of fluorescence increases with each PCR cycle in 
proportion to the increased amount of target DNA sequence, which can bind the fluorescent 
probes.  
Compared to SYBR Green I the probe technology is more specific because it measures only 
the PCR product with a specific sequence whereas SYBR Green I binds any double stranded 
DNA molecules. However, fluorophore-containing probes can be relatively expensive.     
2.5.3. qRT-PCR experiments 
In this project qRT-PCR was performed using SYBR Green I-based amplicon detection 
because this technique was already well established in the laboratory at NIBSC and less 
expensive than the use of fluorophore-containing probes.    
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Fig.  2.2. The use of SYBR Green I in real-time PCR. 
Throughout the elongation step an increasing amount of SYBR Green I molecules bind to the 
newly synthesised double-stranded DNA so that the fluorescent intensity of SYBR Green I 
increases at the end of the elongation step of each cycle. Adapted from Avison (Avison, 
2007).    
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For the analysis of gene expression via qRT-PCR the total RNA of experimental samples 
was isolated (section 2.5.3.1.) and reverse transcribed into cDNA (section 2.5.3.3.). Total 
RNA from human adult and foetal heart tissue was purchased from Agilent (Wokingham, 
U.K.). All gene expression values of experimental samples obtained by qRT-PCR were 
quantified relative to a standard curve, which was prepared for each gene of interest 
including the house keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
Each standard curve was generated from seven gene standards serially diluted 10-fold (gene 
standard preparation in section 2.5.3.5). All results were further normalised to GAPDH 
expression. In addition, the human adult heart control (section 2.5.3.2) was used as calibrator 
thus the normalised gene expression values of experimental samples were divided by the 
normalised corresponding gene expression values of the human adult heart control.  
Also, after each qRT-PCR run a DNA melt-curve analysis was performed to confirm the 
identity of PCR products (because SYBR Green I binds to double-stranded DNA non-
specifically). For the generation of melt-curve profiles the PCR products are heated slowly 
from 72 °C to 95 °C and the fluorescence of SYBR Geen I is measured and ploted as a 
function of temperature. A sharp drop in fluorescence can be observed when the DNA 
reaches its melting point, which is defined as the temperature at which 50 % of the double-
stranded DNA molecules dissociate into single strands and is generally unique for each PCR 
product type. 
2.5.3.1. Isolation of total RNA 
Total RNA from cell samples was isolated using RNeasy Mini Kit from Qiagen (Crawley, 
U.K.) following the protocol in the RNeasy Mini Handbook. The Qiagen technique is based on 
the RNA-selective binding properties of a silica membrane, which is attached to a spin 
column. Briefly, total RNA was isolated by following procedure:    
1) Cells grown in feeder-free conditions on Matrigel were lysed by adding the highly 
denaturing guanidine-thiocyanate-containing RLT buffer directly to the cell-culture 
dish (typically 700 µl/well of 6-well plate). The RLT buffer also inactivates RNases to 
maintain RNA integrity.  
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2) The cell lysate was vortexed and passed 5 times through a 1 ml gauge needle (0.9 
mm) for homogenisation.  
3) The homogenised lysate was mixed with ethanol (70 %) to precipitate the RNA and 
centrifuged through the RNA-binding silica membrane in RNeasy spin columns. The 
column was then washed once by centrifugation with buffer RW1.  
4) The precipitated RNA sample was treated on the column for 15 min at RT with 
DNase I to digest any genomic DNA.  
5) The membrane was washed in a series of washes by centrifugation with the buffers 
RW1 and RPE to remove contaminants and the RNA finally eluted by centrifugation 
with RNase-free water (30 µl). 
All centrifugation steps were performed at 8000xg. All RNA eluates were quantified using a 
NanoDrop spectrophotometer (NanoDrop ND1000; ThermoScientific, NanoDrop products, 
Wilmington, USA) and reverse transcribed into cDNA immediately or transferred to -80 °C for 
long term storage to prevent RNA degradation. 
2.5.3.2. Human adult and foetal heart controls   
Total RNA from human adult heart (1.0 μg/μl) and foetal heart (0.8 μg/μl) tissue were 
obtained from Agilent. Total RNA from human adult heart was derived from a single, 63-year-
old female donor whereas total RNA from human foetal heart was derived from a pool of ten 
female donors at 19 weeks (x4), 20 weeks (x5) and 21 weeks of gestation. No further 
information about the RNA source was available.  
2.5.3.3. cDNA synthesis via RNA reverse transcription 
Total RNA was reverse transcribed into cDNA using the reverse transcriptase derived from 
the Molony Murine Leukaemia Virus (MMLV-RT). All reagents for the reverse transcription 
reaction were purchased from Promega (Madison, USA). For cDNA synthesis up to 1 μg total 
RNA was mixed with 1 μl Oligo (dT)15 primers (0.5 μg/μl), 1 μl random primers (0.5 μg/μl) 
and nuclease free water to a total volume of 12 μl. The mixture was heated for 5 min to 70 °C 
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to melt any secondary structures within the template, then cooled for 5 min on ice and 
combined with the reverse transcription reaction mix to a final volume of 20 µl (see Table 
2.1.).  
The combined reverse transcription reaction mix was incubated for 50 min at 42 °C to 
activate the MMLV-RT enzyme and allow cDNA synthesis before incubating for 15 min at 70 
°C to inactivate the enzyme. cDNA was stored at -20 °C.  
Reagent  Volume (1x) in μl 
Reaction buffer (5x) 4  
dNTP mix (10 mM)  1  
RNAse inhibitor (40 U/μl) 2  
MMLV-RT (200 U/μl) 1  
Table 2.1. Reverse transcription reaction mix for cDNA synthesis. 
2.5.3.4. PCR and qRT-PCR primers  
Forward and reverse oligonucleotide primers complementary to a gene sequence of interest 
were designed online via Roche Universal ProbeLibrary Assay Design Center 
(http://qpcr.probefinder.com/organism.jsp) and chemically synthesised by Integrated DNA 
Technologies (IDT; Leuven, Belgium). The lyophilised IDT primers were reconstituted in 
molecular biology grade water at a stock concentration of 100 μM. All primers used in 
standard PCR were also used in qRT-PCR and are detailed in Table 2.2.  
2.5.3.5. Preparation of gene standards via standard PCR  
The initial undiluted gene standards were generated by standard PCR amplification of gene 
sequences of interest using cDNA of the adult human heart control as template because it 
was assumed that this control sample expressed all relevant cardiac genes of interest. The 
PCR reaction mix was set up by diluting the cDNA of the human adult heart control 1:5 with 
DNase-free water and preparation of a 50 μl PCR mix (see Table 2.3.) including a target- 
specific primer pair (see Table 2.2.). Subsequently the PCR mix was loaded into a PCR 
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Gene Forward primer (5’ 
to 3’) 
Reverse primer (5’ 
to 3’) 
Product 
size (bp) 
T 
(°C) 
GAPDH  gtcagtggtggacctgacct ccctgttgctgtagccaaat 251  60 
MYH6 (αMHC) ctcaagctcatggccactct gcctcctttgcttttaccact 75  61 
MYH7 (βMHC) acaccctgactaaggccaaa tccagggatccttccagat 64  60 
MYL2 (MLC2v) 
 
acatcatcacccacggagaa
g aga 
attggaacatggcctctgga
t gga 
247  
 
62 
TNNT2 (cTnT) 
 
ttcaccaaagatctgctcctcg
ct 
ttattactggtgtggagtggg 
tgtgg 
166  
 
63 
NKX2-5 (Nkx2.5) acctcaacagctccctgactct ataatcgccgccacaaact
ct cc 
155  
 
62 
GATA4 (Gata4) ggaagcccaagaacctgaat gttgctggagttgctggaa 98  61 
NPPA (ANP) caggatggacaggattggag tcctccctggctgttatcttc 77  
 
61 
CACNA1C (Cav1.2) tgacatcgagggagaaaact acattagacttgactgcggc 129 
 
60  
CACNA1 (Cav3.1) tgctcttcaatttgctggtc tcttcccgtttgctgatttc 70  60 
SLC8A1 (NCX1) ggttgggactaacagctgga ccacattcatcgtcgtcatc 84 63 
KCNJ2 (Kir2.1) gtgtccgaggtcaacagctt ggttgtctgggtctcaatgg 60  
 
62 
KCND3 (Kv4.3) cttgtggatgatcccctgtt gctcatcaataaactcgtggt
tc 
67  60 
RYR2 (RyR2) ctgcgccattcctatagtgg agttgaagaccgggaggtg 60  
 
60 
ITPR2 (IP3R2) cctactccaaaactgcacagg gtctgacattgatatccccat
ct 
77  
 
60 
ATP2A2 
(SERCA2a) 
aacgtcggggaagttgtct gaatcaaagcctcgggaa
at 
64  
 
61 
PLN  tgatgatcacagctgccaag tgagcgagtgaggtattgga 147  
 
60 
CASQ2 (CSQ2) 
 
gagtttgatggcgagtttgc ttgctgctgatgatctccac 86  
 
62 
BIN1 (Bin1)  acgggagcaacaccttca gccgcgaaaacagtttactt 63  
 
60 
CAV3 (Cav3) gaggcccagatcgtcaag tcacgtcttcaaaatccacct 106  61 
JPH2 (JP2) ctgaccgtcgcttaccaga cctggcactgcaaaaagac 70  
 
62 
TCAP (Tcap)  
 
ggcagaatggaaggatctga tctcatgtctctgggtgtcct 83  
 
60 
THRA (THRα) 
 
ggctgtgctgctaatgtcaa aggtacgcctcctgactcttc 78  
 
60 
THRB (THRβ) gggcactggtaatttggcta cagaaggaaatcgcagat
cc 
61  
 
60 
DIO3 (D3) caacggacaattgactgaact
t 
cttggtttgaggcgcttg 76 
 
60 
Table 2.2. Primers used in PCR and qRT-PCR. T: primer annealing temperature. 
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thermal cycler (Applied Biosystems 2720 Thermal Cycler; Applied Biosystems, Carlsbad, 
USA). A standard PCR programme was performed, which included the following steps: 
1) Heat activation of the GoTaq Hot Start Polymerase at 94 °C for 2 min. 
2) 40 cycles of denaturation at 94 °C for 45 seconds, primer annealing at 57 °C 
(annealing temperature) and elongation (polymerisation of single-stranded DNA) at 
72 °C for 1 min. 
3) Annealing at 72 °C for 2 min (formation of double-stranded DNA from single-stranded 
products). 
4) Cooling to 4 °C and hold for short term storage of the reaction mix.  
To confirm that the DNA sequence of interest was amplified 20 µl of each PCR sample 
were loaded on an agarose gel and detected via gel electrophoresis (section 2.5.3.6.). If 
the resulting DNA bands showed the expected product size the remaining 30 µl of the 
PCR reaction were purified via the QIAquick PCR Purification Kit (Qiagen; section 
2.5.3.7.). 
Reagent Volume (1x) in μl  
5x Reaction buffer 10  
dNTP mix (10 mM) 2  
MgCl2 (25 mM) 3 
Forward primer (10 μM) 2.5 
Reverse primer  (10 μM) 2.5 
cDNA/H20 mix 1.5 
GoTaq polymerase  0.5 
PCR-grade H20  28 
Total volume 50 μl 
Table 2.3. Reagents for 50 μl standard PCR mix. 
2.5.3.6. Gel Electrophoresis 
2.5.3.6.1. Preparation of agarose gels 
Agarose gels (1.8 %) were prepared by dissolving 0.9 g agarose (UltraPure agarose, 
Invitroge) in 50 ml of 1X Tris borate EDTA buffer (TBE) buffer (see Appendix) and heating the 
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mixture in a microwave for approximately 2 min until all agarose had dissolved. Subsequently 
the agarose solution was cooled and supplemented with 5 μl SYBR SAFE DNA gel stain 
(10000x; Fisher). The mixture was poured into a gel tray and allowed to set.  
2.5.3.6.2. Electrophoresis 
Each cDNA sample was mixed with 6 µl of 3x loading buffer (Promega) and loaded onto an 
agarose gel in an electrophoresis tank filled with 1x TBE buffer. A PCR DNA ladder was also 
added to each gel to allow the identification of PCR products by size. Electrophoresis was 
conducted at 70 V for approximately 45 min. Afterwards the DNA was visualised under UV 
light using a transilluminator. Images were taken using a gel documentation imaging system 
(InGenius LHR; Syngene, San Diego, USA).  
2.5.3.7. Purification of PCR product 
cDNA samples (gene standards) amplified via standard PCR were purified via spin-column 
purification using the QIAquick PCR Purification kit (Qiagen) to remove primers, nucleotides, 
enzymes, mineral oil, salts, and other impurities, which may interfere with downstream qRT-
PCR assays. The purification procedure was carried out as described in the handbook of the 
kit. Briefly, the following steps were performed: 
1) 5 volumes of Buffer PB were added to 1 volume of the PCR sample and mixed. 
Buffer PB contains high-salt concentrations, which are required to bind DNA to the 
silica-based membrane in the QIAquick spin-column. 
2) The sample was transferred into a QIAquick spin-column and centrifuged for 30-60 s 
to bind the cDNA to the silica-based membrane. 
3) The flow-through was discarded and the sample washed by adding 0.75 ml Buffer PE 
to the QIAquick column and centrifuging for 30–60 s. Buffer PE contains ethanol, 
which removes salts from the sample. 
4) The flow-through was discarded and the column centrifuged once more for an 
additional 1 min to remove all residual ethanol from Buffer PE. 
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5) The QIAquick column was placed in a clean 1.5 ml microcentrifuge tube and the 
cDNA was eluted by adding 30 μl DNAse-free H2O (pH 7.0–8.5) to the QIAquick 
membrane and centrifuging the column for 1 min.  
All centrifugation steps were carried out at 17900xg at RT. The purified cDNA samples were 
stored at -20 °C. 
2.5.3.8. qRT-PCR assay 
qRT-PCR reactions were carried out using the SensiMix SYBR No-ROX Kit (Bioline, QT650-
05), which is a 2x mastermix containing SYBR Green I dye, dNTPs, heat-activated Taq DNA 
Polymerase, stabilisers and enhancers. A qRT-PCR reaction was prepared for each gene 
(including the housekeeper GAPDH) in a total volume of 20 μl (Table 2.4.) using 
approximately 150 ng of cDNA of a sample of interest (cell sample or adult and foetal heart 
control) as a template. The samples of interest were run together with the corresponding 
seven gene standard dilutions and a negative control, in which the template cDNA was 
replaced with H2O.  
All qRT-PCR reactions were prepared using the CAS-1200 automated PCR set-up robot 
(Corbett Research/Qiagen, Crawley, U.K.) and carried out on the Rotor-Gene™ 6000 real-
time PCR cycler (Corbett Research/Qiagen). The reaction conditions were as follows: 10 min 
at 95 °C followed by 40 repeated cycles of 5 s at 95 °C, 15 s at 57 °C (primer annealing 
temperature) and 10 s at 72 °C. The fluorescence was acquired at the end of the elongation 
step.  
Reagent  1x  
2x SensiMix SYBR No-ROX 10μl  
dH2O  6 μl  
10μM Forward Primer  1μl  
10μM Reverse Primer  1 μl  
cDNA /dH2O 2 μl  
Total  20 μl  
Table 2.4. Typical qRT-PCR reaction mix. 
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2.6. Immunofluorescence studies 
For immunofluorescence analysis of fixed samples cells were cultured in plastic cell culture 
dishes on sterilised glass cover slips (10–20 mm diameter, grade 0; Agar Scientific, Stansted, 
U.K.). For immunofluorescence imaging of live cells the samples were cultured on glass-
bottom dishes (MatTek Corporation, Ashland, USA).  
Bright field and fluorescence images were captured using an inverted fluorescent microscope 
(Olympus IX71; Olympus, Japan) or a confocal laser microscope (Leica TCS SP2; Leica, 
Vienna, Austria). The contrast and brightness of acquired images were adjusted using the 
software Image J and Imaris x64 7.5.0 (Bitplane, Zurich, Switzerland). 
2.6.1. Immunofluorescence analysis of fixed cell samples  
2.6.1.1. Cell fixation 
Cell culture medium was removed and the cells were washed once with PBS. Subsequently, 
the samples were incubated for 12 min at 37 °C in paraformaldehyde (4 % in PBS; Agar 
Scientific, Stansted, U.K.). After fixation the samples were washed three times with PBS and 
immunolabelled. 
2.6.1.2. Immunostaining of fixed cell samples 
All fixed cell samples were immunolabelled according to the following protocol: 
1) Fixed cell samples were permeabilised and blocked simultaneously for 30 min at RT 
in blocking buffer (PBS, 3 % bovine serum albumin, 0.2 % Triton X-100). 
2) Samples were incubated for 1 h at RT with primary antibodies (Table 2.5.) diluted in 
blocking buffer. Afterwards the cells were rinsed four times for 5 min with blocking 
buffer. 
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3) Cell samples were incubated for 1 h at RT in the dark with a fluorescein-conjugated 
secondary antibody (Table 2.6.) diluted in blocking buffer. Subsequently, the samples 
were rinsed three times at 5 min with blocking buffer and two times in PBS. 
4) Cell nuclei were stained for 1 min at RT with 4',6-diamidino-2-phenylindole (DAPI; 
Invitrogen). Then the cells were washed two times in PBS. 
5) Cell samples grown on glass cover slips were mounted with mounting medium 
(ProLong Gold antifade reagent; Invitrogen) onto a microscope slide, left to air dry at 
RT overnight and then sealed with clear nail varnish.  
Control samples were prepared as described above but without primary antibodies.  
2.6.2. Immunofluorescence analysis of live cells 
2.6.2.1. Cell plasma membrane staining with di-8-ANEPPS 
Di-8-ANNEPS (Invitrogen) is a member of the ANEP (Amino/Naphthyl/Ethenyl Pyridinium) 
class of voltage-sensitive membrane dyes. These dyes respond to alterations of electrical 
potential in their environment by changes in their electronic structure, which alter the 
fluorescence intensity (typically 2-10 % per 100 mV) and the spectral profile of the dyes 
(Loew et al., 1992; Invitrogen, 2006). When bound to phospholipid membranes, di-8-
ANEPPS show excitation and emission maxima of approximately 467 nm and 631 nm, 
respectively.  
The plasma membrane of cardiomyocytes was labelled with Di-8-ANEPPS according to the 
protocol provided by Invitrogen. Briefly, cells were incubated for 15 min at RT in the dark with 
cell culture medium supplemented with di-8-ANEPPS (10 uM) and pluronic F-127 (0.05 %; 
Invitrogen), a polyol which facilitates the solubilisation of water-insoluble dyes. Afterwards, 
the cells were washed once for 30 min with PBS (with Ca
2+ 
and Mg
2+
) to allow time for de-
esterification and then imaged immediately in PBS (with Ca
2+ 
and Mg
2+
) via confocal 
microscopy.  
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Antibody Isotype Host Conc. Working 
dilution 
Manufacturer 
Oct-3/4 
(C-10; sc-5279) 
IgG Mouse 200 µg/ml 1:50 Santa Cruz 
Biotechnology, 
Santa Cruz, 
USA 
SSEA-4 
(MC813; ab16287) 
IgG Mouse 1 mg/ml 1:50 Abcam, 
Cambridge, U.K. 
Tra-1-60 
(ab16288) 
IgM Mouse 2 mg/ml 1:50 Abcam 
α-Actinin 
(EA-53; A7811) 
IgG Mouse Ascites 1:100 Sigma-Aldrich 
Caveolin 3 
(ab30750) 
IgG Rabbit 0.3 mg/ml 1:60 Abcam 
Bin1 
(Clone 99D; B9428) 
IgG Mouse Ascites 1:50 Sigma-Aldrich 
Telethonin  
(G11; sc-25327) 
IgG Mouse 200 µg/ml 1:100 Santa Cruz 
RyR 
(34C; ab2868) 
IgG Mouse 1 mg/ml 1:500 Abcam 
SERCA2a 
(2A7-A1; ab2861) 
IgG Mouse 2.1 mg/ml 1:400 Abcam 
Cav 1.2 
(Cardiac type α1c; 
ACC-013) 
IgG Rabbit 0.8 mg/ml 1:100 Alomone Labs, 
Jerusalem, 
Israel 
Phospholamban 
(A1; A010-14) 
IgG Mouse 1 mg/ml 1:200 Badrilla, Leeds, 
U.K. 
Junctophilin-2 
(C-term; 40-5300)  
IgG Rabbit 0.25 mg/ml 1:125 Invitrogen 
Connexinx 43 
(AB1727) 
IgG Rabbit 0.5 mg/ml 1:50 Millipore 
Myosin heavy chain 
(3-48; NB300-284) 
IgG Mouse Ascites 1:500 Novus 
Biologicals, 
Littleton, USA 
Table 2.5. List of primary antibodies. 
Conc.: stock concentration. 
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Antibody Excitation/ 
Emission maxima 
(nm) 
Host Conc. Working dilution 
Alexa Fluor 488 
anti-mouse IgG 
494/517 goat 2 mg/ml 1:800 
Alexa Fluor 488 
anti-rabbit IgG 
494/517 goat 2 mg/ml 1:800 
Alexa Fluor 594 
anti-mouse IgG 
590/617 goat 2 mg/ml 1:800 
Alexa Fluor 594 
anti-rabbit IgG 
590/617 goat 2 mg/ml 1:800 
Alexa Fluor 594 
anti-rabbit IgM 
590/617 goat 2 mg/ml 1:800 
Alexa Fluor 647 
anti-mouse IgG 
650/668 goat 2 mg/ml 1:800 
Alexa Fluor 647 
anti-rabbit IgG 
650/668 goat 2 mg/ml 1:800 
Alexa Fluor 555 
anti-mouse IgG 
556/573 goat 2 mg/ml 1:800 
Alexa Fluor 555 
anti-rabbit IgG 
556/573 goat 2 mg/ml 1:800 
Table 2.6. List of secondary antibodies. 
All secondary antibodies were purchased from Invitrogen. Conc.: stock concentration.  
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2.6.2.2. Cell plasma membrane staining with a fluorescent wheat germ 
agglutinin conjugate 
Wheat germ agglutinin (WGA) is a lectin, which selectively binds to specific sugar residues, 
such as sialic acid and N-acetylglucosaminyl residues, present in the glycocalyx of cell 
membranes, thus it can be used for labelling of cell plasma membranes in non-permeabilised 
cells (Wright, 1984).  
For staining of cell plasma membranes non-permeabilised cells were rinsed once with Hank’s 
balanced salt solution (HBSS; Invitrogen) and incubated for 10 min at 37 °C with WGA-Alexa 
Fluor 488 (5 µg/ml; Invitrogen) or for 30 min at 37 °C with WGA-Tetramethylrhodamine-
isothiocyanate(TRITC) (100 μg/ml; Sigma-Aldrich) diluted in HBSS. Subsequently, the cells 
were washed three times with HBSS and analysed immediately via fluorescence microscopy. 
WGA-Alexa Fluor 488 displays fluorescence excitation/emission maxima of 496/524 nm and 
WGA-TRITC of 555/580 nm. 
2.6.2.3. Cell plasma membrane staining with CellMask Orange  
CellMask Orange (CMO; Invitrogen) stains plasma membranes in live cells. It shows slower 
internalisation times (45-60 min) compared to WGA conjugates and has fluorescence 
excitation and emission maxima at 554 and 567 nm, respectively. For staining, culture 
medium was removed and samples were incubated with CellMask Orange (2.5 µg/ml) in PBS 
(with Ca
2+
 and Mg
2+
) for 5 min at 37 °C. Samples were then rinsed three times with PBS (with 
Ca
2+ 
and Mg
2+
) and imaged immediately in PBS. 
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2.7. Transmission electron microscopy 
2.7.1. Principle of transmission electron microscopy 
Observation of structures with a microscope is defined by the Abbe diffraction limit. Ernst 
Abbe found in 1873 that light with wavelength λ, travelling in a medium with refractive index n 
and converging to a spot with angle  will make a spot with diameter 
 
The denominator n sin θ is called the numerical aperture (NA) and with modern light 
microscope optics can reach about 1.4, giving an Abbe limit of approximately d=λ/2. Thus, 
taking the example of green light at around 500 nm the Abbe limit would be 250 nm.  This is 
large when compared to most nanostructures in biological cells which have sizes on the 
order of sub-nm. 
In transmission electron microscopy (TEM) a beam of electrons instead of light is used to 
illuminate the specimen. Due to the smaller wavelength [in the order of 0.025 Å (0.0025 nm) 
in a 200 kV TEM] of electrons it is possible to resolve much smaller objects (in the range of 
nanometres) than with a light microscope.  
In a transmission electron microscope (Fig.  2.3) electrons are produced from an electron 
source such as tungsten filament or a lanthanum hexaboride crystal (LaB6), which is heated 
up with current. The emitted electrons are pulled and accelerated into the column, under high 
vacuum, of the microscope by a high voltage at an anode plate. A condenser (a series of 
electromagnetic lenses and apertures) focuses the electrons into a thin beam before they 
pass through the specimen. Depending on the density of the specimen some of the electrons 
are deflected (change in phase) when they pass through the sample. After passing the 
specimen the partially scattered electron beam is focused by objective lenses forming an 
image, which is then expanded by the projector lenses onto a fluorescent screen and can be 
digitally recorded via a CCD camera.  
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Fig.  2.3. Schematic image of a transmission electron microscope. 
Adapted from learning.covcollege.ac.uk.  
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The contrast of TEM images depends principally on the degree of electron deflection (phase 
contrast) caused by the density of the specimen. Image contrast can be enhanced by 
staining of samples with compounds containing electron-dense heavy metals (e.g. osmium, 
lead, uranium or gold), which can absorb or scatter a part of the electron beam. In this study 
the samples were treated with osmium tetroxide (OsO4), uranyl acetate and potassium 
ferrocyanide prior to TEM imaging. Osmium is primarily known as a lipid fixative because 
osmium oxidises unsaturated double-bonds, which are prominent in lipids (Dykstra and 
Reuss, 2003b), but it also stains membranes. Uranyl stains are known to interact with anionic 
components and to bind to phosphate groups in nucleic acids and phospholipids (Dykstra 
and Reuss, 2003a). Uranyl acetate is also used as both a fixative and staining compound. 
Post-fixation of cells in a mixture of OsO4 and potassium ferrocyanide has been shown to 
enhance the staining of membrane structures such as the cell plasma membrane and 
endoplasmic reticulum. The exact mechanism of the staining is not known but the presence 
of ferrocyanide-reduced osmium intermediates seems to be essential (Hayat, 2000).  
2.7.2. Fixation and standard room temperature resin embedding of cell 
suspensions  
2.7.2.1. Trypsinisation of iCell-CMs  
For obtaining cell suspensions iCell-CMs cultured in 6-well plates were treated with 0.25 % 
trypsin-EDTA (Invitrogen) by following procedure: 
1) Culture medium was removed from each well and the cells were washed once with 2 
ml/well PBS.  
2) 1 ml 0.25 % trypsin-EDTA was added to each well and the plate was incubated at 37 
°C for 1-2 min or until cell began to lift off the plate. 
3) 3 ml iCell-CMs Maintenance Medium was added to each well to quench trypsin and 
the medium was pipetted gently up and down 1-2 times to ensure that all cells 
detached from the culture dish.  
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4) The cell suspension was transferred into a 15 ml centrifuge tube and pelleted with a 
desktop centrifuge for 5 min at 180xg. 
5) The supernatant was removed and the cells were resuspended in 1-2 ml iCell-CMs 
Maintenance Medium. 
2.7.2.2. Fixation of cells in suspension 
Cell suspensions of freshly isolated rat adult ventricular cardiomyocytes or iCell-CMs were 
fixed in 2.5 % glutaraldehyde in 0.1 M sodium cacodylate buffer (glut-fixative; see Appendix) 
at 4 °C for 24 h. The fixative was added directly to the cell suspension medium at a ratio of 
1:1. Fixed samples were stored at 4 °C.  
2.7.2.3. Automated sample processing and standard room temperature resin 
embedding 
For resin embedding approximately 1 million cells in suspension were used per sample. 
Before embedding in resin all cell samples were fixed in glut-fixative and embedded in 1.5 % 
low gelling temperature agarose in 0.1 M sodium cacodylate buffer (pH 7.4). For embedding 
in agarose the fixed samples were centrifuged in a 1.5 ml eppendorf tube with 0.5 ml glut-
fixative and 0.5 ml agarose for 5 min at 17900xg. Subsequently, the agarose was allowed to 
set on ice and the agarose-embedded samples were cut into approximately 1 mm cubes. The 
cubes were then loaded into the EM TP automated tissue processor (Leica microsystems, 
Vienna, Austria), where the samples were post-fixed in osmium tetroxide, dehydrated in 
graded ethanol and infiltrated with an epoxy resin based on Epon 812 (TAAB, Aldermaston, 
U.K.). The processing steps performed during automated tissue processing are detailed in 
Table 2.7. Finally, after automated processing the samples were embedded in labelled 
capsules with freshly prepared 100 % resin and polymerised at 60 °C for 48 h.   
  
Chapter 2: Materials and methods 
85 
 
 
 Processing step  
 
Time (min) Temperature (°C) 
 
1 Wash in 0.1 M sodium cacodylate 
buffer  
5  22 
2 Post-fix in 1 % OsO4 and 1 % 
potassium ferrocyonyde in 0.2 M 
sodium cacodylate buffer 
120  
 
22 
3 Rinse in 0.2 M sodium cacodylate 
buffer  
3 times, 5 min 
each 
22 
 
4 1 % tannic acid in 0.2 M sodium 
cacodylate buffer  
60  22 
5 1 % sodium sulphate in 0.2 M 
sodium cacodylate buffer 
5  22 
6 1 % sodium sulphate in 0.2 M 
sodium cacodylate buffer 
10  
 
22 
7 Stain with 2 % aqueous uranyl 
acetate  
180  22 
8 Wash in H2O 5  22 
9 Dehydrate in 70 % ethanol  20  20 
10 Dehydrate in 96 % ethanol  30  20 
11 Dehydrate in 100 % ethanol  2 times, 30 min 
each 
20 
 
12 Dehydrate in propylene oxide  
 
2 times, 30 min each 20 
 
13 Resin infiltration: propylene 
oxide/epoxy resin mixture (1:1) 
180  
 
20 
14 Resin infiltration: propylene 
oxide/epoxy resin mixture (1:2) 
240  25 
15 Resin infiltration: 100 % resin  945  25 
16 Resin infiltration: 100 % resin  945  30 
Table 2.7. Sample processing steps in the EM TP automated tissue processor. 
2.7.3. Fixation and room temperature resin embedding of cell monolayers 
attached to sapphire discs  
2.7.3.1. Plating of cells on sapphire discs 
For TEM analysis of cell monolayers adult rat cardiomyocytes and iCell-CMs were plated on 
clear sapphire discs (3 mm in diameter; Leica) pre-coated with laminin (14 mg/m; Cultrex 3D 
Culture Matrix Laminin; R&D Systems) or gelatin, respectively. Freshly isolated rat 
cardiomyocytes attached to laminin-coated sapphire discs within 1 h and were fixed 
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immediately after attachment in 4 % formaldehyde and 0.05 % gluteraldehyde in 0.2 M 
HEPES (FA-fixative, see Appendix). In contrast, iCell-CMs were cultured on the sapphire 
discs at least for three days before being fixed in FA-fixative.         
2.7.3.2. Manual sample processing and room temperature resin embedding 
Cells plated on sapphire discs and fixed in FA-fixative were further processed and embedded 
in resin manually following a similar protocol as described for automated sample processing 
and standard RT resin embedding (see Table 2.7). Cells were post-fixed in OsO4, dehydrated 
by sequential washes in ethanol and gradually infiltrated with resin (see Table 2.8. for 
details). However, the cells were embedded into the resin block together with the sapphire 
discs with the cell monolayer facing inside the block. A sapphire disc was only removed from 
a sample once the resin has polymerised by brief immersion of the resin block in liquid 
nitrogen and careful lifting of the disc with a razor blade.  
2.7.4. Sectioning of resin blocks 
Cell samples embedded in polymerised resin blocks were cut into ultra-thin sections (with a 
nominal feed of 100 nm at a cutting speed of 10 mm/s) on an UC6 ultramicrotome (Leica, 
U.K.), using an ultra 35 diamond knife with boat (Diatome, Biel/Bienn, Switzerland). Sections 
were floated onto water and stretched with chloroform in order to remove any folds and 
creases prior to collection with a perfect loop (EMS, Germany).  
2.7.5. Immunogold labelling  
For the detection of specific antigens in TEM samples cell sections collected on grids were 
immunogold labelled using the following protocol:  
1) Cell sections on grids were washed three times with PBS (by floating on a PBS drop) 
and incubated with a drop of blocking/permeabilisation buffer (see Appendix) for 20-
30 min.  
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 Processing step  
 
Time  
1 Post-fix in 2 % OsO4 in 0.1M phosphate buffer (pH 
6.8) on ice 
25-30 min 
2 Wash in H2O 3 times, 1 min each 
3 Add 1% thiocarbohydrazide diluted in H2O  5 min 
4 Wash in H2O 3 times, 1 min each 
5 Add a 1:1 mixture of 2 % OsO4 and 3 % potassium 
ferrocyanide  
25 min 
6 Wash in H2O 3 times, 1 min each 
7 Add 0.5 % uranyl acetate in H2O and incubate at 
4°C 
overnight  
8 Wash in H2O 6 times, 1 min each 
9 Dehydrate in 50 % ethanol   10 min 
10 Dehydrate in 60 % ethanol 10 min 
11 Dehydrate in 70 % ethanol   10 min 
12 Dehydrate in 80 % ethanol   10 min 
13 Dehydrate in 90 % ethanol   10 min 
14 Dehydrate in 100 % ethanol 3 times, 10 min each 
15 Resin infiltration: ethanol/epoxy resin mixture (2:1)  2 h 
16 Resin infiltration: ethanol/epoxy resin mixture (1:1)                        overnight
17 Resin infiltration: ethanol/epoxy resin mixture (1:2)  2 h 
18 Resin infiltration: 100 % epoxy resin  5 h 
19 Add 100 % epoxy resin and polymerise at 60 °C  overnight. 
Table 2.8. Manual sample processing and resin embedding steps. 
All steps were performed manually at RT except stated otherwise. 
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2) The samples were incubated for 1 h with a drop of a primary antibody (anti-Bin1 or 
anti-α-actinin, see Table 2.5.) diluted in blocking/permeabilisation buffer (anti-Bin1: 
1:5 and anti-α-actinin: 1:10).  
3) Samples were washed six times with PBS and incubated for 2 h in one drop of a 
secondary antibody, the Fab’ fragment conjugated to 10 nm gold particles (BBI 
International) diluted 1:50.  
4) Cell sections on grids were washed three times with PBS and left to air dry for 15 
min.   
2.7.6. Silver enhancement  
In order to increase the size of gold particles and improve detection of particle signals the 
immunogold labelled samples were enhanced using the Silver Enhancement Kit from BBI 
International (Cardiff, U.K.) following the procedure described in the kit manual:  
1) The samples were washed five times in distilled water. 
2) Three drops of initiator were mixed with three drops of enhancer and one drop of the 
solution was added to the sample. 
3) The reaction was left to develop for 15 min. The progress of the reaction could be 
monitored by placing the sample-containing grids on a microscope slide and 
analysing with a conventional microscope. If reaction is successful, the labelled sites 
will change from invisible to dark brown to black.  
4) The reaction was stopped by washing the samples for 1-2 min in water.      
2.7.7. Analysis via transmission electron microscopy 
All samples were examined in the JEM 2100 transmission electron microscope at 200 kV, 
with magnification ranging from x6000 to x25000. Images were recorded with a Gatan 4kx4k 
Ultrascan CCD camera (Gatan, Pleasanston, USA) and processed using Gatan Digital 
micrograph (GMS2 v2.0).  
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The loading of specimen into the microscope and core alignments were performed by Dr. 
Kirsty MacLellan-Gibson. The examination of the samples was mostly performed under Dr. 
MacLellan-Gibson’s supervision.  
2.8. Microelectrode array recordings  
To investigate the electrophysiological properties of hPSC-CMs their extracellular field 
potential (FP) was recorded using microelectrode arrays (MEAs). Small clusters of 
contracting Shef3-CMs or a cell monolayer of iCell-CMs were plated on pre-gelatinised MEA 
probes (MED64; Alpha Med Scientific, Ibaraki Osaka, Japan) consisting of 64 planar platinum 
black microelectrodes (70 µm in diameter) arranged in an 8 x 8 grid with an inter-electrode 
distance of 150 µm (Fig.  2.4) or 300 µm. Data were recorded at 10 kHz with the software 
MED64 Mobius 0.2.16 (MED64; Alpha Med Scientific). All recordings were made non-
superfused in cell culture medium in a chamber at 37 °C, 5 % CO2 and 60 % humidity.  
2.9. Whole cell patch-clamping measurements 
2.9.1. Basic overview of the patch-clamping technique  
The patch-clamping technique allows low-noise recording of currents flowing through ion 
channels (or even only a single channel) of the plasma membrane (Zhao et al., 2008). The 
principle of the technique used today is that gentle suction of the cell membrane through a 
fine glass pipette can establish a high-resistance seal in the gigaohm range (GΩ) so that ion 
currents can pass only through the pipette but not through the seal. For signal detection the 
pipette is connected to a system of highly-sensitive amplifiers. The configuration most 
commonly used in cell-culture and tissue preparations is the “whole-cell” patch. In this set up 
stronger suction is applied to rupture the patched portion of the cell membrane so that the 
pipette has access to the cell interior. The cell bath and the pipette tube are filled with 
electrolyte solutions, which match the cellular osmolarities. This method allows the 
observation of currents from all ion channels within the cell or separation of specific current  
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Fig.  2.4. MED64 Microelectrode array probe with an inter-electrode distance of 150 µm. 
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types by controlling the intra- and extra-cellular environment of the cell or by utilising specific 
voltage protocols. For example, to measure calcium currents the intracellular potassium can 
be replaced with caesium, which cannot pass through most of the potassium channels. The 
whole-cell patch clamping technique can be performed in two modes: a) the voltage-clamp 
mode, in which the membrane voltage is kept constant and the current can be measured, or 
b) the current-clamp mode, in which the current is controlled and alterations in the membrane 
potential are recorded.          
2.9.2. Measurement of calcium currents  
All whole-cell patch-clamping measurements were carried out by James Cartledge. For the 
measurements iCell-CMs were cultured on glass-bottom MatTek dishes (MatTek) at low 
densities (4.5x10
4
-6.2x10
4
 cell/cm
2
) so that Ca
2+
 current (ICa) and cell capacitance could be 
recorded in single isolated cells. Briefly, ICa (in pico-Amperes, pA) was measured with the 
patch-clamp technique in the whole cell configuration as described previously (Soppa et al., 
2008) using a MultiClamp 700A patch-clamp amplifier (Axon Instruments, Union City, CA, 
USA). The resistance of the borosilicate glass pipette was 2-3 MΩ and the pipette-filling 
solution contained 115 mM caesium aspartate, 20 mM tetraethylammonium chloride, 10 mM 
EGTA, 10 mM HEPES, and 5 mM MgATP, adjusted to pH 7.2. The external solution 
contained 140 mM NaCl, 10mM glucose, 10 mM HEPES, 1 mM CaCl2, 1 mM MgCl2, and 6 
mM CsCl, pH 7.4. Current-voltage (I-V) relationships for ICa were generated using 450-ms 
depolarization steps from a holding potential of -40 mV (range -40 to +40 mV, in 5mV 
increments) at 1 Hz. All experiments were conducted during superfusion with the external 
solution at 37 °C. 
For specific isolation of ICa measurements were repeated in the presence of nitrendipine, a 
dihydropyridine inhibitor of L-type Ca
2+
 channels; the cells were perfused with 0.1 mM 
nitrendipine for 5 min after an initial control recording of ICa had been made in the cells 
without nitrendipine.  
Control of the current and voltage clamp protocols, data acquisition and analysis were 
performed with pClamp 7 software (Axon Instruments). 
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2.9.3. Measurement of cell capacitance 
The cell capacitance (in pico Farads; pF), which is an index for the cell membrane area, was 
determined using a capacitive surge technique (Fenwick et al., 1982). This consists in 
applying hyperpolarising pulses from -40 to -50 mV at approximately 100 Hz and fitting a 
monoexponential curve to the decay phase of the resulting membrane current trace. The 
measurement was performed on-line by the Multiclamp software (Axon Instruments) during 
the electrophysiological experiments. 
2.10. Treatment of cells with triiodothyronine  
To determine the effect of T3 on iCell-CMs the cells were incubated with 3 nM T3 for 48 h. T3 
was added directly to the cell culture medium.   
2.11. Transfection studies 
2.11.1. Bin1-EGFP plasmid information 
The Bin1-EGFP plasmid (1 µg/µl), which encodes the Bin1-EGFP(enhanced green 
fluorescent protein) fusion protein, was kindly donated by Dr Marta Fernandez-Fuente from 
The Royal Veterinary College, London, U.K. This plasmid was constructed by cloning Bin1 
(muscle specific amphiphysin 2) into the backbone vector pEGFP-C1 (Clontech, Mountain 
View, USA; Fig.  2.5).  
pEGFP-C1 codes for EGFP, which is the red shifted variant of wild-type GFP (green 
fluorescent protein) with excitation and emission maxima at 488 nm and 507 nm, respectively 
(Cormack et al., 1996). The pEGFP-C1 vector also contains the immediate early promoter of 
the human cytomegalovirus (PCMV IE), which mediates the expression of EGFP in mammalian 
cells; a Simian Virus 40 polyadenylation signal (SV40 poly A), which ensures the proper 
processing of the 3’ end of the EGFP mRNA; and a multiple cloning site (MCS) between the 
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EGFP and SV40 poly A sequence. The MCS typically contains various restriction sites 
allowing the insertion of a DNA fragment.  
Furthermore, pEGFP-C1 codes for an SV40 origin (SV40 ori) for replication in mammalian 
cells, which express the SV40 T-antigen (e.g. COS-7); a neomycin resisting cassette, which 
is composed of the SV 40 early promoter (PSV40), the kanamycin/neomycin resistance gen 
(Kan/Neo) and polyadenylation signals from the Herpes simplex virus thymidine kinase gene 
(HSV TK poly A) and permits stably transfected eukaryotic cells to be selected with the 
antibiotic G418; a bacterial promoter for the expression of kanamycin resistance in E. coli.; a 
pUC origin of replication (pUC ori) for propagation of the vector in E.coli.; and a f1 origin for 
single-stranded DNA production.    
Bin1 was inserted into the multiple cloning site (MSC) so that Bin1 is expressed as a fusion 
protein to the C-terminus of EGFP. 
2.11.2. Transfection of cells via Lipofectamine  
All transfection experiments were performed using Lipofectamine 2000 transfection reagent 
(Invitrogen). Lipofectamine is a cationic lipid (containing a positively charged head group and 
one or two hydrocarbon chains), which can significantly increase the transfection efficiency of 
nucleic acids (RNA or plasmid DNA) into the cells (Chesnoy and Huang, 2000; Invitrogen, 
2005). It is thought that the positive head groups of the Lipofectamine lipids can a) complex 
with the negatively charged nucleic acids and promote their condensation and b) interact with 
the negatively charged surface membrane of living cells allowing the fusion of the 
lipid/nucleic acid complexes with the surface membrane and delivery of the nucleic acids into 
the cells. 
For the transfection assays iCell-CMs were seeded at densities of 1x10
5
- 1.5x10
5
 cells/cm
2
 at 
least 7 days prior transfection. The transfection with Lipofectamine was performed according 
to the protocol provided by Invitrogen with a typical DNA (µg) to Lipofectamine (µl) ratio of 
approximately 1:2.5. The plasmid DNA and Lipofectamine reagent were diluted with Opti-
MEM Reduced Serum Medium (Opti-MEM; Invitrogen).  
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Fig.  2.5. Map of vector pEGFP-C1. 
The vector encodes EGFP, the enhanced green fluorescent protein. A DNA fragment coding 
for the muscle-specific Bin1 was inserted into pEGFP-C1 by cloning into the MCS (multiple 
cloning site) downstream of the EGFP sequence. pEGFP-C1 also contains: PCMV IE, the 
immediate early promoter of the human cytomegalovirus; SV40 poly A, Simian Virus 40 
polyadenylation signal; f1 ori, f1 phage origin of replication; SV40 ori, Simian Virus 40 origin 
of replication; PSV40, Simian Virus 40 early promoter; Kan/Neo, kanamycin/neomycin 
resistance gen; HSV TK poly A, polyadenylation signals from the Herpes simplex virus 
thymidine kinase gene; and a pUC ori, a pUC origin of replication. 
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The transfection experiments were typically performed in a 96- or a 24-well format using the 
following media volumes and reagent amounts per well: 
Culture format Volume of cell 
culture 
medium 
Volume of 
dilution medium 
(Opti-MEM) 
Plasmid DNA Lipofectamine 
2000 
96-well 150 µl 2x25 µl 0.2 µg 0.5 µl 
24-well 500 µl 2x50 µl 0.8 µg 2 µl 
Table 2.9. Sample preparation for Lipofectamine transfection. 
 
For example, for a 96-well well format the transfection samples were prepared as following 
for each well: 
1) 0.2 µg plasmid DNA was diluted in 25 µl Opti-MEM and mixed gently. 
2) 0.5 µl Lipofectamine was mixed gently, diluted in 25 µl Opti-MEM, mixed and 
incubated for 5 min at RT. 
3) The diluted DNA was combined with the diluted Lipofectamine, mixed and incubated 
for 20 min at RT to allow complex formation between the DNA molecules and 
Lipofectamine.  
4) The complex solution (total volume = 50 µl) was added to each well containing cells 
and cell culture medium and mixed gently by rocking the plate back and forth. 
5) Cells were incubated at 37 °C with 4 % CO2 for 24-48 h prior to testing for transgene 
expression. 4-6 h after transfection the cell medium was replaced with fresh cell 
culture medium.  
2.12. Statistical analysis 
Results were expressed as mean ± SEM. Statistical significance between means was 
determined using Student’s t-test for unpaired samples. A p value smaller than 0.05 was 
considered significant. For whole-cell patch-clamping measurements “n” represents the 
number of single iCell-CMs and for MEA studies the number of cell clusters studies. For qRT-
PCR studies “n” represents the number of qRT-PCR runs. In the figures *indicates p<0.05, 
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**p<0.01, and ***p<0.001. Statistical analysis was performed using Prism 5 software 
(GraphPad software, San Diego, USA). 
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3.1. Introduction 
The aim of the work in this chapter was to establish a Shef3 hESC culture and a robust 
cardiac differentiation protocol to generate a sufficient amount of cardiomyocytes for 
subsequent characterisation and maturation studies.  
We chose the Shef3 line for the derivation of cardiomyocytes for various reasons: (1) this line 
was available and previously cultured at our laboratory at NIBSC; (2) the Shef3 line was 
described as being chromosomally stable over more than 180 passages (Catalina et al., 
2008); (3) spontaneous beating in EB-differentiated Shef3 cultures was observed previously; 
(4) at the start of the project no data existed about the cardiac differentiation efficiency of the 
Shef3 line (as judged by beating clusters/plated EBs).  
For cardiac differentiation of Shef3 hESCs initially two approaches were evaluated: 1) serum-
induced differentiation from EBs (conventional EB formation) and 2) directed cardiac 
differentiation by sequential treatment of hESC monolayers with the growth factors activin A 
and BMP4 [activin A/BMP4 method; (Laflamme et al., 2007)]. Cardiac differentiation via 
conventional EB formation was chosen because it is a standard widely used cardiac 
differentiation strategy, which has been reported for many hESC lines [e.g. H1, H7, H9 and 
HUES7 (Xue et al., 2005; He et al., 2003; Denning et al., 2006)]. The activin A/BMP4 method 
was chosen because it is well-established and has been successfully used for cardiac 
differentiation of the H7 line at our laboratory at Imperial College. In addition, two other EB-
based differentiation strategies were assessed. For both approaches EBs were initially 
formed by centrifugation of defined hESC numbers into microwells (AggreWell plates) in 
serum-free APEL medium (Stemcell Technologies). Subsequently, EBs were differentiated in 
a) serum-containing medium in suspension or b) in APEL medium directly in AggreWell 
plates with sequential addition of growth factors (activin A, BMP4, bFGF, VEGF and Dkk1) 
according to the stage-specific protocol developed by Stemcell Technologies (Stemcell 
Technologies, 2012b), which is based on the publication by Yang and co-workers (Yang et 
al., 2008). 
Chapter 3: Shef3 hESC culture and cardiac differentiation  
99 
 
In this project Shef3 hESCs were initially cultured on mitotically-inactivated MEFs, which was 
the routine culture method at the time in our lab at NIBSC. However, it was aimed to transfer 
the line to feeder-free conditions on Matrigel as this is critical for the use of the directed 
cardiac activin A/BMP4 differentiation method. 
3.2. Methods 
3.2.1. Culture of Shef3s on iMEFs 
See section 2.1.1. 
3.2.2. Shef3 culture on Matrigel  
For the adaptation of Shef3 cells to feeder-free culture conditions on Matrigel various culture 
media were evaluated including MEF-conditioned medium (with addition of 8 ng/ml bFGF), 
which was previously prepared, and the commercially available media NutriStem (Stemgent) 
and mTeSR1 [Stemcell Technologies; (Ludwig et al., 2006a)], which were shown to support 
the growth of various other undifferentiated hESC lines on Matrigel. Shef3s were cultured 
and passaged as described in section 2.1.2.  
3.2.3. Immunostaining  
To determine whether Shef3 hESCs cultured on iMEFs or Matrigel were pluripotent the cells 
were immunolabelled for the pluripotency markers SSEA-4, Tra-1-60 and Oct4 (Thomson, 
1998; Reubinoff et al., 2000).    
3.2.4. Cardiac differentiation of Shef3s via conventional EB formation method 
Shef3 colonies were cultured either on iMEFs in hESC medium or on Matrigel in mTeSR1 
medium before being dissected manually into cell clumps of approximately 1 mm
2
, cultured in 
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suspension in the presence of ROCK inhibitor and differentiated with serum in standard 
differentiation medium as described in section 2.2.1. 
3.2.5. Non-EB based differentiation via activin A/BMP4 method 
For the differentiation experiments, Shef3 colonies, previously grown on iMEFs in hESC 
medium or on Matrigel in mTeSR1 medium, respectively were passaged via manual 
dissection on Matrigel and cultured for 5-6 days in MEF-conditioned medium or mTeSR1 
medium, respectively, Afterwards differentiation was induced according to the directed 
differentiation protocol with activin A/BMP4 (Laflamme et al., 2007) as outlined in section 
2.2.2. 
3.2.6. EB formation and differentiation via AggreWell plates 
Shef3 hESCs were grown on Matrigel in mTeSR1 medium for at least five passages, before 
being dissociated into single cells, seeded at appropriate densities into AggreWell 400 plates 
and aggregated into EBs of 1000 or 2000 cells by centrifugation in the presence of ROCK 
inhibitor according to the protocol by Stemcell Technologies (Stemcell Technologies, 2012a). 
EB formation in AggreWells was performed in serum-free proprietary defined APEL medium. 
For cardiac differentiation the formed EBs were transferred to a low attachment plate and 
differentiated via the conventional EB-based differentiation protocol with serum (see section 
2.2.3.2.). Alternatively, EBs were differentiated directly in the AggreWell plates in APEL 
medium by sequential treatment with a number of growth factor (specifically activin A, BMP4, 
bFGF, VEGF and Dkk1) over a course of 16 days following the directed cardiomyocyte 
differentiation protocol by Stemcell Technologies (Stemcell Technologies, 2012b) (see 
section 2.2.3.3). For this directed differentiation approach 1000 hPSCs per EB is suggested 
by Stemcell Technologies to be the optimal cell number for cardiac differentiation. 
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3.3. Results 
3.3.1. Shef3 hESC culture  
3.3.1.1. Culture of Shef3s on iMEFs 
Vitrified colonies of Shef3 hESCs could be successfully recovered and cultured in an 
undifferentiated state on iMEF feeder layers in hESC culture medium. After two passages on 
iMEFs (dashed arrows in Fig. 3.1) by manual dissection the Shef3 colonies showed generally 
robust growth and many characteristics typically described for undifferentiated hESCs, 
including relatively uniform round cell morphology with high nuclear to cytoplasm ratio and 
well-defined colony boundaries (arrow in Fig.  3.1. A). Only small amounts of spontaneous 
differentiation occurred between two passages (6-7 days) at the edges and in the centres of 
some colonies, as seen by the appearance of bright multilayered colony areas (arrow in Fig.  
3.1. B) or enlarged, elongated stromal-like cells (arrow in Fig.  3.1. C). 
Immunofluorescence analysis revealed that most of the Shef3 cells on iMEFs expressed 
markers associated with pluripotency such as the nuclear expressed Oct4 (Fig.  3.2. A1-A2) 
and the surface antigens SSEA-4 (Fig.  3.2. B1-B2) and Tra-1-60 (Fig.  3.2. C1- C2).  
3.3.1.2. Shef3 culture on Matrigel in MEF-conditioned medium 
In order to establish a feeder-free Shef3 culture on Matrigel, cells grown and expanded on 
iMEFs were transferred by manual dissection onto Matrigel-coated plates into previously 
prepared MEF-conditioned medium supplemented with additional bFGF (8 ng/ml). After the 
first passage on Matrigel about half of the cell clumps were observed to attach. Three days 
after passaging the attached colonies showed large areas of undifferentiated morphology as 
described above. However, at the edges and occasionally the centres of virtually all colonies 
spontaneously differentiated fibroblast-like cells were visible. For the next passage only areas 
with cells showing undifferentiated morphology were excised and transferred to fresh culture 
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plates. However, only few cells clumps attached to the plates and cell differentiation 
increased dramatically (Fig.  3.1. D) preventing culture expansion generally beyond passage 
three.  
3.3.1.3. Shef3 culture on Matrigel in NutriStem and mTeSR1 medium 
Next, it was examined whether another culture medium would support the Shef3 Matrigel 
culture better. Undifferentiated Shef3s cultured on iMEFs were manually-dissected and 
transferred onto Matrigel-coated plates either into NutriStem or mTeSR1.  
Shef3 cells transferred into NutriStem showed, after two passages on Matrigel, similar low 
attachment rates and differentiated morphology as the cultures in MEF-conditioned medium 
(Fig.  3.1. E). Thus, the NutriStem cultures could not be further expanded. In contrast, cell 
colonies in mTeSR1 displayed generally an undifferentiated and phenotypically 
homogeneous morphology (Fig.  3.1. F) with only few differentiated areas (arrows in Fig.  3.1. 
F) over more than six passages and expressed multiple antigens associated with 
pluripotency such as Oct4  (Fig.  3.2. D1-D2), SSEA-4 (Fig.  3.2. E1-E2) and Tra-1-60 (Fig.  
3.2. F1-F2). The successfully established cultures were used in further experiments.  
3.3.2. Cardiomyocyte differentiation of Shef3 hESCs 
3.3.2.1. Cardiac differentiation of Shef3s via conventional EB formation 
method 
In this section we evaluated the suitability and efficiency of the conventional EB formation 
method for the generation of cardiomyocytes from both the Shef3 feeder-based and the 
established Matrigel-based cultures in mTeSR1. For EB formation undifferentiated Shef3 
colonies were manually dissected into smaller sections, cultured in suspension as cell clumps 
for four days in a medium containing serum and then plated on gelatin-coated plates. EBs 
generated via manual-dissection of colonies were heterogeneous in shape and size (Fig.  
3.3. A) with aggregates of 10 µm to 150 µm in diameter.  
  
 
Fig.  3.1. Morphology of Shef3 colonies in different culture conditions (day 5 after passaging). 
(A-C) Undifferentiated Shef3s on iMEFs in hESC medium (P44) showed compact colony structure with relatively uniform round cells (A, arrow 
shows Shef3 colony; dashed arrows show iMEFs). Only little spontaneous differentiation occurred in the centres and at the edges of colonies 
as seen by the appearance of bright multilayered colony areas (B, arrow) or enlarged stromal-like cells (C, arrow). Shef3 colonies on Matrigel 
(P2) cultured in MEF-conditioned medium (D) or NutriStem medium (E) revealed large areas of spontaneous differentiation with stromal-like 
stretched cells (D, E, arrows) at the edges and in the centres of the colonies. Shef3s on Matrigel (P2) in mTeSR1 medium (F) formed compact 
colonies with well defined boundaries and showed only little spontaneous differentiation (F, arrow). Scale bars 500 μm. Bright field. 
A B C 
D E F 
  
 
 
Fig.  3.2. Immunostaining of pluripotency markers expressed by Shef3 hESCs. 
Shef3 hESCs, cultured on iMEFs in hESC medium (A1-C2) or on Matrigel in mTeSR1 (D1-F2), were fixed in 4 % paraformaldehyde and 
stained with antibodies against Oct-4 (A1-A2 and D1-D2), SSEA-4 (B1-B2 and E1-E2) or Tra-1-60 (C1-C2 and F1-F2). The secondary 
antibodies were Alexa Fluor 488 anti IgG (green) or Alexa Fluor 594 anti IgM (red). The nuclei were visualized via DAPI (blue). Scale bars 100 
µm. 
A1 A2 
D1 D2 
B1 B2 
E1 E2 
C1 C2 
F1 F2 
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The first spontaneously contracting cells, derived from either of the Shef3 cultures, appeared 
in clusters usually on day 8 after induction of differentiation and increased in numbers up to 
day 15. However, contracting clusters were identified in only 3-10 % of total plated EBs (Fig.  
3.3. B) counted on day 15. Plated EBs could be cultured for more than three months without 
losing their beating capacity but we found that every three weeks it was necessary to dissect 
and to re-plate beating clusters since they were significantly overgrown by non-cardiac cells.  
3.3.2.2. Non-EB based differentiation via activin A/BMP4 method 
Due to low yields of differentiation reached by the conventional EB formation method it was 
investigated whether the non-EB-based directed differentiation protocol with activin A/BMP4 
described by Laflamme et al. (Laflamme et al., 2007) (see 2.2.3.) was more efficient to 
produce cardiomyocytes from the Shef3 line. This protocol was evaluated using the Matrigel-
based cultures grown in MEF-conditioned medium (short-term) or mTeSR1.  
For differentiation experiments in MEF-conditioned medium Shef3s, initially grown on feeder 
layers, were seeded at high densities (approximately at 200x10
3
 cells/cm
2
) on Matrigel, 
cultured for 4-5 days in MEF-conditioned medium and then sequentially treated with activin A 
and BMP4 in RPMI-B27 medium. However, due to poor adaptation of Shef3s to Matrigel 
culture in MEF-conditioned medium (as described in section 3.3.1.2) only half of the seeded 
cell clusters attached to the matrix and approximately 30 % of the attached cells 
differentiated spontaneously during the culture in MEF-conditioned medium. Nevertheless, by 
day 12 after induction of differentiation the appearance of beating clusters could be 
observed. However, the yield of differentiation was low with a maximum of 2 clusters per 
400x10
3
 cells seeded. This experiment was repeated three times. 
For differentiation experiments with mTeSR1-cultures on Matrigel Shef3 cultures were used, 
which were passaged in mTeSR1 for at least three passages. Shef3s were seeded in high 
densities on Matrigel-coated plates as described above but instead of MEF-conditioned 
medium the cells were seeded in mTeSR1 to ensure high attachment rates. Directed 
differentiation was induced 5-6 days after passaging by replacing the mTeSR1 medium with 
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RPMI-B27 supplemented with activin A/BMP4. The differentiation experiment was repeated 
four times but no beating cluster could be detected at any time. 
3.3.2.3. EB formation and differentiation via AggreWell plates 
The aggregation of Shef3s in AggreWells resulted in EB formation in virtually all microwells 
after 24 h. The formed EBs were consistently spherical in shape and relatively uniform in size 
(Fig.  3.3. C) at approximately 100 µm (1000 hESCs/EB) or 150 µm (2000 hESCs/EB) in 
diameter. Furthermore, for many EBs it was visible in phase contrast that the cells within the 
EBs were organised in an inner core domain and an outer layer domain (arrows in Fig.  3.3. 
C). Cardiac differentiation was performed via two approaches: First, EBs (1000 or 2000 
hESCs/EB) were transferred from AggreWells to low attachment plates 24 h or 48 h after 
formation and cultured for 4 days in suspension in serum-containing differentiation medium 
before being placed on pre-gelatinised culture plates for attachment. This approach did not 
produce any beating clusters. Second, without removing the EBs (1000 or 2000 hESCs/EB) 
from the microwells, the EBs were further cultured in APEL medium and treated sequentially 
over a course of 16 days with a number of growth factors including BMP4, activin A, bFGF 
Dkk1 and VEGF (Stemcell Technologies, 2012b). The integrity of the EBs was examined 
daily using a light microscope (day 0 in Fig.  3.4. A-B; day 2 in Fig.  3.4. C-D). From day 8-10 
of the differentiation procedure the EBs disintegrated increasingly and appeared darker (Fig.  
3.4. E-F) suggesting that the cells underwent apoptosis. By day 16 all EBs were disintegrated 
and no beating clusters could be observed. All AggreWell-based differentiation approaches 
were repeated at least three times but no spontaneously contracting EBs were observed.  
3.4. Discussion 
3.4.1. Shef3 hESC culture 
In this project the Shef3 hESC line was successfully maintained and expanded on iMEFs for 
more than 30 passages by passaging the colonies weekly via manual dissection. However,   
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Fig.  3.3. Shef3 EBs. 
(A) EBs formed via manual dissection of Shef3 colonies (grown on Matrigel in mTeSR1) 
differed widely in their size and shape (48 h after formation). (B) Percentage of Shef3-EBs 
containing spontaneously contracting clusters derived from Shef3 cultures on iMEFs in hESC 
medium or Shef3 cultures on Matrigel with mTeSR1 medium (counted on day 15 after 
induction of EB formation). n represents the number of separate differentiation experiments.  
(C) EBs generated via AggreWells (400 µm
2
) were predominately homogeneous in their size 
and shape (48 h after formation) and displayed the presence of two different domains 
(arrows), which were visible in phase contrast. Scale bars 100 µm. Bright field (A and C). 
  
A 
C 
B 
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Fig.  3.4. Formation and differentiation of Shef3-EBs in AggreWell 400 with APEL 
medium. 
EBs of 1000 (A, C and E) or 2000 Shef3 cells (B, D and F) were formed in AggreWells in 
APEL medium with ROCK inhibitor and treated sequentially with the growth factors BMP4, 
activin A, bFGF, VEGF and Dkk1 over a course of 16 days according to the cardiomyocyte 
differentiation protocol by Stemcell Technologies. EBs were successfully formed and cultured 
in the AggreWell plates for 7-9 days and monitored daily for the appearance of beating 
clusters. However, after day 7-9 the cells appeared dark and the EBs started to disintegrate. 
No beating clusters could be detected. Displayed are AggreWells with Shef3 cells at day 0 
(A-B), Shef3 EBs at day 2 (C-D) and disintegrated Shef3 EBs at day 10 (E-F). Scale bars 100 
µm. Bright field.    
A B 
C D 
E F 
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there were difficulties in adapting the Shef3 line to a feeder-free culture on Matrigel in MEF-
conditioned medium (supplemented with 8 ng/ml bFGF). This line showed poor attachment 
and high differentiation rate post passage on Matrigel in MEF-conditioned medium. The 
adaptation difficulties of Shef3 to feeder-free culture might be attributed to inherent line 
properties since a successful adaptation to Matrigel culture in MEF-conditioned medium (with 
8 ng/ml bFGF) has been already reported for the H7 hESC line (Laflamme et al., 2007). On 
the other hand, Catalina et al. (Catalina et al., 2008) described in their study the 
establishment of a Shef3 culture on Matrigel in medium conditioned by human foreskin 
fibroblasts (X-ray inactivated; supplemented with 8 ng/ml bFGF). This suggests that the main 
problem for the poor growth of Shef3 hESCs on Matrigel was probably the MEF-conditioned 
medium. This medium was prepared and handled in the laboratory according to a standard 
protocol and the medium was conditioned on the same mitotically-inactivated MEF line, 
which supported undifferentiated growth of Shef3s in feeder-based culture conditions. 
However, the performance of MEF-conditioned medium can vary significantly batch-to-batch, 
this medium is not fully defined and it is not completely understood which factors, supplied by 
feeder cells, support undifferentiated hESCs.  
Other media tested for the Matrigel culture were the fully defined, xeno-free media NutriStem 
(Stemgent) and mTeSR1 (Stemcell Technologies). Only mTeSR1 sustained undifferentiated 
Shef3 proliferation on Matrigel. To asses why the Shef3 culture could be adapted in mTeSR1 
but not in NutriStem is difficult because the commercially prepared media are complex 
combinations of growth factors and other additives and their exact formulation is proprietary 
and not published. It is reported though that both media contain key growth factors such as 
bFGF and TGFβ or activin A, which stimulate the bFGF and TGFβ signalling pathways 
known to maintain the pluripotent state in hESCs (Ludwig et al., 2006a; Villa-Diaz et al., 
2013). However, mTeSR1 presumably also contains lithium chloride (LiCl), which mediates 
the activation of Wnt signalling, which is also implicated in the maintenance of pluripotency 
(Satoh et al., 1996), and γ-aminobutyric acid (GABA), which is involved in stimulation of cell 
proliferation (Watanabe et al., 2002; Ludwig et al., 2006b). It is not published whether GABA 
and LiCl are also present in NutriStem.  
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However, in this study mTeSR1-cultures failed to produce any beating cardiomyocytes via 
the activin A/BMP4 protocol, which is discussed in the next section.  
3.4.2. Cardiac differentiation 
3.4.2.1. Cardiac differentiation of Shef3s via conventional and AggreWell EB 
formation 
Shef3 hESCs, cultured on feeders in hESC medium or on Matrigel in mTeSR1 could be 
successfully differentiated into cardiomyocytes via conventional EB formation method, 
although with a low efficiency of 3-10 % of beating EBs per total number of plated EBs. This 
differentiation efficiency is in the same range as efficiencies reported by other studies, which 
used other hESC-lines and observed similar low yields of beating EBs differentiated in the 
presence of serum (Kehat et al., 2001; Xue et al., 2005). However, there are also reports that 
beating clusters could be identified in significantly higher numbers of EBs (10 to 70 %) (Xu et 
al., 2002; He et al., 2003). One possible explanation for such variability of cardiac 
differentiation efficiency is that EB formation by scraping or such as in our study by manual 
dissection of hESC colonies is not standardised and usually results in the formation of EBs 
widely heterogeneous in size and shape. Studies initially performed in mESCs and later in 
hESCs showed however that the cardiac differentiation potential of EBs might partially 
depend on the EB size (Bader et al., 2001; Burridge et al., 2007) because EB size and total 
cell number within the EB may greatly influence the micro-environment of cells within EBs 
(Ungrin et al., 2008). With the aim to standardise the EB formation process and to control the 
EB size AgreeWell plates were employed in this project to produce Shef3-EBs of uniform size 
and shape by forced aggregation (centrifugation). Shef3-EBs were formed in the serum-free, 
chemically defined, low-growth factor APEL medium. For cardiac differentiation, EBs were 
either cultured with serum according to the conventional EB-mediated differentiation method 
or cultured in APEL medium with sequential addition of growth factors, which are implicated 
in normal cardiac development, following a protocol by Stemcell Technologies (Stemcell 
Technologies, 2012b). None of these methods produced beating clusters. In contrast, 
Chapter 3: Shef3 hESC culture and cardiac differentiation  
111 
 
Stemcell Technologies reported that their growth-factor directed cardiac differentiation 
protocol using EBs formed in AggreWells and APEL medium results in 5 %-95 % of beating 
EBs with a cardiomyocyte yield of 3.2 % (±2.3 %) (Antonchuk et al., 2011). However, the 
AggreWell protocols were designed by Stemcell Technology using the H7 and the H9 hESC 
lines (correspondence with Stemcell Technology) so the protocol might require optimisation 
to achieve cardiomyocyte induction in the Shef3 line. Critical parameters, which may 
influence the differentiation process, include for example input cell numbers to form EBs, the 
medium used for EB formation, the time point of EB plating in serum-induced protocols 
(Boheler et al. 2002). Apart from testing two different input cell numbers for EB formation 
(1000 and 2000 cells/EB) the protocol was not further optimised.  
3.4.2.2. Non-EB based differentiation via activin A and BMP4 
The non-EB-based activin A/BMP4 differentiation approach is reported to be considerably 
more efficient than conventional EB formation yielding consistently more than 30 % 
cardiomyocytes as shown with the H7 line (Laflamme et al., 2007). In this study this method 
generated only a few beating clusters with the Shef3 line. This is most likely due to the poor 
adaptation of Shef3s to Matrigel in MEF-conditioned medium (discussed in section 3.4.1), 
which prevented the establishment of a high-density hESC Matrigel culture essential for this 
method. In order to reach the high-density culture of Shef3s the cells were seeded on 
Matrigel in mTeSR1, which supported the growth of Shef3s in an undifferentiated state, and 
cardiac differentiation was induced according to the actA/BMP4 protocol. However, this 
approach was not successful as no spontaneously beating cells could be detected. mTeSR1 
was described to contain large amounts of bFGF (100 ng/ml) and a relatively high 
concentration of insulin (0.023 g/l). Whilst bFGF and insulin can maintain hESCs in an 
undifferentiated state and promote cell proliferation (Xu et al., 2005; Levenstein et al., 2006; 
Beattie et al., 2005; Beattie et al., 2005; James et al., 2005; McDevitt et al., 2005) both 
factors (in high concentrations) might also influence the differentiation potential of the cells 
and interfere with the activin A/BMP4 protocol. Insulin was recently suggested to block 
cardiac differentiation by surpressing the formation of endoderm and mesoderm and to 
promote the expression of neuroectoderm in differentiating hESCs (Freund et al., 2008).   
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3.5. Conclusion 
For downstream characterisation and maturation studies a reproducible and robust 
differentiation protocol was required to generate sufficient amounts of cardiomyocytes from 
the Shef3 hESC line. A long-term Shef3 hESC culture was successfully established on 
iMEFs in hESC medium and on Matrigel in mTeSR1. Spontaneously beating clusters could 
be generated from the Shef3 cells via directed differentiation with activin A/BMP4 (only after 
short-term culture in MEF-conditioned medium) and via conventional EB formation method in 
the presence of serum. However, both methods resulted in very low yields of beating 
clusters. These results urged us to look for alternative sources of hPSC-CMs.  
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Fig.  3.5. Diagram summarising major results of chapter 3. 
Cardiac differentiation of hESC monolayers via act A/BMP4 is based on the publication by 
Laflamme and co-workers (Laflamme et al., 2007). Cardiac differentiation of EBs within 
AggreWells via sequential treatment with act A, BMP4, bFGF, VEGF and Dkk1 is based on 
the publication by Yang et al. (Yang et al., 2008). act A: activin A, CM: cardiomyocyte, Diff: 
cardiac differentiation, EBs: embryoid bodies, hESC: human embryonic stem cell, MG: 
Matrigel, MEFs: mouse embryonic fibroblasts, iMEFs: mitotically-inactivated MEFs.  
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4.1. Introduction 
In the previous chapter the challenges of Shef3 hESC culture and cardiomyocyte 
differentiation were discussed. Due to the difficulties in producing a sufficient quantity of pure 
Shef3-CMs as well as the limited access to alternative stem cell lines and the time restraints 
of this project it was finally decided to purchase pre-differentiated commercially produced 
hPSC-CMs for successive characterisation and maturation studies. In 2011 commercially 
produced hPSC-CMs were available from two major suppliers: GE Healthcare, which offered 
hESC-CMs at approximately 50 % purity, and Cellular Dynamics International (CDI), which 
offered hiPSC-CMs (iCell-CMs) at more than 98 % purity. Since the purity is a critical issue 
for studies such as qRT-PCR and TEM we decided to purchase iCell-CMs from CDI. CDI 
launched their iCell-CMs in December 2009. These cells are manufactured in large amounts 
in industrialised fashion via a CDI proprietary process (Anson et al., 2011), which includes: a) 
the generation of hiPSCs from human fibroblasts via a non viral-based protocol; b) 
standardised and scalable hiPSC culture; c) differentiation of hiPSCs into cardiomyocytes via 
a non EB-based directed differentiation method; d) purification of hiPSC-CMs via antibiotic 
(blasticidin) resistance gene, which is under the control of the cardiac αMHC promoter. The 
purified population of iCell-CMs represents a mixture of spontaneously beating atrial, nodal, 
and ventricular-like myocytes.  
iCell-CMs are advocated as suitable cardiac model systems for drug discovery and 
cardiotoxicity assays (Anson et al., 2011). However, as described in section 0. hPSC-CMs 
are generally reported to be relatively immature compared to adult cardiomyocytes. For 
example, their gene expression pattern resembles that of developing cardiomyocytes (Gai et 
al., 2009; Synnergren et al., 2008), they are structurally immature as evident by the lack of 
TTs (Gherghiceanu et al., 2011; Snir et al., 2003) and they display immature 
electrophysiological features (Ma et al., 2011).  
In this chapter the aim was to examine key molecular features, the overall ultrastructural 
cellular organisation and the basic electrophysiological properties of iCell-CMs. These 
characteristics may serve as a base line for the subsequent maturation studies. An additional 
aim was to analyse the cardiac protein expression in Shef3-CMs via immunofluorescence 
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microscopy. A more comprehensive characterisation of these cells was not possible due to 
the low numbers of the generated beating Shef3-clusters and the heterogeneity of the cell 
population within the beating Shef3-clusters.  
During the analysis of morphology and (ultra)structure iCell-CMs and Shef3-CMs were 
compared to freshly isolated adult rat ventricular cardiomyocytes due to the lack of access to 
adult human ventricular cardiomyocytes. Adult rat ventricular cardiomyocytes demonstrate a 
similar morphology and (ultra)structure compared to their human counterparts, with all 
components of the excitation-contraction coupling system reproduced, as well as having 
a particularly well-formed TT system. 
4.2. Methods 
4.2.1. iCell-CMs culture 
For detailed culture method see section 2.3. All iCell-CMs were cultured for no longer than 
approximately two weeks. 
4.2.2. Culture of Shef3-EBs 
See section 2.2.4. 
4.2.3. qRT-PCR 
For qRT-PCR experiments iCell-CMs were seeded into 6-well plates at densities of 
approximately 3x10
5
 cells/well. For details see section 2.5. 
4.2.4. Bright field and immunofluorescence analysis 
For bright field and immunofluorescence microscopy beating outgrowths of Shef3-EBs, which 
were generated from Shef3 cultures on iMEFs via conventional EB formation, were 
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microdissected and enzymatically dispersed into smaller clusters or single cells. iCell-CMs 
were plated as single cells at low density. Freshly isolated adult rat cardiomyocytes, which 
were used as control cells, were seeded on laminin-coated plates and were not cultured for 
more than one day.  
4.2.5. Plasma membrane staining 
Cell plasma membranes of live cells were stained either via: a) WGA-conjugated to Alexa 
Fluor 488, which binds to specific sugar residues in the glycocalyx of cell membranes; b) the 
voltage-sensitive membrane dye Di-8-ANNEPS or c) the lipid dye CellMask Orange (CMO). 
Cells were not permeabilised prior to staining and incubated with the membrane dyes as 
recommended by the manufacturer’s protocol to ensure that only the outer cell membranes 
were stained.  
4.2.6. Transmission electron microscopy 
For TEM iCell-CMs were embedded in resin either via a standard RT resin embedding 
method using cell suspensions or via RT resin embedding using cells attached to sapphire 
discs. Freshly isolated adult rat ventricular cardiomyocytes were used as controls.  
4.2.7. Micro electrode array studies 
For electrophysiological studies iCell-CMs were plated at low density (30x10
3
 cells/well) on 
MEAs and their field potential was measured. To analyse the effect of caffeine and 
thapsigargin on iCell-CM contraction, 1 mM and 10 mM caffeine and 1 µM and 10 µM 
thapsigargin, respectively, were applied sequentially directly into the cell culture medium.  
The specified drug concentrations have been reported in various studies to be sufficient to 
affect hPSC-CMs (Sartiani et al., 2007; Liu et al., 2007a).  
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4.3. Results 
4.3.1. Culture of iCell-CMs and Shef3-CMs and analysis via bright field 
microscopy  
iCell-CMs were cultured as monolayers on gelatin-coated plates at densities of 3x10
4
-6.5x10
4
 
cells/cm
2
 and formed after 2-4 days in culture spontaneously-contracting syncytia with a 
rhythmic beating rate at 40-80 beats per minute (bpm). Shef3-EBs showing spontaneously 
contracting clusters (with beating rates of 27-74 bpm) were cultured on gelatin-coated plates 
with serum in standard differentiation medium.  
Analysis via bright field microscopy showed that the morphology of dispersed Shef3-CMs and 
iCell-CMs differed significantly from adult rat cardiomyocytes, which were used as mature 
cardiomyocyte controls. Dispersed Shef3-CMs (Fig.  4.1. A) and iCell-CMs (Fig.  4.1. B) had 
a spindle, round, or multi-angular shape, usually displayed a “fried egg morphology” with a 
roughly spherical elevation (nucleus) centred on a flatter apron (Itzhaki et al., 2006) and were 
relatively flat (approximately 6 µm at the nucleus and 3 µm at the periphery). Adult rat 
cardiomyocytes on the other hand were approximately 10-20 µm thick and displayed rod-
shaped morphology and a characteristic regular striation pattern (Fig.  4.1. C). Shef3-derived 
cardiomyocyte were usually mononuclear whilst cultures of iCell-CMs showed mono- as well 
as binuclear cells.  
4.3.2. qRT-PCR 
qRT-PCR was used to examine the expression profiles of selected cardiac gene transcripts 
in order to elucidate the developmental stage of iCell-CMs. The analysed genes included: a) 
general cardiac markers and structural proteins; b) ion channels, which modulate the 
contractile activity of cardiomyocytes; c) genes coding for SR Ca
2+
 handling components, 
involved in mature ECC and d) genes coding for proteins implicated in the development or 
maintenance of TTs, a hallmark of mature ventricular cardiomyocytes. An overview of all 
analysed genes is given in Table 4.1. Gene expression levels measured in iCell-CMs were 
  
Fig.  4.1. Differences in cell morphology of adult cardiomyocytes and hPSC-CMs. 
Dispersed single cells or small clusters of Shef3-CMs (A) and iCell-CMs (B), which were both approximately 30 days old, displayed similar 
roughly round or multi-angular morphology and no visible banding pattern. (C) An adult ventricular rat cardiomyocyte showed rod-shaped 
morphology and a highly aligned striation pattern throughout the cell typical for mature cardiac cells. Scale bars 20 µm. Bright field. 
A C B 
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Gene Encoded protein information 
 
αMHC  
 
Alpha myosin heavy chain 
βMHC  
 
Beta myosin heavy chain 
MLC2v  
 
Cardiac ventricular myosin light chain 2 
cTnT  
 
Cardiac troponin T type 2 
Nkx2.5  
 
Cardiac tissue-restricted homeobox-containing 
transcription factor, early cardiac marker 
GATA4 
 
Cardiac-specific zinc-finger transcription factor, early 
cardiac marker 
Io
n
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ANP  
 
Atrial natriuretic peptide 
Cav1.2  
 
Alpha 1S pore-forming subunit of voltage-dependent L-
type calcium channel 
Cav3.1  
 
Alpha 1G subunit of voltage-dependent T-type calcium 
channel 
NCX1  
 
Sodium/calcium exchanger 
Kir2.1  
 
Inward rectifier potassium channel 2, responsible for IK1 
current 
Kv4.3  
 
Voltage-gated potassium channel subunit Kv4.3, 
mediates transient outward potassium currents Ito1 
S
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RyR2  
 
Cardiac ryanodine receptor 2 
IP3R2  
 
Inositol 1,4,5-trisphosphate receptor type 2;  transcriot 
variant predominantly expressed in human ventricular 
cardiomyocytes (Kockskamper et al., 2008) 
SERCA2a 
  
Cardiac sarcoplasmic reticulum calcium ATPase 2 
PLN  
 
Phospholamban 
CSQ2  
 
Cardiac calsequestrin 2 
T
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 Bin1  
 
Bridging integrator 1 (muscle specific) 
Cav3  
 
Caveolin 3 
JP2  
 
Junctophilin 2 
Tcap 
 
Titin-cap, telethonin 
Table 4.1. List of genes analysed via qRT-PCR. 
SR: sarcoplasmic reticulum. 
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compared to gene expression levels measured in foetal (FH) and adult human heart (AH) 
controls. 
The majority of the gene expression profiles measured in iCell-CMs resembled foetal heart 
controls. However, a number of genes were closer to adult controls or corresponded neither 
to the foetal nor to the adult phenotype. qRT-PCR analysis showed that in iCell-CMs the 
expression levels of early immature cardiac markers such as Nkx2.5 and GATA4 
corresponded to the expression values detected in FH and were notably higher than in the 
AH controls (Fig.  4.2. A). Similarly, mRNA levels of the contractile proteins αMHC, βMHC 
and MLC2v correlated with the expression levels detected in FH: the expression of βMHC 
and MLC2v was approximately two-fold lower than in AH whereas the expression levels of 
the αMHC isoform were close to the values detected in AH. In contrast, the expression of 
cTNT, which regulates cardiac muscle contractility as part of the troponin complex, did not 
correlate with FH. Its expression corresponded to the AH levels being two-fold higher than in 
FH.  
qRT-PCR analysis of a set of ion channels (Fig.  4.2. B) exhibited that both L-type Ca
2+
 
channels (referred to as Cav1.2), which play a crucial role in ECC coupling in mature 
cardiomyocytes, and T-type Ca
2+
 channels (referred to as Cav3.1) were notably higher in 
iCell-CMs and FH controls relative to AH. The expression of Cav1.2 was approximately two-
fold and that of Cav.3.1 twenty-fold higher than in the AH controls. The expression of NCX1 
in iCell-CMs and in FH expression levels correlated with the expression values detected in 
AH. In contrast the expression of Kir2.1 was markedly lower in iCell-CMs with mRNA levels 
five times lower compared to FH and more than ten times lower compared to the AH 
samples.  
Gene expression analysis of major SR Ca
2+
 handling elements (Fig.  4.2. C) in iCell-CMs 
delivered diverse results. On the one hand, the expression levels of RyR2 and CSQ2 were 
considerably lower relative to the adult and foetal controls. On the other hand, the expression 
of SERCA2a was two-fold higher than in FH and close to the levels measured in AH. 
Moreover, the expression of PLN, which regulates SERCA2a, was two-fold higher in iCell-
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CMs compared to AH and five-fold higher compared to FH. The expression of the SR Ca
2+
 
channel IP3R2 corresponded to the expression levels of the FH controls.  
Assessments of the expression profiles of TT-associated genes (Fig.  4.2. D) such as Bin1 
and Cav3 demonstrated that their mRNA levels in iCell-CMs were significantly below the FH 
and AH controls. The expression of Bin1, which was shown to induce membrane invagination 
in muscles (Lee et al., 2002), was 10-fold lower than in FH and 30-fold lower than in AH. The 
expression level of the caveolae membrane protein Cav3 was almost 40-fold and 20-fold 
lower compared to FH and AH, respectively. In contrast, the expression of JP2 was almost 
five-fold and three-fold higher in iCell-CMs and FH, respectively, relative to the adult heart 
samples. The expression of Tcap correlated with the levels of FH and was approximately 
five-fold lower than in AH. 
4.3.3. Immunofluorescence studies 
4.3.3.1. Expression of sarcomeric and Ca
2+
 handling proteins 
iCell-CMs and EB-derived Shef3-CMs were identified and characterised via immunostaining 
against cardiac markers including the myofibrillar protein α-actinin and SR components such 
as RyR2 and SERCA2a. Adult rat ventricular cardiomyocytes were used as controls.  
The fluorescence images of spontaneously contracting Shef3 clusters dissected from EBs 
revealed that EB-derived cells represented α-actinin expressing myocytes (Fig.  4.3. A1-A4) 
but also cell types, which were α-actinin negative (arrows in Fig.  4.3. A2) confirming that EB 
aggregates did not exclusively contain cardiac cells. In contrast, the highly purified iCell-CMs 
showed consistent staining for α-actinin for virtually all cells (Fig.  4.3. B1-B2). Both cell types 
exhibited α-actinin stained fibres with characteristic sarcomeric striation, which were 
organised in separated bundles but also cell regions with rather disorganised α-actinin 
staining (arrows in Fig.  4.3. A3 and B1). In contrast, adult rat cardiomyocytes displayed a 
continuous highly aligned α-actinin banding pattern throughout the depth of the cell (Fig.  4.3. 
C1-C2). Negative controls, which did not receive a primary antibody (Fig.  4.3. D-F), showed  
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Fig.  4.2. mRNA expression of cardiac genes in iCell-CMs evaluated via qRT-PCR. 
The graphs display mRNA expression levels of structural proteins and general cardiac 
markers (A), ion channels (B), genes coding for SR Ca
2+
 handling components (C) and 
genes coding for proteins implicated in TT development (D). qRT-PCR results from iCell-CM 
samples were obtained in triplicate (represent three independent culture preparations) and 
results from human foetal (FH) and adult heart (AH) controls in singlets, in n=2 qRT-PCR 
runs. All values were normalized with respect to GAPDH and shown relative to the 
corresponding values in AH (AH=1). Error bars represent ±SEM. Statistical significance 
between the two means was determined using unpaired Student’s t-test (*p<0.05, **p<0.01, 
***p<0.001). 
 
A B 
D C 
  
 
The image shows Shef3-CMs (A1-A4), 
iCell-CMs (B1-B2) and an adult rat 
ventricular cardiomyocyte (adult rat 
CMs; C1-C2), which were stained with 
anti-α-actinin as primary antibody (A1-
C2). The secondary antibody was Alexa 
Fluor 488 (green) and Alexa Fluor 647 
(red), respectively. Negative controls 
received a secondary antibody but no 
primary antibody (D, E and F). Arrows in 
A2 show α-actinin negative cells within 
the Shef3-CM cluster. Arrows in A3 and 
B1 show cell areas with disorganised α-
actinin staining pattern. Cell nuclei were 
stained with DAPI (blue). Scale bars 20 
µm except A1-A2 with 50 µm.  
B C 
D E F 
A1 
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Fig.  4.3. Immunostaining against 
sarcomeric α-actinin. 
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no fluorescence staining confirming that immunolabelling with the secondary antibody was 
specific. 
Next the expression of Ca
2+
 handling molecules such as Cav1.2 and the SR components 
RyR2, SERCA2a and PLN was evaluated. As displayed in Fig.  4.4. all of these proteins 
could be detected and showed similar expression in Shef3-CMs and iCell-CMs. 
Immunolabelling of the sarcolemmal Cav.1.2 showed punctate staining without a distinct 
pattern in both Shef3-CMs (Fig.  4.4. A1-A2) and iCell-CMs (Fig.  4.4. B1-B2). Expression of 
RyR2 (Fig.  4.4. D1-D2 and E1-E2), SERCA2a (Fig.  4.4. G1-G2 and H1) and PLN (Fig.  4.4. 
J1 and K1-K2) was exhibited throughout the cytosol of Shef3-CMs and iCell-CMs, 
respectively. However, the fluorescence signals for RyR2 were noticeably weaker compared 
to SERCA2a and PLN. PLN staining showed in some cell regions a defined banding pattern 
(arrows in Fig.  4.4. J1 and K1). In contrast, adult rat controls displayed a characteristic 
striated staining for Cav1.2 (Fig.  4.4. C1-C2), RyR2 (Fig.  4.4. F1), SERCA2a (Fig.  4.4. I1-
I2) and PLN (Fig.  4.4. L1). The regular striation in the adult cells reflects the high degree of 
structural organisation of mature cardiomyocytes with highly aligned myofibrils, SR and TT 
structures.  
Double-immunostaining for Cav1.2 and RyR2 in iCell-CMs showed no visible spatial 
association of the two proteins (Fig.  4.5. A1-A3) suggesting that iCell-CMs did not possess 
any Cav1.2/RyR2 Ca
2+
 release units (couplons). On the contrary, adult rat cardiomyocytes 
showed overlapping of the Cav1.2 and RyR2 fluorescence signals throughout the cells (Fig.  
4.5. B1-B3). 
4.3.3.2. Staining of the cell plasma membrane 
In order to reveal the presence of any TT invaginations non-permeabilised Shef3-CMs, iCell-
CMs and adult rat cardiomyocytes were incubated with WGA-Alexa Fluor 488 (Fig.  4.6. A-
C), which binds specific sugar residues in the sarcolemmal glycocalyx. However, since 
hPSC-CMs may not express the same repertoire of sugar components in their glycocalyx as 
adult cells iCell-CMs and adult rat cardiomyocytes were also stained with the membrane-
dyes CMO (Fig.  4.6. D-E) and Di-8-ANNEPS (Fig.  4.6. F-G).  
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For figure legend see page 128. 
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For figure legend see page 128. 
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Fig.  4.4. Immunostaining for Ca
2+
 handling proteins. 
Clusters of Shef3-CMs (A1-A2, D1-D2, G1-G2 and J1), iCell-CMs (B1-B2, E1-E2, H1 and K1-
K2) and adult rat ventricular cardiomyocytes (adult rat CMs; C1-C2, F1, I1-I2 and L1) were 
stained with anti-Cav1.2 (A1-C2), RyR2 (D1-F1), SERCA2a (G1-I2) and PLN (J1-L1) as 
primary antibodies. The secondary antibodies were either Alexa Fluor 488 (green) or Alexa 
Fluor 647 (red). Arrows in J1 and K1 depict cell regions showing a striated PLN staining 
pattern. Nuclei were stained with DAPI (blue). DAPI staining is missing in adult rat CMs 
stained for RyR2, in iCell-CMs stained for SERCA2a and in Shef3-CMs and adult rat CMs 
stained for PLN. Scale bars 20 µm. 
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Fig.  4.5. Double immunostaining for Cav1.2 and RyR2. 
iCell-CMs (A1-A3) and adult rat cardiomyocytes (adult rat CMs; B1-B3) were double-stained 
with the primary antibodies anti-Cav1.2 (A1, B1, A3 and B3) and anti-RyR2 (A2, B2, A3 and 
B3). The secondary antibodies were Alexa Fluor 488 (green) and Alexa Fluor 647 (red). iCell-
CMs were nuclear counterstained with DAPI (blue). Scale bars 20 µm. 
A1 B1 
A2 
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In Shef3-CMs (Fig.  4.6. A) and iCell-CMs (Fig.  4.6. B) staining with WGA-Alexa Fluor 488 
resulted in occasional fluorescent dots but no fluorescent tubular structures penetrating the 
membrane were detected within the cells. Similarly, labelling of iCell-CMs with CMO (Fig.  
4.6. D) also revealed infrequent punctual staining but no tubular invaginations. In further 
immunofluorescence studies with Di-8-ANNEPS no fluorescent signal could be detected in 
iCell-CMs (Fig.  4.6. F). The mature rat cardiomyocytes exhibited for all three dyes a typical 
striation pattern (Fig.  4.6. C, E and G) resulting from the diffusion of the dye into the TT 
invaginations, which penetrate the cell membrane in regular intervals. 
4.3.3.3. Staining of iCell-CMs for TT-associated markers and other cardiac 
proteins 
For further characterisation iCell-CMs were stained for proteins associated with TT 
development using antibodies against Bin1, Cav3, JP2 and Tcap. The cells were also 
labelled for the gap junction protein connexin 43. As shown in Fig.  4.7. A1-A2 
immunolabelling against Bin1 in iCell-CMs gave a weak fluorescent signal, which appeared 
predominantly in the cell nuclei. Adult rat cells stained against Bin1 (Fig.  4.7. B1-B2) showed 
the characteristic banding pattern but also a nuclear expression. Cav3 and JP2 proteins 
could also be detected in iCell-CMs and displayed a punctuate expression pattern (Fig.  4.7. 
C1-C2 and E1-E2). The expression of the Z-disc protein Tcap could also be confirmed (Fig.  
4.7. G1-G2) and some iCell-CMs showed a striated banding pattern. However, the staining 
intensity was low. In stark contrast, adult rat cardiomyocytes consistently showed intense 
positive staining for Cav3 (Fig.  4.7. D1-D2), JP2 (Fig.  4.7. F1-F2) and Tcap (Fig.  4.7. H1-
H2), which was organised in regularly spaced bands.  
Connexin 43 in iCell-CMs was preferentially expressed at cell borders to neighbour cells  
(Fig.  4.8. A1-A2), though some staining could be visible randomly over the whole cell plasma 
membrane. Nevertheless, the concentrated expression at the cell-cell junctions suggests that 
iCell-CMs could couple electromechanically with neighbouring cells. In adult rat 
cardiomyocytes connexin 43 was predominantly expressed at the cell poles (Fig.  4.8. B1-
B2). 
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For figure legend see page 132. 
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Fig.  4.6. Staining of the cell plasma membrane. 
Shef3-CMs (A) and iCell-CMs (B) stained with WGA-Alexa Fluor 488 showed fluorescent 
spots but no tubular like staining, suggesting that no TT invaginations were present. The 
absence of TTs in iCell-CMs was further confirmed by staining with CellMask Orange (CMO; 
D), which also did not reveal tubular shaped fluorescent structures. iCell-CMs labelled with 
Di-8-ANNEPS (F) did not reveal any detectable fluorescence. Adult rat cardiomyocytes (adult 
rat CMs) labelled with WGA-Alexa Fluor 488 (C), CMO (E) or Di-8-ANNEPS (G) showed for 
all dyes a regular striated staining pattern revealing its highly aligned TTs. Scale bars 20 µm. 
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Fig.  4.7. Expression of TT-associated proteins in iCell-CMs and adult rat 
cardiomyocytes. 
iCell-CMs (A1-A2, C1-C2, E1-E2 and G1-G2) and adult rat cardiomyocytes (adult rat CMs; 
B1-B2, D1-D2, F1-F2 and H1 and H2) were stained with anti-Bin1 (Bin1 AB; A1-B2), caveolin 
3 (Cav3; C1-D2), junctophilin 2 (JP2; E1-F2) and Tcap (G1-H2) as primary antibodies. As 
secondary antibodies either Alexa Fluor 488 (green) or Alexa Fluor 647 were used (red). The 
cell nuclei were stained with DAPI (blue). Scale bars 20 µm. 
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Fig.  4.8. Expression of connexin 43 in iCell-CMs and adult rat cardiomyocytes. 
iCell-CMs (A1-A2) and adult rat cardiomyocytes (adult rat CMs; B1-B2) were labelled with the 
primary antibody anti-connexin 43 (A1-B2) and the secondary antibody Alexa Fluor 488 
(green). Also, the actin cytoskeleton was stained with Alexa Fluor 594 phalloidin (red; A2 and 
B2). The cell nuclei were detected with DAPI (blue). Scale bars 20 µm. 
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4.3.4. Ultrastructural analysis via transmission electron microscopy 
The ultrastructural characteristics of iCell-CMs were investigated via transmission electron 
microscopy and compared to adult rat cardiomyocyte controls. In initial experiments cell 
samples for TEM imaging were processed via a standard RT resin embedding protocol. For 
this method cell suspensions of adult rat cardiomyocytes and iCell-CMs, which were 
enzymatically removed from their culture substrate, were fixed and concentrated into a dense 
pellet in agarose before being further processed and infiltrated with resin. The TEM images of 
such resin embedded adult rat controls revealed a vast amount of damaged cells and cell 
debris (De) with recognisable free-floating rounded mitochondria (M) and dispersed 
myofilaments (Myfil; Fig.  4.9. A). However, a few intact rat cardiomyocytes could also be 
detected. These exhibited a highly organised ultrastructure with various subcellular structures 
recognisable (Fig.  4.10. A-C). The electron micrographs revealed the cell nucleus (N) and 
the cell cytoplasm packed with highly aligned myofibrils (Myf), which were in close 
association with mitochondria. The myofibrils contained parallel Z lines and I bands, which 
confine the typical sarcomeric pattern. The mitochondria appeared empty, due to contents 
leaching out during the sample preparation technique, probably due to osmotic effects of the 
media. Also, the nucleus showed some signs of dehydration artefacts (convoluted membrane 
appearance). Other membrane structures visible in close association with the sarcomeres 
might represent SR cisternae [25-100 nm; (Jorgensen et al., 1988)], which can appear in the 
interfibrillar spaces along the sarcomeres, and cross-sections of T-tubules [mean diameter in 
rat ventricular cardiomyocytes 200-300 nm; (Brette and Orchard, 2003)], which occur close to 
the Z lines of sarcomeres. In contrast, TEM images of the iCell-CM samples showed only 
poorly preserved cells and cell debris (Fig.  4.9. B). These results prompted us to test another 
sample preparation method. Adult cardiomyocytes and iCell-CMs, respectively, were plated 
as monolayers on small sapphire discs (3 mm diameter) and fixed, processed and embedded 
into resin in a similar way as with the standard RT resin embedding method but with the cells 
still attached to the sapphire discs. These discs were only removed after the cells were tightly 
anchored in cured resin blocks so that the morphology and orientation of the cells within the 
cell monolayer remained preserved. With this method a number of well-preserved rat adult 
cardiomyocytes and iCell-CMs could be detected via TEM.  
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The micrographs of adult rat cardiac cells from sapphire discs (Fig.  4.10. D) were of similar 
quality as the images of cells prepared via the standard RT resin embedding method. Several 
cellular structures, which are described above, were visible including parallel aligned 
myofibrils, mitochondria, cell nucleus, SR and TT structures.  
In TEM images of iCell-CMs from sapphire discs (Fig.  4.11) various cell features could be 
observed. Generally these cells did not display the highly organised arrangement of 
subcellular components as seen in the adult rat controls. iCell-CMs displayed variable 
degrees of myofibrillar organisation. Some cell sections showed a scattered distribution of 
myofilaments bundles (Myofil) throughout the cytoplasm (Fig.  4.11. A), whilst other foci 
displayed parallel arrays of myofibrils organised into sarcomeres (Fig.  4.11. B-C), which 
were separated by Z bands. No I- or A- bands were recognisable in the myofibrils. 
Furthermore, various other cell components were visible in the cytoplasm: abundant 
mitochondria (Fig.  4.11. B and E), free ribosomes (Fig.  4.11. C), large glycogen deposits 
(Fig.  4.11. D), cell nucleus (Fig.  4.11. E) and various other membrane structures, which 
might represent the SR or the rough SR (Fig.  4.11. E-F) but seemed generally not to be 
associated with the myofibrils. No TTs-resembling structures, which have an average 
diameter of 400 nm in human adult ventricular cardiomyocyts (Jayasinghe et al., 2011), could 
be detected. Additionally the cells possessed clustered 50 nm structures morphologically 
consistent with caveolae (Fig.  4.12. A-B). 
4.3.5. Electrophysiological studies: response of iCell-CMs to chronotropic 
drugs 
In mature cardiomyocytes the SR Ca
2+
 has a major contribution to cell contraction. The 
immunofluorescence and qRT-PCR studies, presented above, demonstrated that iCell-CMs 
expressed major proteins implicated in Ca
2+
 cycling including L-type Ca
2+
 channels and the 
SR components SERCA2a and RyR2 (though in low amounts). In order to examine whether 
these Ca
2+
 handling proteins are functional and whether the SR Ca
2+
 release has a 
substantial contribution to ECC iCell-CMs were tested for their sensitivity to drugs, which 
affect SR function. The drugs tested included caffeine (Caf), a reversible activator of RyR2, 
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Fig.  4.9. TEM images of an adult rat cardiomyocyte and iCell-CM processed via 
standard RT resin embedding. 
The images display a damaged adult rat cardiomyocyte (adult rat CM; A) and a poorly 
preserved iCell-CM (B) with free floating rounded mitochondria (M), scattered myofilaments 
(Myfil) and other cell debris (De). Scale bars 0.5 µm (A) and 2 µm (B). 
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Fig.  4.10. TEM images of adult rat cardiomyocytes. 
Image A, B and C show adult rat cardiomyocytes processed via standard RT resin 
embedding as cell suspensions. The cells are packed with mitochondria (M) in close 
association with parallel aligned myofibrils (Myf). The myofibrils contain sarcomeres (Sc), 
which are flanked by Z-lines (Z), and I-bands (I) are also visible. Sarcoplasmic reticulum (SR) 
structures are located adjacent to myofibrils and T-tubules (TT) occur at the Z-line junctions. 
Electron micrograph C displays the cell nucleus (N), which shows some signs of dehydration 
artefacts. D displays an adult rat cardiomyocyte processed and embedded in resin attached 
to a sapphire disc. Scale bars 0.5 μm (A-C) and 2 µm (D). 
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Fig.  4.11. Electron micrographs of iCell-CMs from sapphire disc cultures. 
The micrographs display iCell-CMs, which were grown and embedded in resin as monolayers on sapphire discs. iCell-CMs showed randomly 
dispersed bundles of myofilaments (Myfil) throughout the cytoplasm (A) as well as organised myofibrils (Myf) with recognisable Z-lines (Z; see 
B-C). The cells also showed the presence of mitochondria (M; see B and E), free ribosomes (Rib; in C), glycogen granules (Gly; see D) and 
sarcoplasmic reticulum (SR) cisternae (see E-F). N: cell nucleus. C shows a magnified view of the region shown in the yellow box in B. Scale 
bars 1000 nm (A and F) and 2 µm (B-E). 
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Fig.  4.12. TEM images of iCell-CMs displaying caveolae. 
iCell-CMs (A-B) exhibited a large amount of caveolae (Cav), the membrane microdomains 
potentially implicated in TT development or organisation and cell signalling. B shows a 
magnified view of the region outlined by the yellow box in A. Scale bars 1000 nm (A) and 500 
nm (B).  
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which empties SR Ca
2+
 stores and inhibits phosphodiesterase; and thapsigargin (Thg), a 
specific, high-affinity inhibitor of SERCA2a, which abolishes SERCA2a-mediated SR Ca
2+
 
reuptake irreversibly. To measure the drug effect iCell-CMs were plated on micro electrode 
array probes (Fig.  4.13. A) and their beating rate was measured by recording the 
extracellular field potential of iCell-CM clusters. 
Treatment with caffeine (10 mM) had a rapid effect on the cells (Fig.  4.13. B): It inhibited 
spontaneous contractility within one minute (n=3). This caffeine effect was reversible as 
spontaneous contraction reappeared after drug wash out. The addition of thapsigargin also 
interfered with the spontaneous contraction of the cells although only after longer incubation 
times (Fig.  4.13. C). Treatment with thapsigargin at 1 µM reduced the beating rate on 
average by 40 % after 15 min. The contraction was further reduced or completely ceased 
within 15 min in 10 µM Thg. These results imply that iCell-CMs were dependent on 
intracellular SR Ca
2+
 for contraction. 
4.4. Discussion 
4.4.1. Bright field analysis of Shef3-CMs and iCell-CMs 
Bright field microscopy revealed that Shef3-CMs and iCell-CMs, which were dispersed into 
single cells or small clusters, exhibited a markedly different morphology compared to primary 
adult rat cardiomyocytes. These cells did not display the typical rod-shaped striated 
phenotype of the adult cardiomyocytes and were approximately three times thinner than the 
adult rat cells. These morphological differences may be partially due to the culture conditions. 
The in vitro culture on a two-dimensional matrix is not representative of the three dimensional 
in vivo environment of the heart muscle tissue, in which cardiomyocytes are joined end to 
end to other cardiomyocytes, are surrounded by extracellular matrix and tightly packed with 
other supporting cell types. Also, it is well known that with prolonged in vitro culture the 
primary adult cardiomyocytes undergo “dedifferentiation“ with noticeable phenotypic 
changes: the cells gradually lose their in vivo rod-shaped morphology becoming more  
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Fig.  4.13. Response of iCell-CMs to caffeine and thapsigargin. 
(A) Monolayer clusters of contracting iCell-CMs on a micro electrode array probe. (B) 
Spontaneously beating clusters of iCell-CMs (n=3) were treated sequentially with 1 mM (t=0 
min) and 10 mM caffeine (Caf; t=3 min) in culture medium and then washed once with 
medium (t=6 min). Spontaneous contractility was inhibited by Caf (10 mM) within 1 min but 
reappeared after drug wash out. (C) Clusters of spontaneously contracting iCell-CMs (n=4) 
were treated in a sequential manner with 1 µM (t=0 min) and 10 µM thapsigargin (Thg; t=15 
min) in cell culture medium. Treatment with Thg (for 15 min at 1 µM) reduced the beating rate 
on average by 40 %. With increased concentration of Thg (10 µM) the contraction was further 
reduced or completely ceased within 15 min. The beating rate in beats per minute (bpm) was 
recorded via MEA.  
A 
B 
C 
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rounded and flatter and show reduced density of the TT network (Piper et al., 1988; Lipp et 
al., 1996).  
Shef3-CMs and iCell-CMs showed similar morphologies. However, although both cultures 
were not elder than approximately 45 days and can be regarded as early-stage hPSC-CMs 
more binucleated cells could be observed in cultures of iCell-CMs than in cultures of Shef3-
CMs. This suggests that the iCell-CMs may have been more mature than Shef3-CMs 
because the generation of a second nucleus usually occurs in a later stage of development 
(Jonker et al., 2007).  
4.4.2. qRT-PCR 
Gene expression analysis via qRT-PCR revealed that iCell-CMs expressed a number of 
cardiomyocyte-characteristic genes including those coding for transcription factors, ion 
channels, structural proteins, TT-proteins and Ca
2+
 handling components. Compared to adult 
and foetal human heart controls, the gene expression levels in iCell-CMs generally 
resembled those measured in the foetal heart tissue (19-21-week). These findings are 
consistent with other studies, which analysed the gene expression profiles in hESC-CMs and 
showed that cardiac gene expression in hESC-CMs was similar to foetal human heart (Asp et 
al., 2010; Cao et al., 2008). 
Relative to AH and similar to FH iCell-CMs showed high expression of immature transcription 
factors such as GATA4 and Nkx2.5, which are highly expressed in early developmental 
stages playing a significant role in early cardiogenesis (Hiroi et al., 2001; Watt et al., 2004). 
Furthermore, the cells demonstrated decreased expression of contractile proteins including 
βMHC, which is the predominant isoform in mature human ventricles [whereas in adult 
ventricular rat cardiomyocytes the αMHC isoform predominates (Weiss and Leinwand, 1996; 
Lompre et al., 1984)], and MLC2v suggesting an underdeveloped contractile machinery. 
Also, iCell-CMs showed high expression of T-type (Cav3.1) and L-type (Cav1.2) Ca
2+
 
channels but several fold lower expression of Kv4.3 and Kir2.1. High T-type Ca
2+
 channel 
expression levels were also shown in hESC-CMs (Otsuji et al., 2010). Indeed, the high 
expression is typical for embryonic hearts and diminishes during development in ventricular 
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cardiomyocytes (Ono and Iijima, 2010; Qu and Boutjdir, 2001). In contrast, the detection of 
high expression levels of L-type Ca
2+
 channels was surprising since Cav1.2 expression is 
generally reported to increase during development. Interestingly, high expression levels of 
Cav1.2 were also observed in hESC-CMs by Asp and co-workers (Asp et al., 2010). An 
explanation for the high expression of Cav1.2 seen in this qRT-PCR study might lie in the 
primer choice. The Cav1.2 subunit undergoes extensive alternative splicing, which results in 
the generation of at least 40 different transcript variants (Tang et al., 2004). The primer used 
for qRT-PCR recognised only twenty transcript variants. It is possible that these might be a 
predominant transcript variant combination in the foetal but not in the adult heart.  
Kir2.1 contributes to the generation of the inwardly rectifying potassium current IK1, which 
plays a role in the stabilisation of the resting membrane potential and the late repolarisation 
phase of the action potential (Chen et al., 1991). The relatively low expression of Kir2.1 
observed in this study in iCell-CMs is in line with the results of other reports, which 
demonstrated low expression or even complete absence of Kir2.1 and the IK1 current in early 
hESC-CMs (Satin et al., 2004; Otsuji et al., 2010). The absence of the inwardly rectifying 
potassium current is suggested to be responsible for the spontaneous activity of hPSC-CMs 
(Satin et al., 2004).  
Apart from PLN, the expression levels of most of the Ca
2+
 handling proteins were below AH. 
Moreover, the expression levels of RyR2, the major SR Ca
2+
 release channel, and CSQ2, 
which is important for Ca
2+
 storage in the SR lumen (Scott et al., 1988) and can modulate the 
activity of RyR2 (Knollmann, 2009), were even significantly lower than in FH. This relatively 
low expression of these key SR Ca
2+ 
regulatory components implies low Ca
2+
 content in the 
SR and altered Ca
2+
 handling properties in iCell-CMs. Interestingly, Lee et. al. (Lee et al., 
2011) reported recently that cardiomyocytes derived from two different hiPSC lines exhibited 
significantly lower expression of RyR2 and SERCA2a than hESC-CMs. The authors argue 
further that the Ca
2+
 handling properties of hiPSC-CMs are immature even compared to 
hESC-CMs.  
The expression of IP3R2 in iCell-CMs was comparable to FH. In adult cardiomyocytes ECC 
relies principally on CICR from the SR stores via RyR2. In immature cardiomyocytes IP3R2-
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mediated SR Ca
2+
 release may stimulate CICR and contribute to the activation of contraction 
(Janowski et al., 2010). 
In contrast to RyR2 and CSQ2 SERCA2a and NCX1, which allow relaxation of cardiac cells 
by removing Ca
2+
 from the cytosol after contraction, were expressed at levels comparable to 
AH. The high expression of the SERCA2a regulator PLN in iCell-CMs (approximately five fold 
higher than in FH) corresponds to the relatively high expression level of PLN seen in hESC-
CMs (Asp et al., 2010) but is nevertheless unexpected, given that the expression of 
SERCA2a does not reflect the same level of relative increase. Such high expression of PLN 
may have a strong inhibiting effect on the function of SERCA2a. The expression of PLN is 
limited to the SR and as a SERCA2a regulator (Koss and Kranias, 1996) PLN can bind 
SERCA2a and lower its affinity for Ca
2+
 and as a result decrease the uptake of Ca
2+
 into the 
SR and reduce contractility. However, the qRT-PCR experiments do not provide any 
information about the phosphorylation status of the expressed proteins thus the PLN protein 
may be phosphorylated in iCell-CMs and have no effect on SERCA2a.  
Finally, qRT-PCR analysis showed that iCell-CMs expressed markedly low levels (even 
compared to FH) of Bin1 and Cav3, which may be implicated in TT development or 
organisation (Lee et al., 2002; Parton et al., 1997; Carozzi et al., 2000; Galbiati et al., 2001). 
The low expression of Bin1 and Cav3 indicated that iCell-CMs are unlikely to possess any 
TTs at this stage of development. Thus the high expression of JP2 (approximately five-fold 
higher in iCell-CMs than in AH), which is reported to link the TT with the SR membrane, was 
surprising. This is further discussed in section 4.4.3.2. Also surprising was the large 
difference between the relatively low Cav3 expression level in iCell-CMs and the high 
expression level detected in FH (almost twice higher than in AH).  
4.4.2.1. General qRT-PCR limitations 
Expression levels of cardiac genes may vary dramatically depending on the heart region and 
healthiness of the heart. In this study the aim was to compare gene expression levels of iCell-
CMs with healthy human ventricular cardiomyocytes. iCell-CMs represent a mixture of nodal, 
atrial and ventricular cardiomyocytes but with 50 % of the cells showing the ventricular-like 
Chapter 4: Characterisation of Shef3-CMs and iCell-CMs  
 
149 
 
action potential (correspondence with CDI), qRT-PCR results most likely have relevance to 
gene expression pattern in the ventricles.  
With regard to the FH and AH controls, which were used in this qRT-PCR study, the 
manufacturer (Stratagene) reassured us that the samples were derived from the ventricles 
but could not exclude that some samples were derived from diseased myocardium. However, 
generally there was a good correlation between the qRT-PCR results obtained in this study 
and previously published data on relevant gene expression pattern in healthy foetal and adult 
human ventricular heart tissue. 
In this study GAPDH was used as a housekeeping gene and was used for normalisation of 
all qRT-PCR values. GAPDH was chosen because it was used as a reference gene 
previously in a number of publication measuring gene expression pattern in human 
embryonic and induced stem cell-derived cardiomyocytes (Sartiani et al., 2007; Földes et al., 
2011; Germanguz et al., 2011). It is reported that cell proliferation and density can alter the 
expression of housekeeping genes, including GAPDH (Goldsworthy et al., 1993; Greer et al., 
2010). However, iCell-CMs are non-proliferative (as specified by the manufacturer CDI) and 
were plated onto 6-well plates with equal densities per well. Thus cell density was assumed 
relatively stable during the course of the experiments and was unlikely to affect the 
expression of GAPDH. 
qRT-PCR data does not give any evidence on mRNA stability, posttranslational modifications 
or subunit assembly thus protein levels may differ from mRNA transcript levels in the cells. 
Protein assays and functional analysis would provide further information to put data into 
physiological context. 
4.4.3. Immunofluorescence studies 
4.4.3.1. Expression of sarcomeric and Ca
2+
 handling proteins 
Immunofluorescence studies of beating Shef3-CMs and iCell-CMs confirmed that these cells 
expressed appropriate cardiac proteins such as the sarcomeric protein α-actinin and the SR 
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Ca
2+
 handling proteins RyR2, SERCA2a, PLN and Cav1.2. However, the staining pattern of 
these proteins in the hPSC-CMs did not represent the highly organised staining pattern, 
which was detected in the adult cardiomyocytes. 
The striated staining pattern of α-actinin and PLN (less defined for RyR2 and SERCA2A) in 
some cell areas revealed that Shef3-CMs and iCell-CMs possessed myofibrils with 
sarcomeric organisation and that the SR was at least partially associated with the myofibrils. 
However, the irregularity of the α-actinin and PLN banding pattern indicates a relatively 
disorganised myofibrillar and SR organisation, which is typical for immature early stage 
cardiomyocytes. Also, RyR2 staining showed a very low fluorescence signal, which indicates 
a low expression of RyR2 at this developmental stage of the cells (30-45 days old). 
Staining for Cav1.2 revealed a punctate expression pattern. Double-labelling for RYR2 and 
Cav1.2 in iCell-CMs exhibited no co-localisation of the two proteins in any cell area. This 
implies that no Cav1.2/RyR2 couplons, which are essential for CICR (Bers, 2002), were 
present in iCell-CMs. This result is surprising because it was reported that in developing 
mammalian cardiomyocytes, which lack TTs, L-type Ca
2+
 channel/RyR couplons can form at 
the cell periphery at the sarcolemma (Sedarat et al., 2000). However, in the present study the 
fluorescent signals of RyR2 and Cav1.2 were weak and the punctate fluorescent signals of 
Cav1.2 were small so that the detection of co-localisation signals was visually difficult. 
4.4.3.2. Plasma membrane staining and expression of TT-associated proteins 
Staining of Shef3-CMs and iCell-CMs with WGA-Alexa Fluor 488 and CMO (iCell-CMs only) 
revealed no evidence that TT-like invaginations were present in these cells. The lack of TTs 
is a feature iCell-CMs share with ventricular cardiomyocytes from embryonic and newborn 
animals and highlights the immature phenotype of these cells. TTs are considered to form 
very late during cardiac development. It was shown in smaller mammals such as rats and 
rabbits that TTs are absent or underdeveloped at birth but develop rapidly after birth (Sedarat 
et al., 2000; Ziman et al., 2010). Also, this study showed that iCell-CMs were relatively thin 
even compared to adult rat cardiomyocytes (3-6 µm versus 10-20 µm; see section 4.3.1.). 
The formation of TT invaginations may not be beneficial in such flat cells but may occur with 
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hypertrophic growth of the cells. Indeed, adult ventricular cardiomyocytes of birds, fish and 
small lizards, which are also only approximately 5 µm thick, also lack TTs (Myklebust et al., 
1980; Myklebust and Kryvi, 1979; Perni et al., 2012). However, despite the lack of TT 
invaginations iCell-CMs sowed positive staining for the TT-associated proteins Bin1, Cav3, 
JP2 and Tcap although their staining pattern in iCell-CMs did not correspond to the regular 
striated staining pattern seen in the adult rat cardiomyocytes. In iCell-CMs the Bin1 staining 
was confined almost exclusively to the nucleus, Cav3 and JP2 showed a punctate staining 
throughout the cytosol of the cells and Tcap displayed striated staining only in some cell 
regions. These results suggest that the detected proteins might play TT-independent roles or 
might be not functional in iCell-CMs at this developmental stage.   
The positive staining for Bin1 in iCell-CMs may also be due to a ubiquitously expressed Bin1 
isoform because the Bin1 antibody used for immunolabelling in this study was not exclusive 
for the muscle-specific Bin1 protein. Bin1 is described to have several isoforms, which show 
a nuclear localisation and were for example implicated in cell growth regulation through both 
Myc-dependent and Myc-independent mechanisms (Elliott et al., 1999). However, so far only 
the muscle-specific isoform was shown to be targeted to the outer cell membrane and to 
induce membrane invaginations. 
Cav3, the scaffolding protein of caveolae, is generally considered as a TT protein marker, 
since it localises on the TT membrane but it is also considered to associate with various 
regulatory proteins and to be important for cell signal transduction (Smart et al., 1999). 
JP2 is thought to complex between the plasma membrane and the membrane of the SR 
(Pozzan et al., 1994; Takeshima et al., 2000). However, since no co-localisation of RyR2 and 
Cav1.2 could be detected in iCell-CMs the strong expression of JP2 mRNA (almost two-fold 
and five-fold higher than in FH and AH, respectively) and the robust staining for the JP2 
protein seen in the immunofluorescence images suggest that JP2 may play additional, yet 
unknown, TTs-independent roles in developing cardiomyocytes.  
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4.4.4. Ultrastructural analysis via transmission electron microscopy 
For ultrastructural analysis of iCell-CMs and adult rat cardiomyocytes via TEM two sample 
preparation methods were evaluated including a RT resin embedding method using cell 
suspensions and a RT resin modified embedding technique using cell samples attached to 
sapphire discs. The standard RT resin embedding technique was successfully used in 
various previous studies for TEM preparation of EBs containing PSC-CMs (Kehat et al., 
2001; Snir et al., 2003). However, in this study it was shown that this preparation technique 
was less suitable for single cell suspensions of iCell-CMs possibly due to the sensitivity of the 
single cells to mechanical stress. Whilst a number of intact adult rat cardiomyocytes could be 
identified no well preserved intact iCell-CMs could be detected in the respective TEM images.  
Growing cells on sapphire discs and processing and embedding them into resin directly with 
the discs showed to be a more suitable strategy. With this technique both iCell-CMs and 
adult rat cardiomyocytes showed improved preservation. Processing the cells on sapphire 
discs has also the benefit of conserving the cell orientation and structure of the cell culture 
and allows light/fluorescence microscope examination of the cell samples prior to TEM 
preparation.   
TEM images of adult rat cardiomyocytes revealed that the cells possessed a highly organised 
ultrastructure with parallel aligned myofibrils and mitochondria, TTs and SR compartments 
(including junctional SR) associated with the myofibrils. In contrast iCell-CMs showed a 
relatively immature structural phenotype. They demonstrated sparse stacks of myofibrils with 
varying degrees of sarcomeric organisation and random orientation within a cell, a high 
content of glycogen, which is characteristic for foetal heart cells (Gutierrez-Correa et al., 
1991), abundant amount of free ribosomes throughout the cytosol, which implies a highly 
active protein syntheses within the cells, mitochondria scattered randomly in the cytosol, 
some SR cisternae and no TTs.  
Furthermore, the ultrastructural analysis revealed the presence of caveolae. These 
specialized lipid rafts in the plasma membrane are not only described to be involved in TT 
development (Galbiati et al., 2001) but are also thought to play an important role in cell 
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signalling in ventricular cardiomyocytes by hosting a wide range of regulatory proteins and 
ion channels including beta 2-adrenergic receptors and Na
+
 channels (Xiang et al., 2002; 
Yarbrough et al., 2002). 
The findings of this study compare to other studies analysing the ultrastructure of hiPSC-CMs 
(Gherghiceanu et al., 2011) and hESC-CMs (EB clusters up to 27 days post plating) (Snir et 
al., 2003; Kehat et al., 2001). These studies found similar cell features and describe hPSC-
CMs as being phenotypically immature. Moreover, Gherghiceanu et. al. (Gherghiceanu et al., 
2011), who analysed the ultrastructure of hiPSC-CMs, reported to have identified structures 
resembling “Ca2+ release units” (couplons; also discussed above), which connected the 
sarcolemma with the peripheral SR cistern. In this study no couplons could be detected via 
TEM in iCell-CMs though since the authors also describe them to be rare it cannot be 
excluded that they appear in iCell-CMs but were not present in the examined TEM cell 
sections.   
4.4.5. Calcium handling properties in iCell-CMs 
To determine whether iCell-CMs exhibited loaded SR Ca
2+
 stores, which release and uptake 
Ca
2+
 via functional RyR2 and SERCA2a, respectively, it was tested whether iCell-CMs 
responded to caffeine and thapsigargin. Caffeine rapidly releases SR Ca
2+
 by opening RyR2 
whereas thapsigargin inhibits SERCA2a thus blocking SR Ca
2+
 reuptake. The MEA 
recordings revealed that iCell-CMs were sensitive to both drugs. Caffeine (10 mM) ceased 
contraction. Thapsigargin (10 µM) decreased and finally ceased spontaneous beating in a 
concentration dependent manner and after prolonged incubation times. These findings 
suggest that functional RyR2- and SERCA2a-mediated SR Ca
2+
 stores were present in iCell-
CMs and contributed to contraction.  
These results are in agreement with a previous study by Itzhaki et al. (Itzhaki et al., 2011a), 
who analysed the Ca
2+
 handling properties in hiPSC-CMs and also found that hiPSC-CMs 
(30-50 days old) were sensitive to caffeine and thapsigargin treatment. The authors tested 
the effects of the drugs on whole-cell Ca
2+
 transients and showed that caffeine application 
triggered a rapid increase in cytosolic Ca
2+
 whilst thapsigargin decreased the amplitude of 
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whole cell Ca
2+
 slowly and progressively. Furthermore, various studies showed that hiPSC-
CMs were also sensitive to the RyR-inhibitor ryanodine (Itzhaki et al., 2011a; Germanguz et 
al., 2011; Lee et al., 2011). Collectively, these findings indicate that hiPSC-CMs express 
functional SR Ca
2+
 stores and that the SR Ca
2+
 release contributes at least partially to ECC. 
However, contraction of iCell-CMs may also depend on transsarcolemmal Ca
2+
 influx similar 
to foetal cardiomyocytes. Ca
2+
 entry into the cytosol can be mediated not only by L-type but 
also by T-type Ca
2+
 channels (Cav3.1) and NCX1. Ca
2+
 removal from the cytosol can depend 
more on NCX1 (in forward mode) and the plasmalemmal Ca
2+
 ATPase (Tohse et al., 2004). 
As shown via qRT-PCR iCell-CMs expressed relatively high levels of both Cav3.1 and NCX1 
(see section 4.3.2.).   
4.5. Conclusions 
In summary the characterisation study of Shef3-CMs and a more comprehensive study of 
iCell-CMs revealed that these cell types show generally an immature phenotype resembling 
embryonic cardiomyocytes. However, some adult-like features are present. 
Immunofluorescence analysis showed that Shef3-CMs and iCell-CMs expressed 
characteristic cardiac contractile proteins such as α-actinin and αMHC and SR Ca2+ handling 
components including RyR2 and SERCA2a. However, the highly organised mature 
sarcomeric pattern for myofibrils and SR has not been established at this developmental 
stage yet. Also, no TTs could be detected. qRT-PCR results for iCell-CMs demonstrated with 
few exceptions generally a foetal-like gene expression profile. TEM analysis revealed overall 
disorganised cell architecture in iCell-CMs unlike the well ordered and aligned ultrastructure 
in adult cardiac myocytes. MEA studies revealed that iCell-CMs showed dependence on 
intracellular Ca
2+
 stores for contraction, which implies mature calcium handling properties.  
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Fig.  4.14. Diagram summarising major results of chapter 4. 
CMs: cardiomyocytes, IF: immunofluorescence microscopy, TEM: transmission electron 
microscopy, TTs: transverse tubules.  
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5.1. Introduction 
In the previous chapter it was demonstrated that iCell-CMs revealed overall an immature 
foetal-like phenotype with regards to their gene expression and (ultra)structural and 
electrophysiological properties. In this chapter the aim was to evaluate strategies to drive 
iCell-CMs towards a more mature phenotype.  
First the effect of T3 administration was investigated. T3 is known to be a key mediator in 
cardiac differentiation and maturation [(Klein, 1990); see section 1.4.4. for details). T3 
signalling is described to drive cardiomyocyte maturation among other by regulating the 
expression of a variety of cardiac genes on a transcriptional or postranscriptional level. T3-
responsive genes include ion channels such as the voltage-gated-potassium channels Kv1.5, 
Kv4.2 and Kv4.3 (Ojamaa et al., 1999; Kahaly and Dillmann, 2005), Ca
2+
 handling proteins 
including SERCA2a (Cernohorsky et al., 1998) and structural proteins such as α-/βMHC 
(Morkin, 1993) [effect seen predominantly in animals (Kahaly and Dillmann, 2005)]. The 
transcriptional effects of T3 are mediated by the T3 nuclear receptors THRα and THRβ. 
Second the effect of the overexpression of Bin1(-EGFP) was evaluated. Bin1 has been 
implicated in the induction of tubules in biological membranes (Takei et al., 1999; Razzaq et 
al., 2001) and also localisation of L-type Ca
2+
 channels (Cav1.2) to Bin1-induced membrane 
tubules (Hong et al., 2010). iCell-CMs were shown to express only low levels of Bin1 and to 
lack TTs (see section  4.2.3. and 4.2.5.). In order to investigate whether Bin1 can induce the 
formation of TTs and promote the maturation of Ca
2+
 handling properties in iCell-CMs Bin1 
tagged to EGFP was overexpressed in iCell-CMs. 
5.2. Methods 
5.2.1. T3-treatment 
iCell-CMs were seeded in 6-well plates at 1.25x10
5
-1.5x10
5
 cells/cm
2
, cultured for 7-10 days 
in iCell-CMs Maintenance Medium and incubated with T3 at 3 nM for 48 h. 
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5.2.2. qRT-PCR 
See section 2.5.3. 
5.2.3. Immunostaining 
See section 2.6. 
5.2.4. Transfection of iCell-CMs with Bin1-EGFP 
iCell-CMs were transfected using Lipofectamine 2000. For transfection iCell-CMs were 
typically seeded at densities of 1x10
5
-1.5x10
5
 cells/cm
2
 and cultured for 7-10 days before 
being transfected with the Bin1-EGFP plasmid.  
5.2.5. Transmission electron microscopy 
The immunogold labelling was performed on cell sections embedded in epoxy resin. Anti-
Bin1 (1:5) or anti-α-actinin (1:10) was used as primary antibodies and antibodies conjugated 
with 10 nm gold particles were used as secondary antibodies. For amplification of the gold 
signal the resin sections were incubated with a silver enhancement kit. 
5.2.6. Whole-cell patch-clamping 
For all patch-clamping experiments iCell-CMs were seeded on glass-bottom MatTek dishes 
at low cell densities at 4.5x10
4
-6.2x10
4
 cells/cm
2
 so that individual transfected and non-
transfected iCell-CMs could be studied. The experimental set up also allowed the use of 
fluorescence microscopy when it was necessary to identify Bin1-EGFP transfected iCell-
CMs, which displayed green fluorescence.   
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5.3. Results 
5.3.1. The effect of triiodothyronine hormone on iCell-CM maturation 
5.3.1.1. Molecular analysis of T3-treated iCell-CMs via qRT-PCR 
qRT-PCR analysis was used to compare mRNA expression levels of non-treated (control) 
with T3-treated iCell-CMs. At 3 nM (2 ng/ml, for 48 h) the administrated T3 concentration 
corresponded to the normal T3 concentration found in human serum at birth (1.9±0.96 ng/ml) 
and was similar to the concentrations used by other investigators, who studied the 
maturational T3 effect on sheep foetal cardiomyocytes (Chattergoon et al., 2012). The group 
of genes analysed in this chapter comprised a) the nuclear T3 receptors THRα and THRβ;  b) 
deiodinase type 3 (D3), which is the main enzyme involved in T3-inactivation (Pol et al., 
2010) and might thereby inhibit the T3 action; c) the panel of genes listed in Table 4.1. 
including contractile proteins, ion channels, TTs- and SR Ca
2+
-handling associated genes 
and d) atrial natriuretic peptide (ANP), a cardiomyocytes marker of hypertrophy (Schaub et 
al., 1997). 
qRT-PCR analysis of the mRNA expression pattern of THRα, THRβ and D3 showed the 
following. The expression levels of THRα, THRβ and D3 in T3-treated iCell-CMs did not differ 
from expression levels in control iCell-CMs (Fig.  5.1. A). The expression levels of THRα in 
iCell-CMs corresponded to the adult heart controls and were approximately 1.6-fold lower 
than in the foetal heart controls. In contrary, the expression levels of THRβ corresponded to 
the foetal control levels and were more than 15-fold lower than in adult control samples. The 
expression of D3 in iCell-CMs was significantly below adult and foetal controls with 
expression levels approximately 10-fold and 35-fold lower than in the adult and foetal heart 
tissue samples. 
Furthermore, the qRT-PCR results revealed that T3-treatment increased the expression of 
the hypertrophic marker ANP (Fig.  5.1. B), the potassium channel Kv4.3 (Ito) (Fig.  5.1. C), 
and the SR Ca
2+
-ATPase SERCA2a (Fig.  5.1. D) by approximately 1.7-fold, 2-fold and 1.6-
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fold, respectively, and down-regulated the expression of the T-type Ca
2+-
channel Cav3.1 (Fig.  
5.1. C) by more than 1.5-fold. T3 did not increase the expression of any other Ca
2+-
handling 
(e.g. RyR2; Fig.  5.1. D) or TTs-related genes (e.g. Bin1 and JP2 Fig.  5.1. E). 
5.3.1.2. Immunofluorescence analysis of SERCA2a expression in T3-treated 
iCell-CMs 
In order to investigate whether the increased SERCA2a expression in the T3-treated iCell-
CMs was accompanied by a remodelling of the SR towards a more mature structural 
organisation control and T3-treated samples were immunolabelled against SERCA2a and 
visualised via confocal microscopy. The resulting fluorescence images revealed that there 
was no detectable difference in the strength of the fluorescent signal of SERCA2a between 
the T3-treated (Fig.  5.2. A-B) and control iCell-CMs (Fig.  5.2. C-D). Also, the T3-treated 
cells did not show a visible higher degree of SR organisation. Both samples revealed cells 
with variable degrees of structural organisation and only a minority of cells with a 
recognisable banding pattern (arrows in Fig.  5.2. A and D).  
5.3.1.3. Plasma membrane staining of T3-treated iCell-CMs 
Finally, it was examined whether T3-treated iCell-CMs showed any evidence of TTs 
formation. For this T3-treated and control iCell-CMs were stained with the membrane dye 
CMO. The resulting immunofluorescence images showed no evidence of TTs formations. T3-
treated (Fig.  5.3. A) as well as control iCell-CMs (Fig.  5.3. B) demonstrated only few 
fluorescent dots and streaks, which represent presumably non-specific staining, but no 
repetitive tubule-like structures could be detected. 
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For figure legend see page 162. 
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Fig.  5.1. Effect of T3 on gene expression in iCell-CMs. 
iCell-CMs were incubated with 3 nM triiodothyronine (T3). After 48 h total RNA was isolated 
and assayed by qRT-PCR to measure the expression levels of (A) T3 receptor alpha and 
beta (THRα and THRβ) and deiodinase type 3 (D3); (B) structural proteins and general 
cardiac markers; (C) ion channels; (D) genes coding for SR Ca
2+
 handling components and 
(E) genes coding for proteins implicated in TT development or maintenance. T3-treated iCell-
CMs were compared with non-treated cells. Adult human heart (AH) and foetal human heart 
tissue (FH) were used as controls. qRT-PCR results from iCell-CM samples were obtained in 
triplicate and results from AH and FH in singlets, in n=2 preparations. All values were 
normalised with respect to GAPDH and shown relative to the corresponding values in AH 
(AH=1). Error bars represent ±SEM. Statistical significance between the two means was 
determined using unpaired Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). 
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Fig.  5.2. Immunostaining of SERCA2a in T3-treated and control iCell-CMs. 
T3-treated (A-B) and control iCell-CMs (C-D) were labelled with a primary antibody against 
SERCA2a. Alexa Fluor 488 (green) was used as secondary antibody. Arrows in A and D 
show cell regions with a striated SERCA2a staining pattern. Nuclei were stained with DAPI 
(blue). Scale bars 30 µm in A and 20 µm in B-D.  
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Fig.  5.3. Staining of the cell plasma membrane of T3-treated iCell-CMs with CellMask 
Orange. 
Non-permeabilised T3-reated (A) and control iCell-CMs (B) were incubated with the plasma 
membrane dye CellMask Orange (CMO) and analysed via immunofluorescence microscopy. 
Arrows show fluorescent dots and streaks within T3-treated and non-treated cells 
representing presumably non-specific staining. Scale bars 20 µm. 
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5.3.2. Overexpression of Bin1-EGFP in iCell-CMs 
5.3.2.1. Transfection of iCell-CMs: Formation of tubular structures 
In order to investigate the effect of Bin1 on cell structure iCell-CMs (Fig.  5.4. A) were 
transfected with a expression plasmid encoding Bin1-EGFP. 48 h after transfection distinctive 
green fluorescent cells could be detected via immunofluorescence microscopy in 30-50 % of 
the plated iCell-CMs (Fig.  5.4. B-C). Higher magnifications of the green fluorescent iCell-
CMs revealed that the cells contained numerous green fluorescent tubular structures 
throughout the cell body (Fig.  5.5. A1 and A4). 
Immunolabelling of transfected and non-transfected (control) iCell-CMs with an antibody 
against the Bin1 protein (Fig.  5.5. A2, A5 and B2) revealed that in transfected cells the Bin1-
antibody staining overlapped with the tubular Bin1-EGFP expression pattern throughout the 
cells (Fig.  5.5. A3 and A6) whereas in control cells it was predominantly confined to the cell 
nucleus (Fig.  5.5. B3). These results imply that the tubular structures detected in transfected 
iCell-CMs were induced by Bin1-EGFP.  
5.3.2.2. Staining of the plasma membrane of transfected iCell-CMs 
In order to determine whether the tubules detected in Bin1-EGFP expressing iCell-CMs were 
continuous with the cell surface membrane the cells were labelled with the lipid dye CMO or 
the glycocalyx binding WGA-TRITC. Immunofluorescence microscopy revealed that the 
tubular structures showed positive staining for CMO (Fig.  5.6. A1-A6) demonstrating that 
they were accessible for the membrane impermeable dye and thus connected to the plasma 
membrane. In contrast, surprisingly, no tubular structures could be detected using WGA-
TRITC which is inconsistent with the CMO data (Fig.  5.6. B1-B6). These observations are 
discussed in section 5.4.3.  
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Fig.  5.4. Overexpression of Bin1-EGFP in iCell-CMs. 
iCell-CMs (A, bright field) were transfected with a plasmid expressing Bin1-EGFP. Analysis of 
the cells via immunofluorescence microscopy revealed that 48 h after transfection bright 
green fluorescent cells emerged (B). The transfection efficiency represented 30-50 % as 
evaluated by the number of green fluorescent cells (C). Scale bars 100 µm.  
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Fig.  5.5. Immunostaining of transfected and control iCell-CMs against Bin1. 
iCell-CMs transfected with Bin1-EGFP (A1-A6; green) and non-transfected control iCell-CMs 
(B1-B3) were stained with a primary antibody against Bin1 (Bin1 AB). Alexa Fluor 555 was 
used as secondary antibody (red). Nuclei were visualised via DAPI (blue). A4-A6 represent a 
magnified view of the region outlined by the yellow box in A1-A3. Scale bars 20 µm. 
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Fig.  5.6. Labelling of the plasma membrane of Bin1-EGFP expressing iCell-CMs. 
iCell-CMs expressing Bin1-EGFP (green; A1, A4, B1, B4) were stained with the plasma 
membrane dyes CellMask Orange (CMO; A2 and A5) or WGA-TRITC (red; B2 and B5) and 
analysed via immunofluorescence microscopy. Labelling with CMO produced a staining 
pattern, which overlapped with the green fluorescent tubule structures (A3 and A6). In 
contrast, staining with WGA-TRICI did not reveal any tubule like staining, which overlapped 
with the green fluorescent structures (B3 and B6). A4-A6 and B4-B6 display a magnified view 
of the region shown by the yellow box in A1-A3 and B1-B3, respectively. Scale bars 20 µm. 
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5.3.2.3. Characterisation of the Bin1-EGFP induced tubules 
To elucidate the structural properties of the tubules induced in Bin1-EGFP expressing cells, it 
was first investigated whether the tubules were associated with the myofibrils within iCell-
CMs. Immunofluorescence analysis of transfected cells stained for sarcomeric α-actinin (Fig.  
5.7. A1-A6) revealed that the green fluorescent tubules showed no continuous overlapping 
with the α-actinin banding pattern (Fig.  5.7. A3 and A6) but a number of foci with overlapping 
fluorescent signals (arrows in Fig.  5.7. A6) could be observed.  
Next it was examined whether the tubules showed any co-localisation with Cav1.2 channels, 
which are found abundantly in TTs of adult cardiomyocytes. Immunofluorescence staining for 
Cav1.2 (Fig.  5.8. A1-A6) in transfected cells showed a punctate Cav1.2 staining pattern (A2 
and A5) similar to that seen in non-transfected iCell-CMs (see section 4.3.3.1.). However, 
only few of the Cav1.2-immunoreactive puncta showed co-localisation with the green 
fluorescent structures (arrows in Fig.  5.8. A6).  
Furthermore, transfected iCell-CMs were labelled against the SR proteins RyR2 (Fig.  5.8. 
B1-B6), SERCA2a (Fig.  5.8. C1-C6) and PLN (Fig.  5.8. D1-D6) to investigate whether the 
tubular structures in the transfected cells were connected with the cellular SR system. Similar 
to the results with Cav1.2 the staining pattern of RyR2, SERCA2a and PLN in transfected 
iCell-CMs resembled the pattern seen in non-transfected cells described in section 4.3.3.1: 
RyR2 gave only a weak fluorescent signal (Fig.  5.8. B2 and B5) indicating a low RyR2 
expression; SERCA2a (Fig.  5.8. C2 and C5) and PLN (Fig.  5.8. D2 and D5) gave a stronger 
signal throughout the cells and PLN staining showed a banding pattern in some cell areas. 
None of the SR protein staining in the transfected cells showed continuous alignment with the 
green fluorescent tubules (see Fig.  5.8. RyR2 in B3 and B6, SERCA2a in C3 and C6 and 
PLN in D3 and D6). However, some overlapping fluorescence signals for the robustly 
expressed PLN and the green fluorescent tubules could be detected (arrows in Fig.  5.8. D6) 
suggesting that a few contact points between the SR and the Bin1-EGFP induced tubules 
might have been present.  
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Fig.  5.7. Immunostaining for α-actinin in Bin1-EGFP expressing iCell-CMs. 
iCell-CMs overexpressing Bin1-EGFP (green; A1 and A4) were labelled with a primary 
antibody against α-actinin (A2 and A5) and the secondary antibody AlexaFluor 555 (red). 
Nuclei were stained with DAPI (blue). A4-A6 show a magnified view of the region outlined by 
the yellow box in A1-A3. Arrows in A6 show overlapping regions of α-actinin and Bin1-EGFP. 
Scale bars 20 µm. 
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For figure legend see page 172. 
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Fig.  5.8. Expression of Ca
2+
 handling proteins in Bin1-EGFP transfected iCell-CMs.  
iCell-CMs overexpressing Bin1-EGFP (green; A1, A4, B1, B4, C1, C4, D1 and D4) were 
labelled with primary antibodies against Cav1.2 (A2 and A5), RyR2 (B2 and B5), SERCA2a 
(C2 and C5) and PLN (D2 and D5). AlexaFluor 555 (red) was used as secondary antibody. 
Nuclei were stained with DAPI (blue). A4-A6, B4-B6, C4-C6 and D4-D6 display a magnified 
view of the region outlined by the yellow box in A1-A3, B1-B3, C1-C3 and D1-D3, 
respectively. Arrows in A6 and D6 show overlapping regions of Cav1.2 and Bin1-EGFP and 
PLN and Bin1-EGFP, respectively. Scale bars 20 µm. 
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5.3.2.4. Molecular analysis of Bin-EGFP expressing iCell-CMs via qRT-PCR 
Overexpression of Bin1-EGFP in iCell-CMs induced a strong upregulation of the Bin1 
expression level relative to non-transfected iCell-CMs (more than a 2x10
6 
-fold increase) and 
the adult heart control (more than a 8x10
4 
-fold increase; Fig. 5.9. A). However, the 
expression of the TT-associated genes Cav3, JP2 and Tcap in transfected cells did not 
change compared to non-transfected samples. The overexpression of Bin1-EGFP had also 
no effect on the expression of the key SR Ca
2+
 release and uptake proteins RyR2 and 
SERC2a, respectively, and the regulatory protein PLN but induced a minor increase in the 
expression of the SR proteins IP3R2 (increased by 1.7-fold) and CSQ2 (increased by 1.6-
fold; Fig. 5.9. B).  
Overexpression of Bin1-EGFP also increased the expression of the potassium channels 
Kir2.1 (2.8-fold increase) and Kv4.3 (3-fold increase; Fig. 5.9. C) and the cardiac transcription 
factor GATA4 (1.3-fold increase; Fig. 5.9. D). However, Bin1-EGFP did not alter the 
expression of Ca
2+
 channels such as Cav1.2 (Fig. 5.9. C) and structural proteins including α- 
and βMHC (Fig. 5.9. D).  
5.3.3. TEM analysis of transfected iCell-CMs 
For further structural analysis of the tubules induced in Bin1-EGFP transfected iCell-CMs the 
transfected cells were grown on sapphire discs, embedded in epoxy resin via a RT resin 
embedding method and sectioned to be analysed via transmission electron microscopy. The 
electron micrographs of transfected samples revealed that these cells had similar features to 
non-transfected cells (described in section 4.3.4.). Various cell organelles could be identified 
including myofibrils with a variable degree of organisation, mitochondria and the cell nucleus 
(Fig. 5.10. A). However, in contrast to non-transfected cells the transfected samples also 
revealed cells, which showed an abundance of tubular membrane structures (thick arrows in 
Fig. 5.10. A-B) with random orientation within the cell and a diameter of approximately 50 nm, 
which is similar to caveolae buds. Moreover, in a few cell sections the tubular structures 
appeared to be connected to the plasma membrane (thick arrows in Fig. 5.10. B). 
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Fig.  5.9. qRT-PCR analysis of iCell-CMs transfected with Bin1-EGFP. 
Displayed are mRNA expression levels of (A) TTs-associated proteins, (B) SR Ca
2+
 handling 
components, (C) ion channels and (D) structural proteins and general cardiac markers in 
iCell-CMs transfected with Bin1-EGFP. The gene expression levels from transfected iCell-
CMs were compared with the expression levels in non-transfected samples. Human foetal 
(FH) and adult heart (AH) tissue were used as controls. qRT-PCR data from iCell-CMs were 
obtained in triplicates (represent three independent culture preparations) and results from FH 
and AH in singlets, in n=2 different qRT-CR runs. All values were normalised with respect to 
GAPDH and shown relative to the corresponding values in AH (AH=1). Error bars represent 
±SEM. Statistical significance between the two means was determined using unpaired 
Student’s t-test (*p<0.05, **p<0.01, ***p<0.001).  
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Next, in order to confirm that the tubular membrane structures were associated with Bin1-
EGFP immunogold labelling was performed to tag Bin1 in transfected iCell-CMs. Adult rat 
cardiomyocytes immunogold labelled for α-actinin, which is expressed abundantly at the Z-
lines of sarcomeres, were used as control. The labelling was carried out on the epoxy resin 
sections of transfected iCell-CMs and adult rat cardiomyocytes, respectively, using primary 
antibodies against Bin1 and α-actinin, respectively, and secondary antibodies conjugated to 
10 nm gold particles. However, when analysing the samples via TEM no gold particles or 
only few gold particles showing non-specific binding (arrow in Fig.  5.11. A) could be detected 
in the cell sections of both transfected iCell-CMs (Fig.  5.11. A) and adult rat controls (Fig.  
5.11. B). This suggests that the immunogold-labelling protocol using resin sections was not 
successful. 
5.3.4. Measurement of cell capacitance and Ca
2+
 current 
In order to determine whether the Bin1-EGFP induced tubules altered the 
electrophysiological properties of iCell-CMs the whole-cell patch-clamping technique was 
used to measure the transmembrane Ca
2+
 current (ICa; in pA), which plays a key role in 
initiating ECC, and cell capacitance (in pF), which can serve as an index for the cell surface 
membrane area, in transfected and non-transfected (control) cells. All patch-clamp 
recordings were kindly conducted by James Cartledge, a PhD student within the cell 
electrophysiology group at the National Heart and Lung Institute, Imperial College London.  
The patch-clamp results revealed that compared to control iCell-CMs the membrane 
capacitance in transfected iCell-CMs was increased by almost 30 % (Fig.  5.12. A) indicating 
an enlarged surface membrane area in transfected cells. Furthermore, patch-clamp 
recordings showed that ICa density (obtained by normalisation of the peak ICa to the cell 
capacitance) was approximately 35 % larger in transfected iCell-CMs than in control cells 
(Fig.  5.12. B), suggesting an increased transmembrane Ca
2+
 flux in the transfected cells. In 
order to assess whether the measured Ca
2+
 current derived from L-type Ca
2+
 channels ICa 
was also measured in cells, which were perfused with nitrendipine (0.1 mM, 5 min), a blocker 
of L-type Ca
2+
 channels. The current recordings revealed that nitrendipine blocked ICa  
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Fig.  5.10. Electron micrographs of iCell-CMs transfected with Bin1-EGFP. 
iCell-CMs, which were transfected with Bin1-EGFP (A and B), displayed various cell 
organelles including mitochondria (M), randomly dispersed myofibrils (Myf) and a cell nucleus 
(N). The transfected samples also revealed an increased abundance of tubular membrane 
structures (A and B, thick arrows). B displays a magnified view of the region outlined by the 
yellow box in A. Arrows in B display tubular structures showing continuity with the cell plasma 
membrane. Scale bars 2 µm in A and 500 nm in B.  
 
 
Fig.  5.11. Immunogold labelling of transfected iCell-CMs and adult rat cardiomyocytes 
for Bin1 and α-actinin. 
Resin section of Bin1-EGFP transfected iCell-CMs (A) and adult rat cardiomyocytes (B) were 
labelled with anti-Bin1 (A) and anti-α-actinin (B), respectively, as primary antibodies, 
incubated with secondary antibodies conjugated to 10 nm gold particles and silver-enhanced. 
However, no specific immunogold labelling could be detected in A or B. Arrow in A shows a 
non-specifically bound gold particle. Z: Z-line. Scale bars 500 nm in A and 1000 nm in B.    
A B 
A B 
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almost completely (Fig.  5.12. C, grey curve). I-V curves depicting the ICa density-voltage 
relationship in control and transfected iCell-CMs (Fig.  5.12. C, red and blue curve) exhibited 
a bell-shaped pattern, which showed that the ICa density in these cells was voltage-
dependent with peaks at 5 mV and 10 mV, respectively. This reflects the voltage-dependent 
properties of L-type Ca
2+
 channels. In contrary, the ICa density obtained from nitrendipine-
treated cells remained close to 0 pA/pF across all depolarisation voltages. 
5.4. Discussion 
5.4.1. Effect of T3 on gene transcript expression in iCell-CMs  
In the present study qRT-PCR analysis was used to investigate the effect of T3 on cardiac 
gene expression in iCell-CMs. First, it was shown that both control and T3-treated iCell-CMs 
expressed high levels of THRα and low levels of THRβ and D3. This indicates that the 
receptors mediating the transcriptional effects of T3 were present in the cells and that the 
biological activity of T3 was not inhibited by degradation through D3. The high expression of 
THRα is in agreement with the literature as THRα is described to be the predominant 
receptor isoform in the heart, which in the absence of T3 represses (and bound to T3 
activates) the transcription of a number of genes including SERCA2a (Gloss et al., 2001). 
Second, the qRT-PCR results suggest that T3 treatment enhanced maturation of iCell-CMs in 
some measure as indicated by the shift of the expression of Kv4.3, SERCA2a and Cav3.1 
closer to the gene expression levels of adult heart controls. However, T3 did not alter the 
expression of other gene transcripts, which are implicated in TTs-development (e.g. Bin1 and 
Cav3) or mature Ca
2+
-handling (e.g. RyR2 and CSQ2). Most of these gene expression levels 
remained below adult levels. The increased expression of the hypertrophic marker ANP in 
T3-treated cells suggests that T3 promoted the hypertrophic growth of iCell-CMs, which is 
part of the normal cardiac maturation process. 
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Fig.  5.12. Cell capacitance and Ca
2+
 currents in iCell-CMs measured via the whole-cell 
patch-clamping method. 
The whole-cell patch-clamping technique was used to measure cell capacitance (A) and peak 
Ca
2+
 current (ICa) in control and Bin1-EGFP transfected iCell-CMs. ICa is displayed as ICa 
density (B), determined by normalisation of the peak Ca
2+
 current to the cell capacitance. ICa 
density-voltage relationship in control, transfected and nitrendipine-treated iCell-CMs is 
displayed in I-V curves (C). Error bars represent ±SEM. Statistical significance between the 
two means was determined using unpaired Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). 
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5.4.2. Staining for SERCA2a and labelling of the plasma membrane  
Immunofluorescence analysis of T3-treated iCell-CMs revealed that, despite the higher 
mRNA levels of SERCA2a, no difference in the strength of the fluorescence signal could be 
detected between T3-treated and untreated cells. Also, the increased expression of 
SERCA2a was not paralleled by a reorganisation of the SR towards a more mature 
sarcomeric structure. Furthermore, staining of the plasma membrane of T3-treated cells with 
CMO did not exhibit the presence of any TT invaginations. The fluorescent dots and streaks 
detected in both T3-treated and non-treated iCell-CMs may be due to membrane folds or 
contaminations. These results imply that T3 did not promote the structural maturation of iCell-
CMs.   
5.4.3. Bin1 transfection and immunofluorescence studies 
Bin1 can bind and invaginate cell membranes into narrow tubules and was linked to TT 
biogenesis (in skeletal muscle) (Takei et al., 1999; Farsad et al., 2001; Razzaq et al., 2001). 
The present study demonstrated that overexpression of Bin1-EGFP in iCell-CMs, which lack 
a TT system, resulted in the formation of green fluorescent tubular structures. 
Immunostaining of the transfected cells for Bin1 confirmed that Bin1 was localised 
continuously along these structures and positive staining of transfected cells with CMO 
implied that these tubules were connected to the cell plasma membrane. Collectively these 
results suggest that the overexpression of Bin1-EGFP induced the formation of plasma 
membrane invagination in iCell-CMs.  
The difficulties to detect the Bin1-induced structures via WGA-TRITC may be explained by a 
change in the glycosylation of the membrane in the nascent membrane tubules, which 
precluded the labelling with WGA-TRITC. Other investigators reported similar problems with 
WGA when labelling thin TTs in human cardiomyocytes (Crossman et al., 2011). 
A limitation of this study is the lack of additional robust controls. In addition to non-transfected 
iCell-CMs cells incubated with Lipofectamine 2000 only, an empty vector or a vector 
containing EGFP only should have been used as transfection controls to confirm that the 
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green fluorescent structures resulted exclusively from the expression of Bin1 and were not 
due to the expression of EGFP or the treatment with the transfection reagent Lipofectamine 
2000.  
5.4.4. Staining for Cav1.2 and SR Ca
2+
 handling proteins 
Hong and colleagues (Hong et al., 2010) reported recently that in addition to its potential to 
initiate membrane curvature Bin1 also recruits L-type Ca
2+
 channels to the Bin1-induced 
invaginations via interaction with the microtubule trafficking network. In the present study 
immunostaining for Cav1.2 in iCell-CMs, which overexpressed Bin1-EGFP, showed only poor 
co-localisation with the Bin1-induced tubular structures. However, regions of co-localisation 
of the Cav1.2-immunoreactive puncta with the green fluorescent tubules were visually difficult 
to identify because although Cav1.2 puncta were present abundantly in the cells they 
appeared very small (as already discussed in section 4.4.3.1.).   
In adult cardiomyocytes mature TTs are aligned approximately at the Z-lines of all myofibrils 
and are closely associated with the SR network. Immunostaining of transfected iCell-CMs for 
α-actinin and the SR proteins RyR2, SERCA2a and PLN aiming to reveal whether the Bin1-
EGFP-induced tubules were connected to myofibrils and the SR showed no continuous 
alignment with the green fluorescent tubules. However, in cells stained for α-actinin and the 
abundantly expressed protein PLN a few co-localisation foci could be detected, which 
suggest that the Bin1-EGFP induced membrane invaginations might have been associated at 
some regions with the contractile apparatus and the SR. In order to confirm the spatial 
coincidence of both Cav1.2 with Bin1 and PLN with BIN1 additional studies (e.g. TEM with 
double immune-gold labelling) are required. Furthermore, iCell-CMs transfected with Bin1-
EGFP were usually analysed 48 h after transfection. However, longer incubation times may 
deliver more conclusive results with regards to the localisation of Cav1.2 at the Bin1-EGFP 
tubules.  
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5.4.5. qRT-PCR result in transfected iCell-CMs 
qRT-PCR analysis of the mRNA expression profile in transfected iCell-CMs showed that the 
expression of Bin1 was substantially higher in transfected iCell-CMs compared to control 
iCell-CMs and foetal and adult heart controls. This confirms that the transcription of the Bin1-
EGFP plasmid was highly active within the transfected iCell-CMs.   
Furthermore the qRT-PCR results revealed that overexpression of Bin1-EGFP was 
associated with a relatively strong increase in the expression levels of the potassium 
channels Kir2.1 and Kv4.3 and a minor increase in the expression levels of the cardiac 
transcription factor GATA4, the Ca
2+
 channel IP3R2 and the SR Ca
2+
 binding protein CSQ2. 
The overexpression of Bin1-EGFP did not alter the expression of any TT-associated genes 
(except Bin1), other major SR Ca
2+
 handling proteins including RyR2 and SERCA2a or any 
structural genes such as α- and βMHC.  
Also, as discussed previously all samples (non-transfected and transfected with Bin1-EGFP) 
were normalised to GAPDH. However, to exclude that transfection using Lipofectamine or the 
overexpression of Bin1-EGFP may have affected the expression of GAPDH in transfected 
iCell-CMs future qRT-PCR experiments should include additional controls: (a) additional 
housekeeping genes (e.g. β-actin and ribosomal RNA 18S); (b) iCell-CMs treated with 
Lipofectamine only or cell samples transfected with a vector expressing for example EGFP 
only. 
5.4.6. Analysis via transmission electron microscopy 
Although the culture of iCell-CMs on transparent sapphire discs allowed the detection of 
transfected cells, which expressed Bin1-EGFP, via immunofluorescence microscopy it was 
not possible to distinguish between transfected and non-transfected iCell-CMs on cell resin 
sections via electron microscopy. However, the high abundance of membrane tubules was 
found only in cell sections of transfected samples, which indicates that the membrane 
structures were associated with the expression of Bin1-EGFP. 
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The attempt to label Bin1 on the cell resin sections via immunogold labelling in order to 
confirm that Bin1 was localised at the detected tubules was not successful. This was 
presumably due to the labelling protocol since the immunogold labelling of control adult rat 
cardiomyocytes for the sarcomeric α-actinin was not successful either. The immunogold 
labelling was performed directly on epoxy resin sections of transfected iCell-CMs and adult 
rat cardiomyocytes. However, it is reported that immunogold labelling of epoxy resin sections 
might be inefficient due to co-polymerisation of epoxy resins with the antigens (Brorson et al., 
1999). Due to time restrictions an alternative labelling protocol, in which the samples are for 
example immunogold labelled before resin embedding, could not be evaluated.  
The diameter of the detected membrane tubules in the captured TEM images of transfected 
iCell-CMs was approximately 50 nm. This diameter size is in line with the data of another 
study (Lee et al., 2002), which demonstrated tubules formation in Bin1-GFP transfected 
Chinese hamster ovary (CHO) cells, but is considerably smaller than the average diameter of 
TTs in adult cardiomyocytes [400 nm (Jayasinghe et al., 2011)]. However, iCell-CMs are 
immature and thin compared to adult cardiomyocytes (as shown in the previous chapter) thus 
the Bin1-EGFP induced tubules might widen with further maturation and hypertrophic growth 
of the cells. 
5.4.7. Measurement of cell capacitance and ICa density 
The whole-cell patch-clamp studies demonstrated that the membrane capacitance and the 
ICa density were significantly increased in iCell-CMs, which had been transfected with Bin1-
EGFP and showed tubule structure formation. The increased membrane capacitance, which 
may be proportional to the cell membrane surface area, supports the evidence that the 
tubules formed in transfected iCell-CMs were connected to the cell plasma membrane thus 
resembling at least structurally TTs in adult cardiomyocytes.   
The increase in ICa density, which is inversely correlated with the membrane capacitance, 
indicated that the formation of the tubules in Bin1-EGFP transfected cells did not only 
increase the plasma membrane surface area but was also accompanied by an increase in 
the number of functional L-type Ca
2+
 channels within the plasma membrane (e.g. via 
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increased gene expression) or an upregulation in channel activity in transfected cells. Given 
that Hong and colleagues (Hong et al., 2010) described that Bin1 can target L-type Ca
2+
 
channels to Bin1-induced membrane invaginations the increased ICa density in transfected 
iCell-CMs implies that L-type Ca
2+
 may have been recruited to the Bin1-EGFP induced 
tubules and contributed to the ICa current in transfected cells.  
5.5. Conclusion 
5.5.1. Effect of T3 on iCell-CMs 
T3 treatment enhanced maturation of iCell-CMs, as measured by a shift in the gene 
expression of various ion channels and SERCA2a, closer to the expression levels of adult 
heart controls. However, T3 treatment did not alter the expression of other genes, which are 
implicated in mature Ca
2+
 handling (i.e. RyR2, CSQ2) or TTs-development (e.g. Bin1 and 
Tcap). Also, T3 did not induce any TT formation in iCell-CMs.   
5.5.2. Overexpression of Bin1-EGFP in iCell-CMs 
Overexpression of Bin1-EGFP in iCell-CMs induced the formation of membrane 
invaginations, which were reminiscent of TT investigations in adult cardiomyocytes. Although 
immunostaining for Cav1.2 did not indicate clearly that L-type Ca
2+
 channels co-localised with 
the Bin1-EGFP tubules the increased ICa densities measured in transfected cells implied that 
L-type Ca
2+
 channels may have been targeted to the nascent tubules and contributed to the 
cell calcium current. qRT-PCR showed that overexpression of Bin1-EGFP did not alter the 
expression of other TT-associated genes or major SR Ca
2+
 handling components.   
Collectively these results show that T3-treatment and overexpression of Bin1-EGFP, 
respectively, enhanced the maturation of iCell-CMs in some measure but seemed not to be 
sufficient to generate a fully mature phenotype.  
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Fig.  5.13. Diagram summarising major results of chapter 5. 
CMs: cardiomyocytes, ICa: Ca
2+
 current, IF: immunofluorescence microscopy, T3: 
triiodothyronine, TEM: transmission electron microscopy, TTs: transverse tubules.  
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6.1. Factors limiting the use of hPSC-CMs 
hPSCs, which include hESCs and hiPSCs, have the capacity for self-renewal and can 
differentiate into almost any cell type of the human body (Thomson, 1998; Takahashi et al., 
2007). Thus they can potentially represent a renewable source of human cardiomyocytes. 
Cardiomyocytes derived from hPSCs could have a variety of applications. They could serve 
as normal cardiac cell models or models of cardiac congenital diseases to study normal 
cardiac development or the pathobiology of cardiac conditions and may eventually replace 
animal models currently used to investigate drug efficacy and cardiac side-effects (Harding et 
al., 2007). hPSC-CMs have also the potential to be used in future in cell-based therapies to 
regenerate damaged heart tissue (Robinton and Daley, 2012). However, for the extensive 
use of hPSC-CMs in pharmacology and in clinical applications there are several limitations to 
overcome. 
First, the culture conditions of hPSCs needs to be further optimised. Most of the hESC and 
hiPSC lines are currently routinely maintained as monolayers on mouse feeders (Thomson, 
1998; Reubinoff et al., 2000) or on Matrigel (Xu et al., 2001; Ludwig et al., 2006a). However, 
the maintenance and expansion of MEFs are laborious, time consuming and hamper the 
scale up of hPSC cultures and animal components in MEFs and Matrigel might limit the use 
of hPSCs in regenerative medicine. However, although much progress has been made to 
develop fully defined, xeno-free culture components [e.g. chemically defined, xeno-free 
culture media and synthetic growth matrices (Villa-Diaz et al., 2013)] a standard widely 
excepted culture method for hPSC lines has not been determined yet, which hampers the 
development of standard differentiation protocols. Also, culture protocols published for some 
lines are often challenging to adapt for other lines (Denning et al., 2006; Allegrucci and 
Young, 2007).  
Second, the cardiac differentiation protocols need to be improved. The introduction of 
directed cardiac differentiation methods, which employ signalling pathways 
(Activin/Nodal/TGFβ, Wnt and BMP) known to drive cardiogenesis have greatly improved the 
efficiency of cardiac differentiation (approximately up to 50 %) (Laflamme et al., 2007; Paige 
et al., 2010). However, it is still not possible to generate pure and lineage-specific cardiac 
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populations. The differentiated cultures typically contain heterogeneous populations of 
different cardiomyocytes subtypes (ventricular, nodal and atrial) and other non-cardiac cell 
types. To obtain relatively pure cardiomyocyte populations, which are for example desirable 
for accurate and consistent drug testing, an additional enrichment step is required (Xu et al., 
2002; Huber et al., 2007). Furthermore, there can be significant line-to-line-variability with 
regards to the efficiency of a cardiomyocyte differentiation protocol (Osafune et al., 2008; 
Pekkanen-Mattila et al., 2009). This may be an issue particularly for the generation of 
cardiomyocytes from different patient-specific hiPSC lines. 
Third, the maturity of hPSC-CMs needs to be enhanced. hPSC-CMs show initially immature 
structural and functional characteristics, which resemble more foetal than adult 
cardiomyocytes (Snir et al., 2003; Liu et al., 2007a; Gherghiceanu et al., 2011). For a safe 
application in potential cell-based therapies, reliable prediction of drug efficacy and toxicity 
hPSC-CMs need to be matured towards a more adult-like phenotype. Although, to some 
extent, maturation of hPSC-CMs occurs during prolonged in vitro culture (Snir et al., 2003; 
Sartiani et al., 2007; Lundy et al., 2013) and a number of pro-maturation approaches have 
been already evaluated by various research groups (described in section 1.6.1), the 
establishment of a fully adult-like phenotype has not been observed yet.  
This study focused on the assessment of two alternative pro-maturation approaches: 
administration of T3, which is described to play an important role in cardiac development and 
maturation (Klein and Ojamaa, 2001; Pantos et al., 2008), and overexpression of Bin1(-
EGFP), which has been reported to initiate membrane curvature in skeletal muscle and 
suggested to be involved in TT biogenesis (Lee et al., 2002). 
For studying the effect of the pro-maturation stimuli initially cardiomyocytes were generated 
by differentiating the Shef3 hESC line. However, due to the inefficiency of cardiac 
differentiation of the Shef3 line all maturation studies were performed on the commercially 
produced iCell-CMs (hiPSC-CMs). In the following paragraphs the most important findings 
and limitation of this study will be discussed and future directions highlighted.   
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6.2. Adaptation of hESC lines to feeder-free culture 
conditions 
The Shef3 hESC line was originally derived and routinely maintained on mouse feeders 
(Draper et al., 2004). In this study considerable effort was applied to adapting Shef3 hESCs 
to feeder-free culture with the target to overcome the limitations associated with the handling 
of MEFs (tedious maintenance, difficulties of culture scale-up) and the aim to evaluate 
directed cardiac differentiation methods, which require feeder-free conditions. 
The Shef3 line was transferred on Matrigel in MEF-conditioned medium, which had been 
prepared beforehand in our laboratory, and the commercially available culture medium 
mTeSR1 and NutriStem, respectively. However, long-term feeder-independent culture of 
Shef3 could only be established in mTeSR1. Neither MEF-conditioned medium nor NutriStem 
supported the undifferentiated growth of Shef3 hESCs long-term.       
An explanation as to why stable long-term culture of Shef3 hESCs could not be established 
in MEF-conditioned medium may lie in the quality of the medium. First, the latter highly 
depends on the density of MEFs used for conditioning. In this study the density of MEFs 
(80000 cells/cm
2
) corresponded to values, which were used for feeder-free culture of the H7 
line in our laboratory at Imperial College. It is possible, however, that this density was not 
high enough for the feeder-free maintenance of the Shef3 line. Future culture set-ups with 
medium conditioned by higher MEF-densities may elucidate this point. Second, MEF-
conditioned medium is not defined and prone to significant batch-to-batch variability, which 
also may have interfered with the undifferentiated growth of Shef3 hESCs. Second, the 
quality of the MEF-conditioned medium may have been affected by the freeze-thaw cycle of 
the medium (it was frozen/thawed once and stored at -80 °C), which could have destroyed 
several cytokines, and the use of mitomycin C for the inactivation of MEFs prior to 
conditioning. Recent studies indicate that different inactivation methods such as treatment 
with mitomycin C and γ-irradiation have a different impact on the metabolic activity of MEFs 
and their expression of cytokines and ligands, which are important for the undifferentiated 
growth of ESCs (Roy et al., 2001; Fleischmann et al., 2009). Although mitomycin C treatment 
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of MEFs and freezing of MEF-conditioned medium have been used routinely within our 
laboratory when preparing conditioned medium for the feeder-free propagation of the H7 line 
the initial adaptation of the Shef3 line to feeder-free conditions may require the use of γ-
irradiated MEFs and freshly prepared MEF-conditioned medium. Finally, MEF-conditioned 
medium is not defined and prone to significant batch-to-batch variability, which also may 
have interfered with the undifferentiated growth of Shef3 hESCs. 
In contrast to MEF-conditioned medium, mTeSR1 and NutriStem are both chemically fully 
defined and principally do not show the quality variations associated with MEF-conditioned 
medium. However, although it is known that both media contain growth factors, which trigger 
bFGF and TGFβ signalling pathways to sustain undifferentiated growth of hPSCs, the 
specific combination and concentration of all components is proprietary. The difficulties to 
adapt the Shef3 line to a feeder-free culture in MEF-conditioned medium and NutriStem and 
the successful adaptation to mTeSR1 may be also explained by both the specific composition 
of the different media and intrinsic properties of the Shef3 line. It is reported that each hESC 
line has a unique gene expression signature showing distinct expression levels for a variety 
of genes (Abeyta et al., 2004; Skottman et al., 2005). In particular potential differences in the 
expression levels of bFGF and TGFβ receptor subtypes and key cell adhesion factors [e.g. 
integrins (Meng et al., 2010)] may lead to distinct factor requirements of different hESC lines 
for undifferentiated growth in culture. Thus some media formulations may be more suitable 
than others for the maintenance of a particular hESC line.  
Furthermore, the transfer of hPSCs to different culture conditions is often challenging 
because it is generally a stressful event for the cells. Recently, it was shown that the transfer 
to a feeder-free culture is associated with considerable changes in gene transcription and 
DNA methylation in hESCs as the cells adapt to the new culture conditions (Tompkins et al., 
2012).  
Data on unsuccessful attempts to adapt an hPSC line to feeder-independent culture are 
generally scarce in the literature. As far as our laboratory is concerned, apart from the Shef3 
line we also encountered difficulties to adapt the H7 line (WA07), which was purchased from 
WiCell Research Institute (Madison, USA), to a long-term Matrigel-culture in MEF-
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conditioned medium (data not published) although the H7 hESCs, which were provided by 
Geron Corporation (Menlo Park, CA), were maintained on Matrigel in MEF-conditioned 
medium routinely in our laboratory. This finding indicate that even the same cell line but 
cultured in different laboratories can behave differently in altered culture conditions.  
Moreover, a recent study by the International Stem Cell Initiative Consortium (Akopian et al., 
2010) compared the potential of eight different published, defined culture media (including 
mTeSR1 and StemPro) in combination with Matrigel or other substrates to support the 
feeder-free culture of several hESC-lines, which were previously maintained on mouse 
feeders. The results of the study revealed that only the commercially prepared media 
mTeSR1 and StemPro supported the undifferentiated proliferation of most tested hESC lines 
long-term. These results highlight that adaption of different hESC lines to feeder-free 
conditions is not straight-forward and also that commercially prepared media, which undergo 
extensive testing and quality controls, are usually superior in the maintenance of hPSCs in a 
feeder-free culture system.        
6.3. Challenges to reproduce cardiac differentiation 
protocols 
In the present study various published cardiac differentiation approaches were evaluated for 
the Shef3 hESC line: the conventional EB differentiation method, which relies on 
spontaneous differentiation in serum (Itskovitz-Eldor et al., 2000); directed cardiac 
differentiation of cell monolayers with activin A/BMP4 based on the protocol by Laflamme and 
colleagues (Laflamme et al., 2007); and directed cardiac differentiation of AggreWell-formed 
EBs with APEL medium and a combination of growth factors (Stemcell Technologies, 2012b). 
Overall, for all applied methods the Shef3 line exhibited low cardiac differentiation propensity.  
Beating clusters of Shef3-CMs could be successfully produced via the conventional EB 
formation method but at 8-10 % the proportion of EBs containing contracting clusters was low 
compared to studies, which reported to produce beating clusters in 10-70 % of EBs (Xu et al., 
2002; He et al., 2003). Similarly, there were difficulties with the Shef3 line to reproduce the 
Chapter 6: General discussion 
 
191 
 
high yield of cardiomyocytes and beating clusters reported for the directed cardiac 
differentiation protocols by Laflamme et al. and Stemcell Technologies (Laflamme et al., 
2007; Stemcell Technologies, 2012b). The success of the directed cardiac differentiation 
method by Laflamme et al. seemed at least partially to depend on culture conditions. Directed 
differentiation of Shef3 hESCs, which were routinely propagated on feeders but transferred 
on Matrigel and exposed to MEF-conditioned medium shortly before induction of 
differentiation with activin A, produced spontaneously contracting clusters, albeit with low 
efficiency. In contrast, directed differentiation of Shef3 cells, which were adapted to long-term 
Matrigel culture in mTeSR1 medium, did not generate any contracting clusters when using 
the protocol by Laflamme et al. The influence of culture conditions on the differentiation 
potential of hPSC lines has been also observed by others and was evaluated in the study by 
Ojala and co-workers (Ojala et al., 2012). Although, Ojala et al. used other hPSC lines (H7 
and four hiPSC lines) and another cardiac differentiation method (co-culture with END-2) it is 
interesting to note that the authors observed that cells cultured on feeder layers showed the 
highest and cells cultured on Matrigel in mTeSR1 showed the lowest cardiac differentiation 
potential.  
The second directed cardiac differentiation protocol, which was evaluated for the Shef3 line 
in this study, was developed by Stemcell Technologies and described to be highly efficient for 
mTeSR1-cultures of H7 and H9 (Stemcell Technologies, 2012b). This method was a novel 
protocol at the time introduced by Stemcell Technologies, and has not been extensively 
evaluated by other independent research groups yet. However, this method did not generate 
any contracting clusters with the Shef3 line, although the line was well adapted to mTeSR1 
medium.  
A possible explanation for failing to reproduce a specific differentiation protocol in an 
individual hESC line may also lie in line-intrinsic properties. As discussed in the introduction, 
individual hPSC lines show transcriptional and epigenetic variations, which may lead to 
different propensities to differentiate into cardiomyocytes and other cell types (Allegrucci and 
Young, 2007; Osafune et al., 2008). A limitation of this study is that no other hESC line, 
which was grown on Matrigel in mTeSR1 medium, was available in our laboratory at the time 
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of the differentiation studies to repeat the differentiation protocol. This may have shed light 
whether the difficulties to adapt the differentiation protocol provided by Stem Cell 
Technologies was associated with intrinsic characteristics of the Shef3 line.        
Furthermore, a key issue for the efficient cardiac differentiation is cardiac mesoderm 
formation. The induction of cardiac differentiation in PSCs via treatment with growth factors, 
which mediate mesoderm formation such as activin A, BMP4, bFGF and DKK1 (see section 
1.3.1.), is crucially dependent on the concentration of these growth factors and the timing of 
their addition and removal, respectively because each step in the process of mesoderm 
formation (and further mesoderm specification and cardiomyocyte formation) requires its own 
growth factor combination and concentration. However, the endogenous signalling can vary 
between different PSC lines or even between different passages of the same line so that the 
optimal concentration and timing of the added factors driving mesoderm formation may need 
to be determined for each individual PSC line (Paige et al., 2010; Kattman et al., 2011). 
Optimisation of the directed cardiac differentiation methods for the Shef3 line was not 
performed in this study due to time restraints of the project.  
Another reason for the poor differentiation of Shef3 hESCs into cardiomyocytes may have 
been that the Shef3 cells lost their pluripotent state with prolonged culture on iMEFs and 
Matrigel, respectively. Although the pluripotency of Shef3 hESCs was confirmed at early 
culture passages via immunostaining against various pluripotency markers (Oct4, SSEA4 
and Tra-1-60) it was not tested prior to the induction of cardiac differentiation. In future 
experiments a more rigorous testing of pluripotency markers at different Shef3 passages and 
immediately prior to cardiac differentiation is required.  
Finally, it is noteworthy that it has been recently demonstrated that cardiac-like cells can be 
induced directly from mouse fibroblasts by overexpression of only three cardiac 
developmental transcription factors (Gata4, Mef2c, and Tbx5) (Ieda et al., 2010) or via brief 
overexpression of the reprogramming factors Oct4, Sox2, Klf4 and c-Myc (Takahashi and 
Yamanaka, 2006) and subsequent exposure to cardiogenic medium (includes BMP4) (Efe et 
al., 2011). These reprogramming strategies do not require the formation of iPSCs beforehand 
or the establishment of any further cardiac differentiation protocols and could represent an 
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alternative method for the generation of cardiomyocytes for therapeutic applications. 
However this approach is still in the early development stage and requires extensive 
characterisation.  
6.4. The importance of hPSC-CM maturation in vitro 
For initial characterisation of iCell-CMs and subsequently for the assessment of the effect of 
the maturation stimuli on the cells the molecular, structural and electrophysiological features 
of iCell-CMs were analysed using a broad spectrum of approaches including qRT-PCR, 
bright field and immunofluorescence microscopy, TEM, MEA and whole-cell patch-clamping 
technique. In addition, the characteristic features of the generated Shef3-CMs were analysed 
via immunostaining and MEA. In line with the studies, which describe early-stage hPSC-CMs 
as being largely immature (Snir et al., 2003; Liu et al., 2007a; Gherghiceanu et al., 2011), the 
characterisation studies conducted in this project showed that Shef3-CMs and iCell-CMs 
displayed principally immature, foetal-like structural features: They contracted spontaneously; 
were smaller and flatter relative to adult cardiomyocytes; showed poor ultrastructural 
organisation with low myofibril density and alignment; did not possess a TT network and the 
SR showed variable degrees of sarcomeric organisation. In addition, it was shown for iCell-
CMs that they displayed relatively low expression of key ion channels (Kir2.1 and Kv4.3), 
Ca
2+
 cycling proteins (RyR2, IP3R2 and CSQ2) and genes implicated in TT formation or 
maintenance (Bin1, Cav3 and Tcap). Electrophysiological studies, however, demonstrated 
that the contraction of iCell-CMs seemed to depend on Ca
2+
 release from the SR stores as 
seen in adult cardiomyocytes although the presence of RyR2/Cav1.2 couplons in iCell-CMs 
could not be definitely confirmed via immunolabelling. We do not have a conclusive 
explanation for these contradictory results. However, as discussed in section 4.4.3.1. the 
difficulties to detect Cav1.2/RyR2 couplons may be due to the relatively weak fluorescent 
signal of the RyR2 staining and the punctate expression pattern of Cav1.2, which make the 
detection of any co-localisation of the two proteins difficult. Both the presence of Cav1.2/ 
RyR2 calcium release units and the contribution of SR Ca
2+
 to cell contraction should be 
verified in additional experiments.  
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The double-labelling for RyR2 and Cav1.2 in iCell-CMs could be repeated at higher antibody 
concentrations and with a different set of antibodies. The role of SR Ca
2+
 may be further 
explored by measuring Ca
2+
 transient amplitudes in iCell-CMs treated with ryanodine, an 
inhibitor of RyR2, or nitrendipine, a specific inhibitor of L-type Ca
2+
 channels. If Cav1.2/ RyR2  
couplons are present in iCell-CMs and the SR Ca
2+
 release contributes substantially to cell 
contraction the Ca
2+
 transient amplitudes should be significantly reduced by ryanodine and 
nitrendipine, respectively.   
hPSC-CMs including iCell-CMs (Cellular Dynamics International, 2012a) are advocated as 
suitable test systems for drug discovery and drug toxicity investigations. However, their 
immature phenotype raises doubts about whether they represent an accurate cardiac cell 
model (Burridge et al., 2012). Furthermore, although it was reported that both hESC-CMs 
and hiPSC-CMs respond to a variety of pharmacological agents and are sensitive to β-
adrenergic stimulation (Rajamohan et al., 2012) our group recently observed, that hESC-CMs 
and hiPSC-CMs (including Shef3-CMs and iCell-CMs) respond differently to hypertrophic 
stimuli (results in print). For example, treatment with the α-adrenergic receptor agonist 
phenylephrine increased the cell area and expression of the hypertrophic marker ANP in 
hESC-CMs but did not alter the cell area or ANP expression of hiPSC-CMs. This distinct 
responsiveness to phenylephrine may stem from different expression profiles of various G-
proteins, which are downstream targets of adrenergic signalling. 
With regard to potential applications of hPSC-CMs in regenerative medicine there are also 
concerns that the immature electrophysiology of the cells may lead to ineffective contractile 
force generation and induce arrhythmia when the cells are transplanted into diseased 
myocardium (Wah Siu et al., 2007). However, on the other hand immature cardiomyocytes, 
which rely on anaerobic glycolysis for their energy production (Porter et al., 2011), have been 
shown to be more resistant to hypoxic environment displaying better integration and survival 
potential than adult cardiomyocytes when engrafted into diseased heart (Boheler et al., 2011; 
Reinecke et al., 1999; Laflamme et al., 2005). Also, their maturation may occur in situ in the 
heart. Thus a fully mature phenotype of hPSC-CMs may not be advantageous for 
applications in cell-based therapies. In contrast, a high degree of maturity in hPSC-CMs is 
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desirable in pharmacological applications since it would increase the predictive potential of 
these cells in drug screening and toxicity assays.  
6.5. Concluding remarks: What is the best maturation 
strategy? 
This study has evaluated T3-treatment and forced expression of Bin1(-EGFP) as strategies 
to promote the maturation of iCell-CMs. The results indicate that both T3 and Bin1-EGFP 
promoted the maturation of the cells in some aspects.  
Treatment with T3 shifted the expression of a number of ion channels (Cav3.1 and Kv4.3) 
and SERCA2a towards adult expression levels and seemed to induce hypertrophic growth as 
evident by an increase in ANP expression, although further analysis of the cell size is needed 
to confirm hypertrophy. T3 did not have a detectable effect on SR organisation and did not 
induce TTs.  
Overexpression of Bin1-EGFP had a dramatic effect on the morphology of iCell-CMs by 
inducing numerous tubular invaginations in the sarcolemma. These were reminiscent of TT 
invaginations of adult cardiomyocytes but lacked continuous alignment to myofibrils and may 
have been linked to the SR only at few connecting points. Furthermore, although no clear co-
localisation of Cav1.2 and the Bin1-induced tubules could be detected via 
immunofluorescence analysis, the measured increase in the Ca
2+
 current density in Bin1-
EGFP transfected cells suggested that L-type Ca
2+
 channels may have been targeted to the 
Bin1-induced tubules as previously observed by Hong and colleagues (Hong et al., 2010). 
Overexpression of Bin1-EGFP was also shown to increase the expression of the ion 
channels Kir2.1 and Kv4.3, which are both preferentially localised in TT membranes (Clark et 
al., 2001; Deschenes et al., 2002), but surprisingly did not alter the expression of other TT 
associated genes Cav3, JP2 and Tcap. Generally, the expression levels of most genes after 
T3 administration or overexpression of Bin1-EGFP remained below adult heart controls and a 
number of genes (e.g. RyR2 and Kir2.1) remained also below expression levels in foetal 
heart cells. 
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One limitation of the transfection experiments in this study was the lack of alternative Bin1 
expression vectors. In this study a vector was used, which allowed the expression of Bin1 as 
a fusion to the C-terminus of EGFP. However, it is possible that the function of the Bin1-
protein was affected by the EGFP tag. In contrast, Hong and co-workers used in their study a 
fusion protein with Bin1 expressed to the N-terminus of EGFP or mCherry (Hong et al., 
2010). In order to exclude that the EGFP fusion affected the function of Bin1, future 
transfection studies should also be conducted with control vectors containing untagged Bin1 
or Bin1 expressed to the N-terminus of EGFP.   
Overall this study represents a comprehensive characterisation of the commercially available 
hiPSC-CM line iCell-CMs (early-stage) and has expanded our knowledge on the effect of T3 
and Bin1 in iCell-CMs. The answer to the question which of the presented strategies is the 
best approach to mature hPSC-CMs is probably that none of the strategies is better than the 
other. Similar to other published pro-maturation approaches (see section 1.6.1.; 3-D 
culturing, mechanical stretch, forced expression of Kir2.1 or CSQ2) T3-treatment and 
overexpression of Bin1-EGFP enhanced various cell features but none of the stimuli was 
sufficient to induce a fully mature phenotype in iCell-CMs. However, to our knowledge, the 
formation of TT-like structures, which are distinctive features of adult cardiomyocytes, has not 
been observed in hPSC-CMs in any other previous study.  
However, a strong limitation of this study was that the exact differentiation conditions of iCell-
CMs and the exact formulation of the iCell-CM Plating Medium (probably serum-containing 
medium) and the iCell-CMs Maintenance Medium are proprietary to CDI and not published. 
Thus it is not known whether the cells have not been already exposed to T3 or other factors, 
which may influence the development of the cell, during their differentiation or maintenance. 
Especially serum may contain a significant amount of T3. So, it is not clear whether this study 
has evaluated the full effect of T3 on hiPSC-CMs. 
Cardiac maturation is a complex process, which depends on a variety of factors and is not 
completely understood. The best maturation strategy would probably be a combination of 
various already evaluated approaches, which provide crucial physiological cues, which may 
be missing during in vitro culture. Thus, such comprehensive pro-maturation approach may 
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include electrical stimuli, mechanical workload, hypertrophic signals and 3-D culturing 
conditions because two-dimensional culture on a rigid matrix does not represent the native 
environment in the heart.    
Recently, the embedding of hPSC-CMs in 3-D constructs has been described (Caspi et al., 
2007b; Tulloch et al., 2011; Schaaf et al., 2011). These constructs aim to mimic the 
microenvironment in the heart (Zimmermann et al., 2006). They comprise a 3-D scaffold 
made of synthetic polymers or protein components of the heart’s ECM (e.g. fibronectin and 
collagen), in which hPSC-CMs can be co-cultured with other cell types such as fibroblasts, 
endothelial cells and stromal supporting cells, which are found in the heart.  
Co-culture and co-transplantation of PSC-CMs with endothelial cells and fibroblasts (with or 
without a 3-D matrix) have primarily shown to induce vascularisation in PSC-CM transplants 
and to improve survival and engraftment of the cell transplants in diseased myocardium 
(Kolossov et al., 2006; Caspi et al., 2007b; Tulloch et al., 2011). However, these cell types 
may play a bigger role in cardiomyocyte development, growth and maturation. Both 
endothelial cells and cardiac fibroblasts have been shown to secrete a variety of cytokines 
and growth factors (Narmoneva et al., 2004; Hsieh et al., 2006; Ottaviano and Yee, 2011) 
and cardiac fibroblasts, which are the most prominent cell type in the heart, have also been 
shown to couple electrically with cardiomyocytes forming a functional syncytium (Ottaviano 
and Yee, 2011). 
A novel strategy to engineer heart constructs is to repopulate decellularised heart tissue with 
neonatal cardiomyocytes or pluripotent stem cells and their derivates, respectively (Ott et al., 
2008; Ng et al., 2011; Lu et al., 2013). The main advantage of using decellularised heart 
scaffolds is that they preserve the 3-D native heart architecture including the complex ECM 
and various growth factors trapped within the ECM. Recently Lu et al. reported the 
engineering of functional human heart tissue by reseeding decellularised mouse hearts with 
hiPSC-derived multipotential cardiovascular progenitor cells (MCPs) (Lu et al., 2013). These 
early heart precursor cells were shown to proliferate and differentiate in situ into specialised 
cell types such as cardiomyocytes, smooth muscle and endothelial cells to reconstruct the 
decellularised hearts. As a result the repopulated mouse heart tissue generated mechanical 
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force by spontaneous contraction and was responsive to various pharmaceutical agents. 
However, the engineered heart constructs did not show full electrical synchronisation, the 
generated mechanical force was not sufficient to pump blood and the hearts exhibited a lack 
of fibroblasts. Lu and co-workers concluded that further studies will focus on enhancing the 
mechanical force and electrical synchronisation, which may be achieved by re-popularisation 
of the constructs with MCPs and fibroblasts. 
In combination with stretch and electrical stimulation, which have been already described for 
3-D constructs (Tulloch et al., 2011), synthesised or decellularised native heart scaffolds, 
which are populated with hPSC-derivates and other heart cell types including fibroblasts, may 
show to be the best strategy to obtain mature hPSC-CMs. Finally, such 3-D heart tissue 
constructs may reproduce the multicellular environment and even architecture of the heart 
and prove to be the most accurate cardiac models for pharmaceutical and clinical 
applications.  
6.6. Future directions 
The pro-maturation approaches T3-treatment and overexpression of Bin1-EGFP, which were 
evaluated in this study, were shown to promote the maturation of iCell-CMs, a hiPSC-CM 
line, to some measure but a fully mature adult-like cardiac phenotype was not reached. So, it 
is still an open question how to enhance the maturity of hPSC-CMs to release their full 
potential for applications in regenerative medicine and pharmacology.  
In addition, a number of further experiments may extend the observations made in this study:  
 Optimisation of directed cardiac differentiation protocols (according to the methods 
described by the Keller group) for Shef3 cultures on Matrigel may result in a more 
efficient cardiomyocyte differentiation. 
 Optimisation of the immunogold labelling protocol for TEM sections may confirm that 
the membrane structures, which were observed in iCell-CMs transfected with Bin1-
EGFP, were associated with the Bin1 protein.  
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 Assessment of the impact of T3 administration in other hiPSC-CM and hESC-CM 
lines generated and maintained in defined conditions without T3. 
 Overexpression of Bin1 in other hiPSC and hESC lines to confirm its tubulating 
effects and analyse possible co-localisation of Cav1.2 and the Bin1 structures.  
 Elucidate the signalling pathways regulating the transcription of Bin1, the 
overexpression of which was shown to be sufficient to induce TT-like structures. This 
may be beneficial for the development of future maturation strategies. 
 Analysis of the protein profile of iCell-CMs for example via mass spectrometry for 
further characterisation of the cells. 
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Appendix 
Reagents for qRT-PCR 
 
Tris borate EDTA (TBE) buffer  
1 l of 10x stock: 109.3 g Tris-(hydroxymethyl) methylamine, 55.65 g Boric acid, 9.31 g EDTA. 
10x stock was diluted 1:10 to 1x solution with dH2O.  
 
Reagents for transmission electron microscopy 
 
Sodium cacodylate buffer 
250 ml of 0.2 M stock solution, pH 7.4: 20.15 g sodium cacodylate trihydrate, 0.1 ml HCl (1 
M) and 250 ml dH2O. 
 
Glut-fixative  
20 ml containing 2.5 % glutaraldehyde in 0.1 M sodium cacodylate buffer: 10 ml 
gluteraldehyde (5 %), 5 ml sodium cacodylate buffer (0.2 M) and 5 ml dH2O.   
 
FA-fixative  
10 ml containing 4 % formaldehyde, 0.05 % gluteraldehyde in 0.2 M HEPES: 5 ml 
formaldehyde (8 %), 2 ml HEPES (1 M), 62.5 µl gluteraldehyde (8 %) and 2.94 ml dH2O. 
 
2 % OsO4 in 0.1 M phosphate buffer  
0.1 g tablet of OsO4 and 5 ml 0.1 M phosphate buffer. 
 
1 % thiocarbohydrazide in dH2O  
0.01 g thiocarbohydrazide in 1 ml dH2O. 
 
2 % OsO4 and 3 % potassium ferrocyanide mixture (1:1)  
0.03 g potassium ferrocyanide in 1 ml dH2O and 1 ml OsO4 (2 %) solution in dH2O 
 
0.5 % uranyl acetate in dH2O  
50 µl (10 %) uranyl acetate in methanol and 950 µl dH2O 
 
Blocking/permeabilisation buffer (0.5 % BSA, 0.1 % saponin, 50 mM) 
 1.4 g NH4Cl, 0.5 g saponin, 2.5 ml BSA and 497.5 ml dH2O.  
